Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42296,-0.232860940437215,0.00522172354062901,-0.243095518576847,-0.222626362297582,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.142101060262489,0.00338481981377696,0.135466813427486,0.148735307097491,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,41843,-0.58641332193696,0.0124793631575549,-0.610872873725768,-0.561953770148153,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.242225321244753,0.00511452989509089,-0.252249799839131,-0.232200842650375,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42137,-0.252441817569549,0.00440263474102886,-0.261070981661965,-0.243812653477132,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.306725631137911,0.00635732087705751,-0.319185980056943,-0.294265282218878,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.164302350380021,0.00395719926578405,-0.172058460940957,-0.156546239819084,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.342797157048885,0.0087858421846029,-0.360017407730706,-0.325576906367063,1.11260320844603e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42080,-0.166203137676436,0.00428898991821169,-0.17460955791613,-0.157796717436741,1.11328396813921e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.113610558877843,0.00302504853090436,0.107681463757271,0.119539653998416,8.73979817493702e-294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9,Complement component C9,39990,0.2181606516942,0.00592664904895642,0.206544419558246,0.229776883830155,2.2658039805635e-280
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42145,0.175839447019295,0.00498661413390264,0.166065683316846,0.185613210721744,1.12100851282242e-260
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.448836201586856,0.0131857465788596,0.422992138292291,0.47468026488142,7.346891636542e-244
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,39979,0.235513113177314,0.00714272905534035,0.221513364228847,0.249512862125781,8.5531877730413e-228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.288038632633542,0.00885160556068258,-0.30538777953248,-0.270689485734604,1.00343963773102e-223
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,39575,-0.336471519902144,0.0104024924443299,-0.356860405093031,-0.316082634711257,2.59578304126032e-219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42047,-0.237150135987588,0.00749518016239639,-0.251840689105885,-0.222459582869291,5.49366751107827e-212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0991418313830886,0.00316858483270609,-0.105352257655193,-0.0929314051109847,1.70884159446798e-207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.28725754363808,0.00919459210265718,-0.305278944159288,-0.269236143116872,6.30578486953675e-207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,39990,0.0844891636250415,0.0027051414262153,0.0791870864296595,0.0897912408204234,1.52804909451609e-205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.262787120565292,0.00854508363851843,-0.279535484496789,-0.246038756633796,1.08371389777564e-200
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.103499794483986,0.0033673892066211,0.0968997116390088,0.110099877328964,1.35403404394008e-200
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0988689019598612,0.00321678558605107,0.0925640022112011,0.105173801708521,3.46071115235642e-199
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.205116652466607,0.00682815772156705,-0.218499841600878,-0.191733463332336,7.04177449615861e-192
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.15102246229632,0.0050694207721815,-0.160958527009796,-0.141086397582844,5.47361909767583e-189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.123845297204069,0.00416962778700846,-0.132017767666606,-0.115672826741532,7.23970779660376e-188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.278289930750432,0.00949849000499194,-0.296906971160216,-0.259672890340648,5.7616726836738e-182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.190595372361853,0.00656727324834486,-0.203467227928609,-0.177723516795097,1.03559692533713e-179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42145,-0.191150895149966,0.00660992734217577,-0.20410635274063,-0.178195437559301,1.73677206503339e-178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0981740125156758,0.00339802472381156,-0.104834140974346,-0.0915138840570051,3.29779891709728e-178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0871789611160209,0.00305425287202125,-0.0931652967451825,-0.0811926254868592,4.73521265801405e-174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,41913,-0.247563151880633,0.00868516932180256,-0.264586083751366,-0.2305402200099,1.60194109439896e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.113015285392461,0.00397394731940035,0.105226348646436,0.120804222138485,6.85333979830691e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.100102691517505,0.0035506988796461,-0.107062061321612,-0.0931433217133989,5.08551604012671e-170
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,39649,-0.246651659520958,0.00875262933872909,-0.263806813024867,-0.229496506017049,8.68638128379297e-169
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.154217009873364,0.00559102093770905,-0.165175410911274,-0.143258608835454,5.54575594601632e-163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FURIN,Furin,42181,-0.0958077467426864,0.00348231230880122,-0.102633078867937,-0.088982414617436,3.32468117723794e-162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0980515399819407,0.00358131738076687,-0.105070922048244,-0.0910321579156377,1.07984796040576e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.134428160398924,0.0049402218172769,0.124745325637062,0.144110995160787,5.08976166009738e-158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.161494214984647,0.00596881832531939,-0.173193098902272,-0.149795331067021,2.82001094203112e-156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.410488160548302,0.0152867969652828,-0.440450282600256,-0.380526038496348,8.01952365033909e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.410326206204494,0.0154241095530931,-0.440557460928556,-0.380094951480431,5.65634290461269e-152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42089,-0.288661637718526,0.0108600646199347,-0.309947364373598,-0.267375911063454,9.02732919790195e-152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.331912714223718,0.0126880981905005,-0.356781386677099,-0.307044041770337,3.18570007066713e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.141566070496637,0.00541687742539763,-0.152183150250416,-0.130948990742857,5.74356333685686e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42296,-0.0796443883353534,0.00308206028407639,-0.0856852264921431,-0.0736035501785636,8.29113457828222e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.178469842933218,0.00690552812416159,-0.192004678056575,-0.164935007809862,9.95388597143585e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42123,-0.153115429328494,0.00596592296689662,-0.164808638343611,-0.141422220313376,6.97262302348488e-142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.229115086262341,0.00896666400327718,-0.246689747708765,-0.211540424815918,1.11207377741221e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.136710191616516,0.00535389943443382,-0.147203834508006,-0.126216548725026,1.97787640722441e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.231450139345367,0.00915709561189035,-0.249398046744672,-0.213502231946062,3.6493747980548e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41225,-0.110479037802668,0.00437983396903879,-0.119063512381984,-0.101894563223352,5.17327885070207e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.14717743239946,0.00596353560320918,-0.15886596218175,-0.13548890261717,1.44995332650703e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.142546446358538,0.00577579413228219,-0.153867002857811,-0.131225889859265,1.56041440862147e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0828481284491877,0.00336250823801836,-0.0894386445957037,-0.0762576123026717,3.50902187219739e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0835008763095701,0.00341759955316929,-0.0901993714337819,-0.0768023811853583,4.65405818826823e-129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.141004025992609,0.00578936060237563,-0.152351172773265,-0.129656879211953,3.15811681981423e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.153108270049028,0.00636524533621461,-0.165584150908008,-0.140632389190047,3.61697144320599e-125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42070,-0.198122166975027,0.00825919770372124,-0.214310194474321,-0.181934139475734,1.48973740850232e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,39468,0.107545604540525,0.00447278875500228,0.0987789385807205,0.116312270500329,1.64603263200054e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.174295619063892,0.00728492637985609,-0.18857407476841,-0.160017163359374,6.2860307053559e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0946361432734509,0.00395736564979001,0.0868797065998625,0.102392579947039,7.97432293406489e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.059707334592264,0.00250823862985212,-0.0646234823067742,-0.0547911868777539,9.58418211469503e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.11215427977897,0.0047439969846302,0.102856045689095,0.121452513868845,4.085606846501e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0772778260019566,0.00329561522513524,-0.0837372318432217,-0.0708184201606915,3.18434298242558e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0701796590254819,0.00300340682154123,-0.0760663363957027,-0.0642929816552611,1.93255282036606e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0802133593963281,0.00343247490427948,-0.0869410102087159,-0.0734857085839404,6.87301341246315e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0809260699679944,0.00348316693085764,-0.0877530771524754,-0.0740990627835134,4.13431493766256e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,39736,-0.0699164955486418,0.00300443922567005,-0.0758051964309552,-0.0640277946663285,5.24867156871546e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.210376490450136,0.00906844150040208,-0.228150635790924,-0.192602345109347,8.98850111880906e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.189255882427881,0.00817654850636804,-0.205281917500362,-0.173229847355399,7.55008492505027e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.206460643897436,0.00893624876627471,-0.223975691479335,-0.188945596315538,8.16073561495893e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42137,-0.0694334599649198,0.00300933114339859,-0.0753317490059811,-0.0635351709238586,1.45565701964671e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,41839,-0.129130056275341,0.00559890975402335,-0.140103919393227,-0.118156193157456,2.00207488921612e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0859662461637158,0.00373105841456819,-0.0932791206562695,-0.0786533716711621,2.91781538787522e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.188956868786652,0.00820717717803838,-0.205042936055607,-0.172870801517697,4.86388758556842e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0888662338870611,0.0038616930062988,-0.0964351521794067,-0.0812973155947154,5.83223420082711e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.19371306281341,0.00850167009686732,-0.21037633620327,-0.17704978942355,8.58445911688646e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42137,0.0649817314224538,0.00287516729799611,0.0593464035183814,0.0706170593265262,4.74614959323717e-111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.203089107523919,0.00903046716889411,-0.220788823174952,-0.185389391872887,5.52432755420755e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.116418749691956,0.00517809862315389,-0.126567822993338,-0.106269676390574,6.03215980910657e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.125144534728702,0.0056038349425004,-0.136128051216003,-0.114161018241401,1.65487814307493e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELN,Elastin,39958,-0.0824715052642696,0.00369541047383408,-0.0897145097929844,-0.0752285007355548,5.16856337885761e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42193,-0.077842778636797,0.00351401804431495,-0.0847302540036543,-0.0709553032699397,7.66306755951171e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.115270674523086,0.00521215079434696,-0.125486490080006,-0.105054858966166,1.79088395687333e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.119182294525259,0.00538955107218122,-0.129745814626735,-0.108618774423784,4.60711515278787e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFM,Afamin,39979,-0.0473364684784762,0.00214942125006361,-0.0515493341286009,-0.0431236028283515,2.70288916978228e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0659207013273543,0.00299810670271063,-0.0717969904646671,-0.0600444121900414,5.7722155729604e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42296,-0.0606476234685956,0.00278792153237718,-0.0661119496720549,-0.0551832972651363,3.52409413918327e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42199,0.0656586621652645,0.00301907422066412,0.0597412766927629,0.0715760476377662,4.09154237692201e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42194,-0.0714642655464411,0.00330260672487282,-0.0779373747271918,-0.0649911563656903,4.06450030327746e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0763822137825277,0.0035643739141401,0.0693960409108131,0.0833683866542423,3.11225030618107e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.11095837149446,0.0051745485974711,-0.121100486745503,-0.100816256243416,5.50102009008202e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.114041984089016,0.00532503286696052,-0.124479048508258,-0.103604919669773,9.54949862118978e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42199,-0.0415308327753993,0.00195283357775909,-0.0453583865878071,-0.0377032789629915,9.24939747732653e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0957092034540874,0.00450148480599522,-0.104532113673838,-0.0868862932343368,1.03484358130875e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.149688987940218,0.00703650525844017,-0.163480538246761,-0.135897437633675,1.65609284974755e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,39638,-0.14244226625078,0.00672286322513552,-0.155619078172045,-0.129265454329514,1.07621696240049e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.121379802402695,0.0057574753557867,0.110095150705354,0.132664454100037,4.41998467837346e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42129,0.397283477055914,0.0189454194953382,0.360150454845051,0.434416499266777,4.14690828067491e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.113933654277108,0.00545147605251405,-0.124618547340036,-0.103248761214181,1.67030849257787e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,39862,-0.0553792483530389,0.00264537203122393,-0.0605641775342378,-0.05019431917184,1.69364724939216e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0614750171371998,0.00294275662338505,-0.0672428201190345,-0.0557072141553651,4.31661080984638e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0752260160649095,0.00360904711434636,-0.0822997484090284,-0.0681522837207906,5.52339932524462e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.23674461025335,0.0113840174031765,-0.259057284363575,-0.214431936143124,1.42372606934727e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.168970254086114,0.00811662187789629,-0.184878832966791,-0.153061675205438,1.7313306526655e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.076371664556551,0.00368018106612257,-0.0835848194461513,-0.0691585096669508,3.28003062532622e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0579804856676247,0.00279519437025633,-0.0634590666333271,-0.0525019047019223,8.09658247093847e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42239,-0.0443531672133669,0.00215073521740107,-0.048568608239473,-0.0401377261872608,4.52168249628098e-93
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.126580978912345,0.00614960097515358,-0.138634196823646,-0.114527761001044,1.03511058434928e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0491552101505572,0.0023994147363799,-0.0538580630338618,-0.0444523572672526,6.93987724047449e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.131974910757316,0.0064441148448707,0.11934444566137,0.144605375853263,7.69970559433282e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42310,-0.110106702015856,0.00538132849707725,-0.120654105870127,-0.0995592981615844,1.1187091815998e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0857400050460806,0.0041846502027057,-0.0939419194433837,-0.0775380906487774,1.31028412958163e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0797114463430595,0.00391812376083764,0.0720319237718178,0.0873909689143013,1.14372864070074e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0716153649682789,0.00352363089190224,-0.0785216815164073,-0.0647090484201505,1.68558336304629e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.113937194461663,0.00561518241272939,-0.124942951990613,-0.102931436932713,3.39106299508822e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.19764738552216,0.00977557423211866,-0.216807511017113,-0.178487260027208,1.48412573948793e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.123287410139132,0.00613030862620731,-0.135302815046498,-0.111272005231766,1.13002611840766e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42296,-0.0972355798353943,0.00485061598552205,-0.106742787167018,-0.0877283725037711,3.99544590216657e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.116825233255564,0.00584954734205324,-0.128290346045988,-0.105360120465139,1.89823210011274e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.262986700969439,0.0131988286423259,-0.288856405108397,-0.23711699683048,4.24414403450183e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0792171270330951,0.00397673976613732,-0.0870115369747242,-0.0714227170914659,4.74440972818512e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.122498820951114,0.00614716031768838,-0.134547255173784,-0.110450386728445,7.79648319885899e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.169620181521902,0.00858174877318637,-0.186440409117348,-0.152799953926457,9.69166425999511e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.151565271906062,0.00770482389940057,-0.166666726748887,-0.136463817063237,5.95709357819806e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.112223977838214,0.00571418055296478,-0.123423771722025,-0.101024183954403,1.94519882105201e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEP,Leptin,42145,-0.145603681784476,0.00743447994345582,-0.16017526247365,-0.131032101095303,3.03050166497494e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0442178508950432,0.00226588186917928,0.0397767224314519,0.0486589793586346,1.1345446399823e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,39966,0.11982960061482,0.00613659506591771,0.107801874285621,0.131857326944019,1.50114352765075e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.088884917814163,0.00457246261058747,-0.0978469445309145,-0.0799228910974116,4.7864781090212e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.11522960024526,0.00594845781227562,-0.12688857755732,-0.1035706229332,1.83548142889005e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.141689280488559,0.00735002344598711,-0.156095326442694,-0.127283234534424,1.01928410024554e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,39802,-0.0482525930736303,0.00250292733502515,-0.0531583306502796,-0.043346855496981,1.69020405390515e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0685583458517544,0.00357234714077317,-0.0755601462476698,-0.0615565454558389,5.07005566573662e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0712362275984783,0.00370854923391098,-0.0785049840969439,-0.0639674711000128,5.96892279523726e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.109316637233065,0.00570093599934295,-0.120490471791777,-0.0981428026743526,1.1266323055257e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,39736,-0.13210548359647,0.00689996954244407,-0.145629423899661,-0.11858154329328,2.04080979341846e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42296,-0.0623275096048009,0.0032702759122625,-0.0687372503928354,-0.0559177688167664,5.99953528147451e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0594415956040299,0.00311593354295166,-0.0655488253482152,-0.0533343658598447,6.95979080602559e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.10093463671638,0.00529927364889393,0.0905480603645475,0.111321213068212,1.21227625912543e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.139626370472626,0.00733411088047699,-0.154001227798361,-0.125251513146891,1.57138932189874e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.122021309108229,0.00642156017333188,-0.134607567047959,-0.109435051168498,1.75401817121973e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.147143806193477,0.00777031905339372,-0.162373631538129,-0.131913980848825,9.24387154434728e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42152,-0.0662149418005677,0.0035030580688797,-0.0730809356155719,-0.0593489479855635,1.12473489864555e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.113743905657996,0.00603147010167043,-0.12556558705727,-0.101922224258722,3.9281686261896e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0437947410081267,0.00232343054397444,-0.0483486648743166,-0.0392408171419368,4.57522099949045e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.133477330969756,0.00710863427969722,-0.147410254157963,-0.11954440778155,1.11866076022545e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42185,-0.0717419002923363,0.00383286729403961,-0.0792543201886539,-0.0642294803960186,3.32330854144443e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.151065521626504,0.00807129412374895,-0.166885258109052,-0.135245785143956,3.3347218447792e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42145,-0.126339767433966,0.00675027718431212,-0.139570310715217,-0.113109224152714,3.42669237674736e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.166949676576906,0.00894797701288145,-0.184487711522154,-0.149411641631658,1.0358386212015e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.071105884297132,0.00381665066405518,0.0636252489955838,0.0785865195986801,1.64783130122301e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.102858034560854,0.00554117332891928,-0.113718734285536,-0.0919973348361721,5.67391510656414e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0768220526280945,0.00415202211867119,-0.08496001598069,-0.0686840892754989,1.64190598615804e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42184,-0.0565605608971094,0.00306505484483795,-0.0625680683929918,-0.0505530534012271,4.0476208601071e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0631197256115053,0.00342509956572664,0.0564065304626811,0.0698329207603295,6.29787390555319e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0815643692636373,0.00442888452498812,-0.090244982932614,-0.0728837555946606,8.01390228808165e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.21994338037447,0.0119503321596251,-0.243366031407335,-0.196520729341605,1.4607513196211e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.149978695605282,0.00817707082539331,-0.166005754423052,-0.133951636787511,4.73921794539961e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0730364842479132,0.00401421109732006,-0.0809043379986605,-0.0651686304971658,6.46481419685618e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,39736,0.0462061939941346,0.00254851941800209,0.0412110959348505,0.0512012920534187,2.00165810117732e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.107628823815287,0.00596162139509653,-0.119313601749676,-0.0959440458808975,5.15646518633791e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,39806,-0.051991282007184,0.00288579903486796,-0.0576474481155253,-0.0463351158988428,1.47848072868278e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.083737844598193,0.00465709989976684,-0.092865760401736,-0.07460992879465,1.82409552573184e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.075977786967013,0.00423182770832264,0.0676834046587007,0.0842721692753254,3.00091530519995e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0665163971462701,0.00370937123749311,-0.0737867647717566,-0.0592460295207836,4.33306376868081e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.158498992654721,0.0088401580631855,-0.175825702458565,-0.141172282850878,4.7960513235347e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0556653080033195,0.00311475918403654,0.0495603800026078,0.0617702360040311,1.2614717424499e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,39736,-0.073273886496337,0.00411051549170782,-0.0813304968600843,-0.0652172761325897,4.16879920300028e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0705508132711735,0.00396399438872072,-0.0783202422730661,-0.0627813842692809,4.64303735974278e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42145,-0.0665633672363644,0.00378059651856248,-0.0739733364127469,-0.059153398059982,1.27257349934577e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0860098697363737,0.00488471767125844,-0.0955839163720402,-0.0764358231007071,1.27796259378011e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,39934,-0.0795649946263762,0.00452256692895831,-0.0884292258071345,-0.0707007634456179,2.25532235620878e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,39638,-0.118674562943819,0.00675014772496424,-0.131904852484748,-0.105444273402889,2.9203191601055e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0635253436471846,0.00362716703438282,0.0564160962597943,0.0706345910345749,6.31549410273651e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.113888982096285,0.00653263210106567,-0.126692941014373,-0.101085023178196,2.45709486980534e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0494304501880627,0.00285783590412125,-0.0550318085601404,-0.0438290918159851,2.57567042092235e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.12654357820078,0.0073254772258534,-0.140901513563453,-0.112185642838107,3.88176431372678e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.121715090736811,0.00705444072749404,-0.1355417945627,-0.107888386910923,5.3681632571783e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.134821537405553,0.00782242299042408,-0.150153486466784,-0.119489588344322,7.37964032879239e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0668746349569409,0.00388526362493326,-0.0744897516618101,-0.0592595182520717,1.0884406004274e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.206120617740241,0.0119787107513403,-0.229598890812868,-0.182642344667614,1.21008290414204e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0732148748460679,0.00425622640476491,-0.0815570785994071,-0.0648726710927287,1.25695759772965e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.105641710569539,0.00614952054499609,-0.117694770837732,-0.093588650301347,2.5495126642242e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0444320542692874,0.00262043411413783,-0.0495681051329975,-0.0392960034055772,7.81177359945721e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42119,-0.161447833078943,0.00957640506652917,-0.18021758700934,-0.142678079148546,3.97800729106501e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.101938758713775,0.00607413255014738,0.0900334589154863,0.113844058512064,1.94403568197753e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0789303982793842,0.00470834874196658,-0.0881587618136387,-0.0697020347451297,1.95449040990452e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0954847010302246,0.00570590515823874,-0.106668275140372,-0.0843011269200766,3.10442339115693e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0344026385916311,0.00205785935119675,0.0303692342632854,0.0384360429199767,4.07552653523811e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.226112600704358,0.013528818996959,-0.252629085938398,-0.199596115470318,4.41297839480318e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0931970614607588,0.00558147958310387,-0.104136761443642,-0.0822573614778752,5.61981843332796e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0499037912138521,0.00298578349230482,-0.0557559268587696,-0.0440516555689347,5.98173151478055e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,39657,-0.150608071416258,0.00901576972500365,-0.168278980077266,-0.132937162755251,6.89948523577287e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0488874768881327,0.00293475072804238,-0.0546395883150957,-0.0431353654611696,1.08674706736903e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.079810507450777,0.0047914207549357,-0.089201692130451,-0.070419322771103,1.51083867718542e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.081550983632719,0.00490477454252216,-0.0911643417360624,-0.0719376255293755,1.77933095241533e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0505081087839974,0.00303532747241523,-0.0564573506299313,-0.0445588669380636,1.90980409007217e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.108588776698989,0.00653156256407078,-0.121390639324568,-0.0957869140734103,2.56537448202073e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.105337828789068,0.00635667442107163,-0.117796910654368,-0.0928787469237675,4.63720287031023e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POSTN,Periostin,39966,0.0673097178762012,0.00406189572914796,0.0593484022470712,0.0752710335053312,5.84544072349633e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0718692713963332,0.00434175662771369,-0.0803791143866521,-0.0633594284060144,6.04997863057567e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0532484116255922,0.00323120072254699,-0.0595815650417843,-0.0469152582094001,2.62338628350989e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0484512282129552,0.00294214082168276,0.042684632202457,0.0542178242234535,3.09198490401876e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0489646074915464,0.00298469763403485,-0.0548146148542547,-0.0431146001288381,6.64756042261251e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0625203726354498,0.00381903307642686,-0.0700056774652464,-0.0550350678056531,1.14605209433559e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.088539391244851,0.00542244813103699,-0.0991673895816835,-0.0779113929080185,2.26631844961794e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.117986915403663,0.00722791727509773,-0.132153633262855,-0.103820197544472,3.15170052348496e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,39979,-0.0338901835153983,0.00208359647129136,-0.0379740325991294,-0.0298063344316673,8.0109122788384e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0404791409419481,0.00249519362975147,-0.045369720456261,-0.0355885614276352,1.2411406565149e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.112519028037345,0.00693731288555178,0.0989218947816631,0.126116161293026,1.31619652498353e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0473283248548048,0.0029162087522308,0.0416125557004324,0.0530440940091771,1.41607028697026e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42217,-0.0993324924322002,0.00612968616585709,-0.11134667731728,-0.0873183075471203,1.63422978326058e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.19799509420622,0.0122456453569075,-0.221996559105759,-0.173993629306681,2.96567873797144e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.114013615757416,0.00705558037954031,-0.127842553301315,-0.100184678213517,3.42114769880823e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.123255141351745,0.00764451980213822,-0.138238400163936,-0.108271882539554,7.69536398516041e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXN,Paxillin,41839,-0.0886190030471617,0.00550457293472414,-0.099407965999221,-0.0778300400951024,9.13352128707022e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REN,Renin,42145,-0.140292669976023,0.00871598777134506,-0.15737600600786,-0.123209333944187,9.33410799482154e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.107012497806916,0.00665210037537909,-0.120050614542659,-0.0939743810711734,1.06075399893545e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0930817486716842,0.00582078811202694,-0.104490493371257,-0.0816730039721113,4.87235682832887e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0721538699605706,0.0045385280830542,-0.0810493850033568,-0.0632583549177844,2.08646864178688e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42171,0.0663815727342085,0.00418198082772778,0.0581848903118621,0.074578255156555,3.111047609917e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.147862973305096,0.00933465693395966,-0.166158900895657,-0.129567045714535,6.7514501006014e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,39736,-0.0787999709091848,0.00497880404024269,-0.0885584268280605,-0.0690415149903091,8.19849710989274e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.170218594763607,0.0107742151434731,-0.191336056444814,-0.1491011330824,1.0334738294077e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.154544538371601,0.00980689537209171,-0.1737660533009,-0.135323023442301,2.30362952165111e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0280890983025425,0.00178480856996774,0.0245908735054057,0.0315873230996793,2.54485037292668e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,39966,-0.192050513762073,0.0122105798410908,-0.215983250250611,-0.168117777273535,3.69226596892053e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0824774890539023,0.00525652610549756,-0.0927802802206775,-0.072174697887127,5.36520596611842e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0653252019888785,0.00416803393503692,-0.0734945485015508,-0.0571558554762061,6.9494771457465e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,41697,-0.0676931651563312,0.00432033633425471,-0.0761610243714705,-0.059225305941192,7.8100554943948e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0591755039606211,0.00377751225144371,-0.0665794279734507,-0.0517715799477914,7.96361736272179e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.140565776111564,0.0089963823494932,-0.158198685516571,-0.122932866706558,1.82072186198763e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0810113085854105,0.00518515475032748,-0.0911742118960524,-0.0708484052747687,1.85496048893522e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42119,0.0744794395830329,0.00477234403454524,0.0651256452753242,0.0838332338907415,1.96215524896522e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.176613989628783,0.0113265008651135,-0.198813931324406,-0.154414047933161,2.42664667342417e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.112458009571217,0.00724380877285959,-0.126655874766021,-0.0982601443764118,6.91211116102149e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0811118958518935,0.0052448480801084,-0.091391798088906,-0.070831993614881,1.75134728310201e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42262,-0.0905278996459136,0.00585861149442142,-0.10201077817498,-0.0790450211168476,2.06549732365275e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.182952172476888,0.0118335154031319,-0.206145862667027,-0.15975848228675,2.24880869147388e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0928751755620257,0.0060213271439638,-0.104676976764195,-0.0810733743598567,4.04394000314575e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,39638,-0.098403995492557,0.00640363624892764,-0.110955122540455,-0.0858528684446589,9.58224677775987e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0752055529093219,0.00491804736813519,-0.0848449257508669,-0.065566180067777,2.35606743772948e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0622679618569851,0.00408328730804808,-0.0702712049807593,-0.0542647187332109,4.499233887041e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0428567230342908,0.00281109943565253,-0.0483664779281697,-0.0373469681404118,4.72453131090522e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.14976570272254,0.00982893628769381,-0.16903041784642,-0.130500987598661,5.38544812091216e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0327068630262153,0.0021496873918777,-0.0369202503142956,-0.028493475738135,7.59941273760648e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0424760471113126,0.00279421807577057,-0.0479527145398229,-0.0369993796828023,9.31491188174019e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0553851775121417,0.0036447077537511,-0.0625288047094938,-0.0482415503147895,1.00228688445447e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.043684093370502,0.00287672979556077,-0.0493224837698011,-0.0380457029712029,1.16781634431382e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0484804369960173,0.00320016809571202,-0.0547527664636129,-0.0422081075284218,2.01252386773278e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0956579085600458,0.00631627701349554,-0.108037811506497,-0.0832780056135946,2.16837608025635e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0317647017760926,0.00210087070582086,0.0276469951926837,0.0358824083595014,3.15621126891924e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OCLN,Occludin,39934,-0.0721276671193752,0.00476899376344071,-0.081474894895719,-0.0627804393430314,3.53277901960294e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.062412117181685,0.0041483921288109,0.0542812686092156,0.0705429657541543,9.53322496900269e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.141809876560572,0.0094433756172724,-0.160318892770426,-0.123300860350719,1.46560338252872e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD248,Endosialin,39966,0.0654242108529883,0.00435494333746661,0.0568885219115538,0.0739598997944228,1.58430058045436e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.102750106611362,0.00684440698202921,-0.11616514429614,-0.089335068926585,1.86180482711755e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42249,-0.0391300277210918,0.00260998082125678,-0.0442455901307551,-0.0340144653114285,2.0712109028329e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0531912583940238,0.00355587394425987,-0.0601607713247731,-0.0462217454632744,4.15055680672035e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.084700819136686,0.00567046981196532,-0.095814939968138,-0.0735866983052339,4.82351789187101e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,39958,-0.044802747282099,0.00300434128425651,-0.0506912561992418,-0.0389142383649562,8.06234322156908e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,41830,-0.0791094017973452,0.00531562876080243,-0.089528034168518,-0.0686907694261724,1.08125629013184e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0592698814894687,0.00398275299905096,-0.0670760773676086,-0.0514636856113288,1.08206123730266e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42185,0.0655886395157215,0.0044095123769532,0.0569459952568933,0.0742312837745498,1.18862981441816e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0504061382612615,0.00339038603906319,-0.0570512948978254,-0.0437609816246976,1.32055216147899e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0683786097448331,0.00460044854040413,-0.0773954888840252,-0.059361730605641,1.39194872553904e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.197762901728522,0.0133228265902181,-0.223875641845349,-0.171650161611695,1.86542819434591e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.155656751522738,0.0104995329717902,-0.176235836147447,-0.135077666898029,2.46712544929349e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0705112382747169,0.00475905714838499,-0.0798389902855514,-0.0611834862638823,2.81034362148304e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.122049924199362,0.00825350727394253,-0.138226798456289,-0.105873049942434,4.24844254002004e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0351676899331062,0.00237641971463878,-0.0398254725737982,-0.0305099072924141,4.37111915853616e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0809557295195664,0.00547962788792673,-0.0916958001799028,-0.07021565885923,5.19013808108422e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42274,0.0852600091623135,0.00577987178344724,0.0739314604667569,0.0965885578578701,7.17514053500006e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.101093631901436,0.00686654531558525,-0.114552060719983,-0.0876352030828888,1.08869596201616e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0326614372940677,0.00221812018134381,-0.0370089528495015,-0.0283139217386338,1.09111634293976e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0471938476747439,0.00320439733469986,-0.0534744664507556,-0.0409132288987322,1.1989185941939e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0745404518261955,0.0050663073768136,-0.0844704142847502,-0.0646104893676409,1.25302844441218e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0509194052210529,0.00346844563521437,-0.0577175586660731,-0.0441212517760328,2.03556879283038e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.127192831168375,0.00866807081527927,-0.144182249966322,-0.110203412370427,2.69956587586018e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0622657083471819,0.00424790906989298,-0.0705916101241721,-0.0539398065701916,2.80669693107164e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.158415082707,0.0108351022921947,-0.179651883199702,-0.137178282214299,5.68096831733478e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42070,-0.0614111761827836,0.00420985541634713,-0.0696624927988239,-0.0531598595667432,7.81232592139707e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.170852866979898,0.0117118320010218,-0.193808057701901,-0.147897676257895,9.06119693264055e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.144402499912449,0.00993926781155519,-0.163883464823097,-0.124921535001801,1.8218964425762e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.14014390675707,0.00965684052268436,-0.159071314181531,-0.121216499332609,2.31270288283848e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,39736,-0.184388579854921,0.0127082991873295,-0.209296846262087,-0.159480313447755,2.85247300317267e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0444704877394444,0.00306879480951736,-0.0504853255660985,-0.0384556499127904,3.08769302462841e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0488094891342869,0.003370004111323,-0.05541469719248,-0.0422042810760939,3.48103247030687e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAST,Gastrin,39929,-0.204015705894116,0.0140882796444822,-0.231628733997301,-0.176402677790931,4.1905093229284e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0618094275190014,0.00427928281528647,0.0534220332010399,0.0701968218369629,6.1178225005028e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.121965414882941,0.00844314143229364,-0.138513972090236,-0.105416857675645,6.989223201509e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.123672372702926,0.00857168068108874,-0.14047286683786,-0.106871878567992,8.95793231838229e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0629283644221052,0.0043651736678063,-0.0714841048110055,-0.0543726240332048,9.17318865922228e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0924038267080689,0.00642730163237226,-0.105001337907519,-0.0798063155086193,1.59914611818594e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0862939675121669,0.00600883175265724,-0.0980712777473751,-0.0745166572769587,1.99008667525198e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,41839,-0.103088216017866,0.00718139962782533,-0.117163759288404,-0.0890126727473288,2.21242408277945e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.104586412992618,0.00728535297835799,-0.1188657048302,-0.0903071211550363,2.57481578617894e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.130994881975977,0.00914482670906447,-0.148918742325743,-0.11307102162621,3.9833035818463e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.131533383526959,0.00919244174450436,-0.149550569346187,-0.11351619770773,4.23117630203186e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0465975340885899,0.00327015869486564,-0.0530070451305266,-0.0401880230466533,9.69600161122671e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0709971036123,0.00498552135402797,-0.0807687254661948,-0.0612254817584052,1.29578796250008e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.100738264729506,0.00708434655852852,-0.114623583984222,-0.0868529454747905,1.46449793139765e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.041277733514708,0.00290677344623825,0.035580457560081,0.046975009469335,1.92579440371331e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0767163433574779,0.00540597950219044,-0.0873120631817712,-0.0661206235331846,2.18189301043665e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.116357733142908,0.00820975157503737,-0.132448846229981,-0.100266620055834,3.26186500785794e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0457828010092873,0.00323864246493833,-0.0521305402405664,-0.0394350617780082,5.45960002970868e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0463171355591441,0.00327959558580592,-0.0527451429073237,-0.0398891282109645,5.70081763838355e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42129,-0.0578229740883996,0.00410162512159731,-0.0658621593267304,-0.0497837888500689,8.15652112479483e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39418,-0.035699312120277,0.00253140257924846,-0.040660861175604,-0.0307377630649501,9.115063055494e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0977855024438174,0.00695197497453976,-0.111411373393915,-0.0841596314937195,1.2575283676597e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.151534595865261,0.0107681216514233,-0.172640114302051,-0.130429077428472,1.32922503627373e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.106935819340609,0.00761203794241135,-0.121855413707735,-0.0920162249734829,1.64108990141023e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42296,-0.0512196694188314,0.00364785898146694,-0.0583694730225066,-0.0440698658151562,1.77833991461481e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0555597125696661,0.00395768710766755,-0.0633167793006945,-0.0478026458386377,1.86550147654477e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42129,-0.0467125389518114,0.0033281766716053,-0.0532357652281578,-0.040189312675465,1.93771146411347e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.077884041027226,0.00556093967947525,-0.0887834827989974,-0.0669845992554545,3.43589837540744e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0551259513078371,0.0039540217073931,-0.0628758338543276,-0.0473760687613467,7.055438250366e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0977609595581973,0.00701207958773734,-0.111504635550163,-0.0840172835662321,7.20505194333424e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0561681547927889,0.00403107804054613,-0.0640690677522593,-0.0482672418333185,7.88790220318275e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.109876469122896,0.00788754477799838,-0.125336056887773,-0.094416881358019,8.43489323996698e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.14199906086928,0.0102257540466728,-0.162041538800759,-0.121956582937802,1.52364364659209e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42181,-0.083556929738965,0.00602595028309133,-0.095367792293824,-0.071746067184106,2.00657949859099e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.114784113152107,0.00828178355997748,-0.131016408929662,-0.0985518173745507,2.2017915130785e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42129,-0.0467876341434371,0.00337799753627029,-0.0534085093145268,-0.0401667589723473,2.488470465904e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0490910713173944,0.00354465269293394,-0.0560385905955449,-0.0421435520392438,2.58175107005947e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.124375044093571,0.00900361618770975,-0.142022131821482,-0.10672795636566,4.13359324223356e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42249,-0.0554391365153476,0.0040209934187194,-0.0633202836160377,-0.0475579894146576,5.88606565351181e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.15773347138344,0.0114413106011425,-0.180158440161679,-0.1353085026052,6.01400042304887e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.112325365485365,0.00815101209657928,-0.128301349194661,-0.0963493817760701,6.45185563126019e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42070,-0.105269384280301,0.00764272184800126,-0.120249119102383,-0.0902896494582185,7.15125126998537e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42119,-0.107981345703998,0.00784473024119444,-0.123357016976739,-0.0926056744312566,8.06465847455579e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.103390440447309,0.00752722108743298,-0.118143793778678,-0.0886370871159406,1.36361900694706e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0432675007509368,0.00315991090774744,-0.0494609261301218,-0.0370740753717518,2.18401378434889e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,39954,0.0524213633245361,0.00382712884960578,0.0449201907793087,0.0599225358697634,2.28642747994266e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.102088155224728,0.00746791564771539,-0.11672526989425,-0.0874510405552056,3.36625787296625e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.119288874996943,0.00876553472972865,-0.136469323067212,-0.102108426926675,6.65367762076123e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0406935663636071,0.00299094077426551,-0.0465558102811675,-0.0348313224460467,6.98815161106644e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,39966,-0.041181349696499,0.00302843816098704,-0.0471170884920336,-0.0352456109009644,8.7046688429412e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.110061718579966,0.0081006370656092,-0.12593896722856,-0.094184469931372,9.13487596280442e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42296,-0.054532779835237,0.00402010311286657,-0.0624121819364555,-0.0466533777340185,1.19923678899554e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0944038454457941,0.00697283150141106,-0.10807059518856,-0.0807370957030284,1.71019608880305e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0988442357097325,0.00731856066815529,-0.113188614619317,-0.0844998568001482,2.65591714946191e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.109028464422189,0.00807039384828621,-0.12484643636483,-0.0932104924795481,2.92797407464954e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42119,-0.0572816767527199,0.00424959129930265,-0.0656108756993531,-0.0489524778060868,3.81543616299577e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0838538783868105,0.00621738505376198,-0.096039953092184,-0.071667803681437,3.87663033965281e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREH,Trehalase,39966,-0.109412472425033,0.00811425000695457,-0.125316402438664,-0.0935085424114017,4.02142234866401e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0715486718734155,0.00531778429616372,-0.0819715290938964,-0.0611258146529346,5.30979433761259e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0792769570460819,0.00589652091777487,-0.0908341380449206,-0.0677197760472431,6.0130413758838e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0516863075644242,0.00384852359736271,-0.0592294138152551,-0.0441432013135933,7.44795009152686e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0764997649444112,0.0057166091292806,-0.0877043188378011,-0.0652952110510212,1.40204164399363e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0277461501038243,0.0020843171247171,-0.0318314116682698,-0.0236608885393787,3.54015124202384e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.201635848261451,0.0151394302375562,-0.231309131527061,-0.171962564995841,3.61597924621693e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0667034034284696,0.00500857109638729,-0.0765202027773887,-0.0568866040795505,3.64515410335173e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.176596016710358,0.0132983113763757,-0.202660707008054,-0.150531326412662,6.14898284381562e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.163662033674536,0.01232979637616,-0.187828434571809,-0.139495632777262,6.59845071900261e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42134,0.0557538255229777,0.00420886047006754,0.0475044590016453,0.0640031920443101,8.33171059677854e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0948014502984986,0.00715928651645359,-0.108833651870748,-0.0807692487262496,9.01235990710751e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0279502312916297,0.0021110421462517,-0.032087873898283,-0.0238125886849763,9.05424400670433e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.142365709313126,0.0107662029604068,-0.163467467115523,-0.121263951510728,1.13355862470894e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.106703376112081,0.00807177263660393,-0.122524050479824,-0.0908827017443368,1.19571844168046e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.059815982244062,0.00454306403763818,-0.0687203877578328,-0.0509115767302911,2.38867824066175e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0799542659909743,0.00609532057171852,-0.0919010943115426,-0.068007437670406,4.51398409337395e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0900135400609866,0.00686939169406957,-0.103477547781363,-0.0765495323406103,5.48970575793935e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0933545338965672,0.00714390801584368,-0.107356593607621,-0.0793524741855136,8.58570194617411e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0598839885656765,0.00458321378527935,-0.0688670875848241,-0.050900889546529,8.79044537209935e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,39657,-0.134281371883011,0.0102905716493465,-0.15445089231573,-0.114111851450292,1.24189671714881e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0736491135763726,0.00564934690402441,-0.0847218335082605,-0.0625763936444848,1.29758286712259e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42230,-0.0969266341076728,0.00744039296029058,-0.111509804309842,-0.0823434639055033,1.45818805241075e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.121531266514583,0.009356303485604,-0.139869621346367,-0.103192911682799,2.38587201090279e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,41843,-0.0670130996089994,0.00515897038570482,-0.0771246815649808,-0.0569015176530179,2.40245624360332e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0857519654126934,0.00660272099113028,-0.0986932985553088,-0.0728106322700781,2.4738978261415e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0341234208588992,0.00262823236627445,-0.0392747562967971,-0.0289720854210013,2.56864724054256e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0690089974334221,0.00531971469305492,-0.0794356382318097,-0.0585823566350344,3.00336862513759e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,41900,-0.0746429819184872,0.00575633677530175,-0.0859254019980787,-0.0633605618388958,3.2047241461122e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0804278753773126,0.00620371982665131,-0.0925871662375491,-0.068268584517076,3.27506417921542e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.115925568760749,0.00894603753351433,-0.133459802326437,-0.0983913351950608,3.54949792848638e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0549822344155595,0.0042462554412177,-0.0633048950803462,-0.0466595737507728,4.45747354466866e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.049053500305492,0.00379095581407448,-0.056483773701078,-0.041623226909906,4.5545404913785e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0816557928153124,0.00633849349675051,-0.0940792400689434,-0.0692323455616814,9.41408607707455e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0975334428860841,0.00757566958176752,-0.112381755266348,-0.0826851305058198,1.05530963979162e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42153,0.0703051109704924,0.00546154646118007,0.0596004799065794,0.0810097420344053,1.06551462240553e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0438169963061446,0.00340779259743569,-0.0504962697971185,-0.0371377228151706,1.29192778502874e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0714294167590507,0.00555529822869613,-0.0823178012872952,-0.0605410322308063,1.42159969953315e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.117213795230427,0.00912345419299754,-0.135095765448702,-0.0993318250121518,1.47015489465018e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0858194940378411,0.00667695801532069,-0.0989063317478697,-0.0727326563278125,1.5114434592351e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42145,0.0435015585542074,0.00338695361794285,0.0368631294630394,0.0501399876453754,1.54174943780879e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42230,0.0377258912683456,0.00293938367630655,0.0319646992627848,0.0434870832739065,1.72916377404359e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.040118896820997,0.00312425284713219,-0.0462424324013761,-0.0339953612406179,1.77866609185359e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0951794904063891,0.0074139233986692,-0.109710780267781,-0.0806482005449975,1.8620885016539e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0494024324723126,0.00385573175175517,-0.0569596667057527,-0.0418451982388725,2.27944879247467e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0865752732037704,0.00675636047702166,-0.0998177397387328,-0.0733328066688079,2.48514561135618e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.126007984091096,0.00983951066771446,-0.145293424999816,-0.106722543182375,2.4901063216535e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0415821214758107,0.00324804674721156,-0.0479482931003453,-0.035215949851276,2.62287631111512e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.127267128318165,0.00994236227800317,-0.146754158383051,-0.107780098253279,2.68203185593093e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0313032982453941,0.0024477932267329,-0.0361009729697906,-0.0265056235209976,3.11421817174048e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42199,-0.0442166432892527,0.00346178016870301,-0.0510017324199106,-0.0374315541585948,3.80226059681091e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.053424817199793,0.00418284152832147,-0.0616231865953031,-0.0452264478042829,4.21470102118439e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.039540069321956,0.00309845803066771,-0.0456130470620647,-0.0334670915818473,4.43186145952049e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0822007633914632,0.00644396767498955,-0.0948309400344427,-0.0695705867484837,4.70555140965057e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42070,-0.140283727848918,0.0110333122411039,-0.161909019841482,-0.118658435856354,7.98943311290239e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.129554250678117,0.0102021385869283,-0.149550442308497,-0.109558059047738,9.68060131761877e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,41992,-0.0687828511063284,0.00542256577300017,-0.0794110800214087,-0.058154622191248,1.17017240425419e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0423189537451228,0.00333810244160254,-0.0488616345306638,-0.0357762729595818,1.27173980266481e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42070,-0.0734203306232217,0.00579228817583857,-0.0847732154478653,-0.0620674457985781,1.30756603690766e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0504789933257548,0.00398935648396601,-0.0582981320343281,-0.0426598546171814,1.72290349556362e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39358,-0.0331959807020932,0.0026231205436876,-0.0383372969677209,-0.0280546644364655,1.90450550161074e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42119,-0.131314867564583,0.0103941269392635,-0.151687356365539,-0.110942378763626,2.21341327727938e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0777744999704925,0.00616366225366052,-0.0898552779876671,-0.0656937219533179,2.67148593845661e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0830788822217122,0.00658561893818135,-0.0959866953405476,-0.0701710691028768,2.79217422912713e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,39757,-0.175749641887465,0.0139346960206022,-0.203061646087846,-0.148437637687085,3.18704814191634e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.112698863145424,0.0089591238912666,-0.130258745972307,-0.0951389803185415,4.82781479142213e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.117274684816621,0.00934674678439999,-0.135594308514045,-0.0989550611191973,6.53436515355371e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0694184736622914,0.00553040733602699,-0.0802580720409043,-0.0585788752836785,6.81313048736827e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0536813141861363,0.00428179823416535,-0.0620736387251004,-0.0452889896471722,7.47795187874343e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0569929078800662,0.0045480907523693,-0.06590716575471,-0.0480786500054224,7.93778016413857e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.149141035697327,0.0118954990385059,-0.172456213812799,-0.125825857581856,8.04285615231197e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0270225353494288,0.00215767982343744,-0.0312515878033662,-0.0227934828954914,8.7397217058771e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0532356733019447,0.00425154090386262,-0.0615686934735154,-0.0449026531303739,8.97286180715144e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0895860893307759,0.00716200062531087,-0.103623610556385,-0.0755485681051666,1.06702226338321e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0680271198227559,0.00544210050949391,-0.0786936368213639,-0.0573606028241478,1.17246441560718e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.140053917858841,0.0112065664660869,-0.162018788132371,-0.11808904758531,1.21247232290088e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0361702053742714,0.00290108367506661,0.0304840813711408,0.041856329377402,1.75141035850187e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.057517437829291,0.00461355183257034,-0.0665599994211289,-0.0484748762374532,1.76912157745459e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.120820355031887,0.00968723433581419,-0.139807334330082,-0.101833375733691,1.81101441991458e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0585025446627173,0.00469085311436625,-0.0676966167668752,-0.0493084725585595,1.8390843981885e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.113812799713686,0.00916902425683595,-0.131784087257085,-0.095841512170288,3.46511527075617e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0638520634156756,0.00514595063704705,-0.0739381266642878,-0.0537660001670634,3.68367261539555e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0857570301335874,0.0069090010781295,-0.0992986722467212,-0.0722153880204536,3.78883717348753e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42262,-0.0522418801060898,0.00421422785747456,-0.0605017667067399,-0.0439819935054396,4.21294870960255e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0977865797365973,0.00788557918376612,-0.113242314936779,-0.0823308445364157,4.38030714589014e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0859002236447701,0.00693699092771339,-0.0994967258630883,-0.0723037214264518,5.05188921465577e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.0341781897233883,0.00276328362342747,-0.0395942256253061,-0.0287621538214704,5.95071627732933e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.084257136960855,0.00681224927326677,-0.0976091455364578,-0.0709051283852521,6.03628787164299e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0537970289334249,0.00435004533520401,-0.0623231177904248,-0.0452709400764251,6.0541752067622e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0529287828537149,0.00427994685240985,-0.0613174786844382,-0.0445400870229916,6.07751488104825e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0812697300735744,0.00657238080597389,-0.0941515964532832,-0.0683878636938655,6.27279604326852e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.087701470127756,0.00709937440157537,-0.101616243954844,-0.0737866963006683,7.82230387675033e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0461272750041326,0.00373776342020941,0.0388012587005222,0.053453291307743,8.3970742698427e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0900305419690635,0.00730521563871064,-0.104348764620936,-0.0757123193171906,1.03207312709494e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0307859996319897,0.00249672798911672,-0.0356795864906585,-0.0258924127733209,1.04447530989832e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,39943,0.025206103814121,0.00204703360204715,0.0211939179541086,0.0292182896741334,1.274906669985e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0539840921447957,0.00439046593954277,-0.0625894053862995,-0.0453787789032918,1.5816533162216e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,39958,-0.0430411961987234,0.00350457549968274,-0.0499101641781016,-0.0361722282193452,1.88454768397179e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0372152932059997,0.00303359559661537,-0.0431611405753658,-0.0312694458366335,2.06049749662007e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_E,,42119,-0.0387788422699239,0.00316136351228603,-0.0449751147540045,-0.0325825697858433,2.08836483842482e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0369503099818184,0.00301344895016159,-0.0428566699241351,-0.0310439500395016,2.23080814651476e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.129071128728705,0.0105282363897866,-0.149706472052687,-0.108435785404723,2.26167516350281e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.102065375754688,0.00832439316765439,-0.118381186363291,-0.0857495651460855,2.41750138072773e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0771950533889709,0.00631053306441325,-0.0895636981952209,-0.0648264085827209,3.41338267130255e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.180483945752775,0.0147674922396694,-0.209428230542527,-0.151539660963023,3.6103712936186e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0569938502686282,0.00467086580453114,-0.0661487472455093,-0.0478389532917472,4.57799465260764e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.125002339011681,0.0102447905170763,-0.145082128425151,-0.104922549598212,4.63712463853146e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0362892425965116,0.00297944426127905,-0.0421289533486186,-0.0304495318444047,6.50108634212139e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.140471685579946,0.0115436356060104,-0.163097211367727,-0.117846159792166,7.41299417839173e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0958705079229155,0.0078821017092933,-0.11131942727313,-0.0804215885727007,8.04409972062482e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.142884755344652,0.0117593874341231,-0.165933154715533,-0.119836355973771,9.22258963912136e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.11309508003243,0.00931683420292482,-0.131356075070162,-0.0948340849946971,1.06476301844485e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0427454572853162,0.00352485423645344,-0.0496541715887649,-0.0358367429818674,1.13925803948756e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.103375087095782,0.00852566180789868,-0.120085384239263,-0.0866647899523003,1.17158641539232e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0471839004036871,0.00388975704400481,-0.0548078242099366,-0.0395599765974377,1.19789837608139e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.110687522958259,0.00914288910993499,-0.128607585613731,-0.0927674603027861,1.45900931724268e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.109211579293273,0.0090182678561985,-0.126887384291422,-0.0915357742951237,1.5056201962867e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0514842130567648,0.00425350470217454,-0.0598210822730269,-0.0431473438405027,1.63861833378361e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.050840819464053,0.00420672783693797,-0.0590860060244514,-0.0425956329036546,1.86838817354173e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0582697336809447,0.00482062814063617,-0.0677181648365916,-0.0488213025252978,1.97324704342209e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0772186094787395,0.00639355613538254,-0.0897499795040893,-0.0646872394533897,2.06186765547316e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0808122338114834,0.00670540189636103,-0.0939548215283511,-0.0676696460946158,3.03078022016993e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0763899963703187,0.00634750788099355,-0.0888311118170661,-0.0639488809235713,3.43971689840632e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,39736,-0.0403501110400266,0.00335107558248383,-0.0469182191816949,-0.0337820028983583,3.47834725547252e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.110243729842039,0.00916811922307288,-0.128213243519261,-0.0922742161648158,3.92205301700061e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0810341319472804,0.00674352559105956,0.0678168217888036,0.0942514421057571,4.2883567541189e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0598874511326982,0.0049848312039167,-0.069657720292375,-0.0501171819730215,4.4220061248542e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0427368681155419,0.0035685499783058,-0.0497312260730212,-0.0357425101580625,6.946092018079e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0809573600187271,0.00676564504495143,-0.0942180243068319,-0.0676966957306223,7.84296772794675e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0308441677742573,0.00258574566783078,-0.0359122292832056,-0.025776106265309,1.22457011071263e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0742724603475388,0.00622802360593896,-0.0864793866151792,-0.0620655340798985,1.26323781051142e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0328034873971683,0.00275010851044709,-0.0381937000776446,-0.027413274716692,1.32285049885716e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0552073731645995,0.00463288129340893,0.046126925829518,0.064287820499681,1.41106428006765e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,39990,-0.0373560997920236,0.00313521840761053,-0.0435011278709403,-0.031211071713107,1.54281547937963e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0666075107618792,0.00559026891764582,-0.077564437840465,-0.0556505836832933,1.56631291893117e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,39930,-0.134869634996952,0.0113368835311225,-0.157089926717952,-0.112649343275952,1.92412706180053e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.122025539793926,0.0102854003520359,-0.142184924483917,-0.101866155103936,2.62538403295165e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,39929,-0.0496658214661422,0.00418635431055997,-0.0578710759148397,-0.0414605670174446,2.83491454791096e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0528684685658325,0.00445749511567295,-0.0616051589925515,-0.0441317781391135,2.94269539033368e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0852092923993422,0.0071891227391968,-0.099299972968168,-0.0711186118305165,3.02394515434053e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0506266148075813,0.00427389677687262,-0.0590034524902517,-0.042249777124911,3.27461822501668e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.14611242928338,0.01234602657194,-0.170310641364383,-0.121914217202378,3.99007393432965e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42119,-0.102443506700489,0.00867060424155829,-0.119437891013943,-0.0854491223870343,4.69261682859588e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0954084634460704,0.00809667657907767,-0.111277949541063,-0.0795389773510781,7.26349264713289e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42296,-0.0603907027142173,0.00512991220320824,-0.0704453306325054,-0.0503360747959291,7.72293228637245e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0409071666758063,0.00347580180457338,-0.0477197382127702,-0.0340945951388425,8.03911811507655e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0334907708338152,0.00284752611183203,-0.039071922013006,-0.0279096196546245,8.81374740160127e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0982867658887255,0.00835845509861127,-0.114669337882004,-0.0819041938954475,9.08054713312086e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,41913,-0.0597067731546529,0.00508337421010134,-0.0696701866064515,-0.0497433597028542,1.06763884856307e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,39736,-0.0885835534182032,0.00753893791764989,-0.103359871736797,-0.0738072350996094,1.08445806913058e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42129,-0.0490134099906124,0.00417582307027392,-0.0571980232083493,-0.0408287967728755,1.1668055270021e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0498115434022616,0.00424672626141079,-0.0581351268746268,-0.0414879599298965,1.29140338399437e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0672880168662701,0.00575257559536672,-0.0785630650331888,-0.0560129686993513,1.8848466341305e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0408454780869034,0.00349099096722074,-0.047687820382656,-0.0340031357911507,1.92618482807463e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0919004339732244,0.00786354994501655,-0.107312991865457,-0.076487876080992,2.10017382806541e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0650848819226665,0.00558959561917655,-0.0760404893362525,-0.0541292745090805,3.48205253080785e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0579108980482159,0.0049713859196646,-0.0676548144507585,-0.0481669816456733,3.52573555292333e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0773008850429689,0.00664041018864001,-0.0903160890127034,-0.0642856810732345,3.61077191914098e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.052884668455516,0.00454544242431554,-0.0617937356071745,-0.0439756013038576,3.86899744139403e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0691937292140853,0.00594805052830041,-0.0808519082495541,-0.0575355501786165,3.96829357191849e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,41881,-0.0649637965211966,0.0055869756283562,-0.0759142687527748,-0.0540133242896184,4.21465705673295e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNST,Consortin,42145,-0.136501789888766,0.0117445143036252,-0.159521037923872,-0.113482541853661,4.44257662114483e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0966994854727592,0.00833430328918673,-0.113034719919565,-0.0803642510259532,5.98003842183291e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0700663895208724,0.00604470618719877,-0.081914013647782,-0.0582187653939629,6.39843093261715e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0565068074601966,0.00487780817863171,-0.0660673114903148,-0.0469463034300785,6.91161374726685e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COCH,Cochlin,39958,-0.057477199290539,0.00496247341410058,-0.0672036471821762,-0.0477507513989019,7.54423255370959e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.105075404312891,0.00907731550990548,-0.122866942712305,-0.087283865913476,8.16731494261599e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0472838844896176,0.0040856921447003,-0.0552918410932302,-0.039275927886005,8.49720839243172e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0364382161838978,0.00315304287970536,-0.0426181802281203,-0.0302582521396753,1.0194346644041e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42185,-0.0590486813007664,0.00511478476909007,-0.0690736594481829,-0.0490237031533498,1.09166039515968e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0826931416392409,0.00717116310610414,-0.096748621327205,-0.0686376619512767,1.27215787261625e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0619449529267469,0.00537827712675572,-0.0724863760951881,-0.0514035297583057,1.49247390115694e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0724038005808369,0.0062941000911105,-0.0847402367594135,-0.0600673644022604,1.75642402709338e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0898147994125788,0.00781081900220372,-0.105124004656898,-0.0745055941682596,1.97426539773491e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0483914467541207,0.00421049238722166,-0.0566440118330751,-0.0401388816751662,1.99328094380165e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,39929,-0.0758212848508242,0.00659669851231982,-0.0887508139349711,-0.0628917557666774,2.08855873962513e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0448045324283225,0.00391838355616544,-0.0524845641984067,-0.0371245006582382,3.89221890946638e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0400247960981978,0.00350371984481344,-0.0468920869940322,-0.0331575052023635,4.70251509331567e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0343165840465956,0.00300575343075728,-0.0402078607708798,-0.0284253073223113,4.71626216690347e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.081633187292421,0.00714836556062163,-0.0956439837912394,-0.0676223907936026,4.89008039522167e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42217,-0.0685418531287562,0.00601144966815699,-0.0803242944783439,-0.0567594117791685,5.59577684664773e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.038752076698306,0.00339882516586827,-0.0454137740234078,-0.0320903793732042,6.03582545335872e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.116576553688726,0.0102333241704558,-0.13663386906282,-0.096519238314633,6.27707934622035e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0307835495335862,0.00270896057776342,0.0254739868011699,0.0360931122660025,8.62669898197688e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0504150270636596,0.00443898593282069,-0.0591154394919881,-0.041714614635331,9.93654926373823e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0987379296178766,0.00870177815009352,-0.11579341479206,-0.0816824444436933,1.04732817528207e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0932048326051621,0.00823494295756788,-0.109345320801995,-0.0770643444083291,1.44798418201326e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.096820567357622,0.00855730908488825,-0.113592893164003,-0.080048241551241,1.61993118449809e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.10554691072669,0.00934252850967312,-0.123858266605649,-0.0872355548477305,1.83046437869479e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.050872012556892,0.0045036824929351,-0.0596992302430448,-0.0420447948707392,1.98057554460086e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.15240626330209,0.0135116073883086,-0.178889013783175,-0.125923512821005,2.23413390308595e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.124961865511906,0.0110756543214946,-0.146670147982036,-0.103253583041777,2.29437611273372e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42145,0.0463972563974857,0.0041183794330405,0.0383252327087263,0.0544692800862451,2.61044779692086e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0890915579883653,0.00790468653748978,-0.104584743601845,-0.0735983723748853,2.62073318861856e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.090504347458975,0.00803071378720447,-0.106244546481896,-0.0747641484360542,2.67425589673536e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0267569423663176,0.00238149751069373,0.0220892072453579,0.0314246774872773,3.69958067377415e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,39978,-0.0677903784338303,0.00603439032710298,-0.0796177834749521,-0.0559629733927085,3.95070562888693e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.042105955668747,0.00375175598723359,-0.0494593974037248,-0.0347525139337692,4.22581182363346e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0519742947684366,0.00463155316457997,-0.0610521389710134,-0.0428964505658599,4.29572819899983e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.106974996635602,0.00955013630238308,-0.125693263788273,-0.0882567294829308,5.6966115967354e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0473275408716844,0.00422548169008203,-0.0556094849842452,-0.0390455967591236,5.80728812662093e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0784148664226261,0.00700541859877396,-0.0921454868762231,-0.0646842459690291,5.87648067027217e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.118975360500831,0.0106414629609366,-0.139832627904267,-0.0981180930973955,6.85364257250204e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0534927634771566,0.00478559222545027,0.0441130027152741,0.0628725242390392,7.00360341070656e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0277333223084665,0.00248129782179341,-0.0325966660391816,-0.0228699785777514,7.09579271662348e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0739005541112346,0.00661301937221712,-0.0868620720807802,-0.0609390361416891,7.23142115633048e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,39736,-0.0641440585635505,0.00573944063918443,-0.075393362216352,-0.0528947549107491,7.60741273265464e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0626186002840088,0.00561863515504463,0.0516060753801213,0.0736311251878962,1.0121711816389e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.132675030352631,0.0119149401249517,-0.156028312997536,-0.109321747707726,1.1950355084051e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42025,-0.0867375491122434,0.0077964263812882,-0.102018544819568,-0.0714565534049185,1.26043283515928e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,41839,-0.040719322046283,0.00366048490474784,-0.0478938724595888,-0.0335447716329772,1.28351918514093e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0276390838529171,0.00248567711171621,-0.0325110109918808,-0.0227671567139533,1.34518862012849e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.05572080703969,0.00502254308270834,0.0458766225975817,0.0655649914817984,1.77268605879341e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0452133070247109,0.00408117507435519,-0.0532124101704471,-0.0372142038789747,2.11357041169353e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0665219369643898,0.00601134340397984,-0.0783041700361903,-0.0547397038925893,2.41885871291947e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0919949529724736,0.00833453532193947,-0.108330642203475,-0.0756592637414722,3.5145670198085e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42123,-0.0325630798697449,0.00295173997208962,-0.0383484902150405,-0.0267776695244492,3.53888639598567e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0783298153578667,0.00711463933575614,-0.0922745084559488,-0.0643851222597847,4.5171133062056e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0617356111163158,0.00561637934901238,-0.0727437146403801,-0.0507275075922516,5.46346204103511e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0732879992960449,0.00667476146853872,-0.0863705317743808,-0.060205466817709,6.26673230718879e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.112132064519779,0.0102182979978386,-0.132159928595543,-0.0921042004440153,6.72265957038838e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0744444447024137,0.00678187789918446,-0.0877369253848152,-0.0611519640200122,6.87322869067787e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0742743611527575,0.00677618648772258,-0.0875556866686938,-0.0609930356368212,7.67985986622291e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42145,-0.0806942758972191,0.00736347384063357,-0.0951266846248609,-0.0662618671695773,7.89721844281149e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0548915597236079,0.00501243787871643,-0.0647159379658921,-0.0450671814813237,8.58708227798351e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.123213022015045,0.0112530767526718,-0.145269052450282,-0.101156991579808,9.22581117963236e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0696295975647447,0.00637088964414537,-0.0821165412672696,-0.0571426538622197,1.0960814536415e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0914867797596452,0.00836904694445799,-0.107890111770783,-0.0750834477485075,1.13080871846564e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,39948,-0.0521534150734273,0.00477652203397898,-0.0615153982600261,-0.0427914318868285,1.287163235568e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0391642328871166,0.00359035018416404,-0.0462013192480781,-0.032127146526155,1.37173319965876e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.045411963481128,0.00416312505148826,0.037252238380211,0.053571688582045,1.44354897716681e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0731345308648143,0.00670967041691542,-0.0862854848819686,-0.0599835768476601,1.50190386759251e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0562645986697365,0.00517043477061217,-0.0663986508201363,-0.0461305465193366,1.9198929533963e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0610753117616692,0.00562922833630034,-0.0721085993008178,-0.0500420242225205,2.59087363972632e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0728048227571679,0.00671137222040316,-0.0859591123091581,-0.0596505332051778,2.7760302881622e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42262,0.0541508357372038,0.00499758623269283,0.0443555667211259,0.0639461047532817,3.01916497009826e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42249,-0.0710304873664264,0.00656051390812407,-0.0838890946263496,-0.0581718801065032,3.30847532606332e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0392705524686396,0.0036309222665052,0.0321539448262894,0.0463871601109898,3.74122778423312e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0850480913953429,0.00786740713170136,-0.100468209373478,-0.0696279734172082,4.17357563938151e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0947764910084263,0.00878129988431259,-0.111987838781679,-0.0775651432351736,5.02659364772374e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.113187052233127,0.0104892344628314,-0.133745951780276,-0.092628152685977,5.18917465321373e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0576367631937523,0.00534820609370734,0.0471542792500859,0.0681192471374186,5.97238762796962e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0337716455109273,0.00314229301654309,-0.0399305398233518,-0.0276127511985029,7.81643007385624e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0617187207285823,0.00575653000792755,-0.0730015195441203,-0.0504359219130443,1.09529863960782e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0626415665366321,0.00584733060241791,-0.0741023345173712,-0.051180798555893,1.19375284692409e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0442455981968136,0.00413285432345555,-0.0523459926707864,-0.0361452037228407,1.22841539667903e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0678246158343373,0.00633639116173119,-0.0802439425113304,-0.0554052891573442,1.2528371095187e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0452498417023817,0.00424088981025274,-0.0535619857304771,-0.0369376976742863,1.79760847491199e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0355534365182437,0.00333434241495248,-0.0420887476515506,-0.0290181253849369,2.05110562658331e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0649876067744352,0.00610847154335122,-0.0769602109994036,-0.0530150025494668,2.50815094563771e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0359891720698659,0.0033848883120406,-0.0426235531614655,-0.0293547909782664,2.67336055429877e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0315272527120661,0.00296545655977696,-0.037339547569229,-0.0257149578549033,2.69808408307467e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.104526144374768,0.0098295736629472,-0.123792108754144,-0.0852601799953913,2.77773048909716e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0692188261119166,0.00653257057214292,-0.0820226644333168,-0.0564149877905165,3.94654826289269e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42146,-0.0645020286691379,0.00609135998621252,-0.0764410942421144,-0.0525629630961613,4.23425310840002e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0967538535886696,0.00913666600069414,-0.11466171895003,-0.0788459882273091,4.4071330354193e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.128732414910065,0.0121940125515418,-0.152632679511087,-0.104832150309043,5.94805718947394e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0888134550945413,0.00841456904844526,-0.105306010429494,-0.0723208997595886,6.37125426767986e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.037724365118639,0.00358451898937232,-0.0447500223378087,-0.0306987078994692,8.38251542736841e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0458626360742587,0.00435994605923265,-0.0544081303503547,-0.0373171417981627,8.8686456894716e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,39492,-0.0802703029124323,0.007630491954878,-0.0952260671439931,-0.0653145386808714,9.31636641247657e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42069,-0.0501815982996047,0.00477781884534547,-0.0595461232364818,-0.0408170733627276,1.0514183334175e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0280945728637726,0.0026768473779011,-0.0333411937244587,-0.0228479520030864,1.18739668897329e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0459098389111651,0.004376603221854,-0.054487981225999,-0.0373316965963313,1.20395522058283e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.122928028369759,0.0117324590690572,-0.145923648145112,-0.0999324085944073,1.43284835621037e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0551692659219902,0.00526584040256639,-0.0654903131110204,-0.0448482187329601,1.45442095743778e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0783431005292716,0.00748470280997722,-0.093013118036827,-0.0636730830217163,1.53177141095923e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.122693428213744,0.011718940333322,-0.145662551267055,-0.099724305160433,1.55684174017076e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0573999396209811,0.00548785834167197,0.046643737271304,0.0681561419706582,1.65887912792423e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.0188270305897674,0.00179965070237535,-0.0223543459664231,-0.0152997152131117,1.6939101189885e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0389832090950214,0.00372893247351188,-0.0462919167431047,-0.0316745014469381,1.75219635013257e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0945050361519981,0.00904396440861057,-0.112231206392875,-0.0767788659111214,1.85220712186427e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.113563823973311,0.0108762542410669,-0.134881282285802,-0.0922463656608195,2.00014126278773e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.12029409212757,0.0115247174288253,-0.142882538288068,-0.0977056459670728,2.07626876121909e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,39979,-0.0787069206964585,0.00754123262336711,-0.0934877366382581,-0.063926104754659,2.19039995955384e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0635089051460551,0.00608913635661746,-0.0754436124050253,-0.0515741978870849,2.2690363227875e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0677879418198588,0.0064992946605238,-0.0805265593544854,-0.0550493242852322,2.35457483887653e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0611320453334153,0.00586406840979106,-0.0726256194166058,-0.0496384712502249,2.48582628112689e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0560245373611397,0.0053779641248529,-0.0665653470458513,-0.045483727676428,2.71965621681796e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.047156345533041,0.00453337410624916,-0.0560417587812894,-0.0382709322847926,3.03278448861091e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0381732261647298,0.00367151718224037,-0.0453693998419209,-0.0309770524875386,3.17742292755864e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0422639552135846,0.00406510430527625,-0.0502315596519261,-0.0342963507752432,3.20315176467352e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0783358966832212,0.0075346539919408,-0.0931038185074252,-0.0635679748590172,3.2039006174063e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0705075122418984,0.00678867979640787,-0.0838133246428578,-0.057201699840939,3.75307696398887e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0635019104616082,0.00611791992362575,-0.0754930335119146,-0.0515107874113017,3.83146337049416e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0787820108181215,0.00758900075879084,-0.0936564523053516,-0.0639075693308915,3.94440262350186e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.038316095897825,0.00369684987171358,-0.0455619216463836,-0.0310702701492664,4.45880848813723e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.044904550505228,0.00433169730356971,-0.0533946772202246,-0.0364144237902313,4.57844599774012e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0279562621331849,0.00270621467989052,-0.0332604429057703,-0.0226520813605995,6.35039517398343e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0597711295777071,0.00578987681974579,-0.0711192881444088,-0.0484229710110053,6.83955028682428e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0411629205249492,0.00398672466795883,0.0333489401757499,0.0489769008741485,7.00206376574326e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0932101670090172,0.00903591141639589,-0.110920553385153,-0.0754997806328812,7.72083772299396e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0276481814211467,0.00268186149273149,-0.0329046299469004,-0.022391732895393,7.9004471643853e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0429492359323512,0.00416757002760012,-0.0511176731864474,-0.034780798678255,8.21161110511851e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0757270838801252,0.0073557790194455,-0.0901444107582384,-0.061309757002012,9.54801458688477e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0381080239216399,0.00370540002989617,-0.0453706079802364,-0.0308454398630434,1.06257655792564e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0544662276921483,0.00529880846952637,-0.06485189229242,-0.0440805630918766,1.12533555397917e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0337622239429993,0.0032914103245455,-0.0402133881791085,-0.0273110597068901,1.34250746190362e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.080462423424132,0.00786624252729099,-0.0958802587776223,-0.0650445880706416,1.81460304705381e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.054257594546203,0.00530305346420452,-0.0646515793360438,-0.0438636097563621,1.8323879905598e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0807425000585343,0.00789699844097231,0.0652643831142286,0.09622061700284,1.96660064573382e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0579150379781937,0.00566825883536268,0.0468052506608829,0.0690248252955046,2.0323564005776e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0304380072582222,0.00297988721273059,-0.0362785861951741,-0.0245974283212702,2.09251427515124e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,41997,-0.0762003985972022,0.00748188091341024,-0.0908648851874863,-0.0615359120069181,2.84598067008067e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0489562922919959,0.00480976696325878,-0.0583834355399831,-0.0395291490440087,3.16351570524981e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42181,-0.0442600848223895,0.00435064647455611,-0.0527873519125195,-0.0357328177322595,3.18929802816854e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0606394834303393,0.00596303963428902,-0.0723270411135458,-0.0489519257471328,3.3163308127652e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0694076185564296,0.00682881050173472,-0.0827920871398297,-0.0560231499730296,3.52332448917909e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0696407524871976,0.00685053699465781,-0.0830678049967269,-0.0562136999776683,3.57991598484984e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0577848803273273,0.00568971221223368,-0.0689367162633053,-0.0466330443913493,3.80876572768233e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42119,-0.0377630807203646,0.00372463817780388,-0.0450633715488602,-0.030462789891869,4.53445740546452e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.095298809796953,0.00939733174990997,-0.113717580026777,-0.0768800395671295,4.60065699906983e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0847145134798829,0.00835699330334865,-0.101094220354446,-0.0683348066053196,4.63542385791988e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0360050392341115,0.00355333734265183,0.0290404980425139,0.0429695804257091,4.81689781364558e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0422176903427557,0.00416732561930397,-0.0503856485565915,-0.0340497321289199,4.92095237160105e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0445342176746305,0.00439462502590122,-0.0531476827253969,-0.0359207526238641,4.98843915612904e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0904915322300531,0.00893045610245185,-0.107995226190859,-0.0729878382692475,4.99344451432158e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42145,-0.134334487856209,0.0132650859651224,-0.160334056347849,-0.108334919364569,5.10978607070344e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.050336077107115,0.00497284144632756,-0.060082846341917,-0.040589307872313,5.37269940951294e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0589042876405626,0.00582181906202633,-0.0703150530021342,-0.047493522278991,5.62247744985893e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0696483219820184,0.00689068457640145,-0.0831540637517653,-0.0561425802122716,6.21865630435698e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0408514891900873,0.00404187333427026,-0.048773560925257,-0.0329294174549176,6.25133608530281e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0257554284811632,0.00254998832274588,-0.0307534055937451,-0.0207574513685813,6.95143576687946e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,39979,-0.0223895657061305,0.00221678639754953,-0.0267344670453276,-0.0180446643669334,6.96393832380443e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0416590646914771,0.00413022404144243,-0.0497543038127043,-0.0335638255702499,7.69857308191806e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0779914205423995,0.00773193370760633,-0.0931460106093079,-0.062836830475491,7.9559614228433e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,41994,0.0297799520526949,0.00295342155447075,0.0239912458059322,0.0355686582994576,7.97257199332536e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.121268029112286,0.0120404065560005,-0.144867225962047,-0.0976688322625249,8.9493002416347e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0606951634479285,0.00602830283204922,-0.072510636998745,-0.048879689897112,9.59243291334979e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0729051866403036,0.00727948656646062,-0.0871729803105664,-0.0586373929700407,1.64402074342976e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0336319102233581,0.00337405276397588,-0.0402450536407508,-0.0270187668059654,2.53718938525876e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0865625298610996,0.00868676099271838,-0.103588581406828,-0.0695364783153716,2.6130126192377e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0638566920406902,0.00641171182407667,-0.0764236472158805,-0.0512897368654999,2.7681922999638e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0458953150141696,0.00461167884164547,0.0368564244845444,0.0549342055437947,2.97412120236804e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0843733579709136,0.00847942833679718,-0.100993037511036,-0.0677536784307911,3.12889919549844e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.104474749464968,0.0105034474701305,-0.125061506506423,-0.0838879924235118,3.26244996923107e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0394301280904974,0.00396803120904357,-0.0472074692602228,-0.031652786920772,3.57677717108933e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,41959,-0.0464986176772274,0.00468194584894778,-0.055675231541165,-0.0373220038132897,3.65399115592346e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0238598649751668,0.00240196643936449,-0.0285677191963212,-0.0191520107540124,3.70271035051078e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0672929677250861,0.00678696356071337,-0.0805954163040843,-0.0539905191460879,4.30103796137989e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0623364682157043,0.00628910844115422,-0.0746631207603665,-0.050009815671042,4.45031700951244e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0402214522241617,0.00405898925567915,-0.0481770711652928,-0.0322658332830306,4.56167130881531e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.111142333713391,0.0112196651632553,-0.133132877433372,-0.089151789993411,4.69176196042481e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0830505187891023,0.0083910648119443,-0.0994970058205131,-0.0666040317576914,5.32114960842021e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42262,-0.118293991564357,0.0119656030536016,-0.141746573549416,-0.0948414095792977,5.70806551033906e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0892156234012686,0.00902274528623833,-0.106900204162296,-0.0715310426402414,5.82128942366003e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0329922733305932,0.00334097820735161,-0.0395405906170023,-0.026443956044184,6.60891394606786e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0591587368043511,0.00599800439490657,-0.070914825418368,-0.0474026481903342,7.47711792103505e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0528313373696885,0.00537375957972507,-0.0633639061459497,-0.0422987685934274,9.86911852568032e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.10921538720171,0.0111183540281441,-0.131007361096872,-0.0874234133065472,1.1043580244329e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42016,0.0365100325487695,0.00372134349619524,0.0292161992962269,0.0438038658013122,1.20340178997399e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.065777094074198,0.0067029032627502,-0.0789147844691884,-0.0526394036792076,1.22223522675241e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42145,-0.03962906952938,0.0040471565618144,-0.0475614963905362,-0.0316966426682238,1.45031494781104e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0390113725025635,0.00398468012570541,-0.0468213455489461,-0.0312013994561809,1.47184884186631e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42070,-0.0328861271614582,0.00336205009943976,-0.0394757453563601,-0.0262965089665563,1.60554553011781e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0338320798644099,0.00345940686682261,0.0270516424054375,0.0406125173233822,1.62981245970662e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.055496323218779,0.00567568991266606,-0.0666206754476044,-0.0443719709899535,1.72529096643298e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0888060017087815,0.00908818448517814,-0.106618843299731,-0.0709931601178323,1.84043177164947e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0797564259333356,0.00817102403162893,-0.0957716330353283,-0.0637412188313429,1.96699411246372e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.100025231729692,0.0102561903875589,-0.120127364889307,-0.0799230985700762,2.13571740543498e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0516922447408635,0.00530085428529955,-0.0620819191400506,-0.0413025703416763,2.14575109242346e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0935755369969814,0.00960983770001062,-0.112410818889002,-0.0747402551049605,2.47242218947835e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0516640890549677,0.00530428373430797,-0.0620604851742113,-0.041267692935724,2.50183977316914e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0273168265037178,0.00280756094690168,-0.0328196459596451,-0.0218140070477905,2.75076144498747e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,39906,-0.034284121205261,0.00352626127888886,-0.0411955933118832,-0.0273726490986388,2.95448177277671e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0823374331149481,0.00847938472429277,0.0657178390553342,0.0989570271745619,3.21893263129279e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,39919,-0.0655554495346463,0.00674916221114084,-0.0787838074684823,-0.0523270916008102,3.23658443760492e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0336438417159597,0.00346554714865592,-0.0404363141273252,-0.0268513693045941,3.29313271066951e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0907340225239347,0.00934407669766608,-0.10904841285136,-0.0724196321965092,3.32595283056467e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0284520654659705,0.00293854965521927,-0.0342116227902002,-0.0226925081417407,4.22427520330498e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0353552948271857,0.00365564946193788,-0.0425203677725839,-0.0281902218817874,4.85241459605828e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0730039956490523,0.00755859350789954,-0.0878188389245354,-0.0581891523735692,5.50363271666082e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0568409137300489,0.00588908330445458,-0.0683835170067799,-0.0452983104533179,5.88060953830521e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,41839,-0.0742445106144261,0.00770128971287598,-0.089339038451663,-0.0591499827771892,6.36331619623077e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0715437480673456,0.00742254636806505,-0.0860919389487531,-0.0569955571859381,6.44449240736244e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0996114009748014,0.0103314394519021,-0.11986102230053,-0.0793617796490733,6.47654894990508e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.130612414270298,0.0135740546989214,-0.157217561480184,-0.104007267060412,7.84525415352312e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42051,-0.0716972283481647,0.00746028370537052,-0.0863193844106909,-0.0570750722856384,8.48103237359111e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0598534044202557,0.00623512297699962,-0.072074245455175,-0.0476325633853365,9.76011890789186e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0400582098943007,0.00418159754996569,-0.0482541410922334,-0.0318622786963679,1.14061048316268e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,39934,-0.0571616582685272,0.00597613066305111,-0.0688748743681074,-0.045448442168947,1.35366559856067e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0326816788198248,0.00341803654652486,-0.0393810304510136,-0.0259823271886361,1.36219078959044e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0701928484285685,0.00734507523733867,-0.0845891958937523,-0.0557965009633847,1.47406731422269e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0548494291641554,0.00574148671845811,-0.0661027431323333,-0.0435961151959776,1.5236005250886e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0589271403748557,0.00617102159877973,-0.0710223427084639,-0.0468319380412474,1.53610055687947e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0164029514445105,0.00172236608273932,0.0130271139223414,0.0197787889666796,1.95053103324991e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0811108301223461,0.00851781562763605,-0.0978057487525128,-0.0644159114921795,2.04242469906745e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0496428232706455,0.00521639724117496,-0.0598669618633484,-0.0394186846779426,2.14888983443701e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0484213761495047,0.00509220533275678,-0.058402098601708,-0.0384406536973014,2.24244202891618e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0780467923377016,0.00820964934503511,-0.0941377050539704,-0.0619558796214328,2.3635023650555e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0852520705237333,0.00897370286224189,-0.102840528133727,-0.0676636129137392,2.44224131080743e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0385152735072682,0.00405963732021816,-0.0464721626548958,-0.0305583843596406,2.76655381441731e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.105718121240948,0.0111420587891871,-0.127556556467755,-0.0838796860141417,2.83272783330502e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0528974443533535,0.0055804302814805,-0.0638350877050552,-0.0419598010016517,3.08529690797244e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0417444776138874,0.00440580163756854,-0.0503798488235217,-0.033109106404253,3.19976086993028e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0718075000142513,0.00758259170635302,-0.0866693797587032,-0.0569456202697993,3.2527452014356e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0438130155538804,0.00462677734658546,-0.0528814991531879,-0.0347445319545729,3.2767598686605e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0679381111639223,0.00717549669250303,-0.0820020846812283,-0.0538741376466164,3.41362230042887e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42070,-0.0305376300354948,0.00323599931971559,-0.0368801887021373,-0.0241950713688522,4.4625797137548e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42084,-0.0818093771661429,0.00868479115051959,-0.0988315678211614,-0.0647871865111245,5.24138043754202e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0738935136420801,0.00784758089691651,-0.0892747722000365,-0.0585122550841237,5.42886738878883e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0460824055254846,0.00489623115300644,-0.0556790185853772,-0.0364857924655919,5.65592514891709e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.067338356962366,0.00715932640553631,-0.0813706367172172,-0.0533060772075149,6.16166116838976e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0258100998073565,0.00274539148607121,-0.0311910671200561,-0.020429132494657,6.42066208522712e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,39958,-0.0309017640198188,0.00329249327453178,-0.0373550508379011,-0.0244484772017366,7.44869510055456e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0150662016678504,0.00160758975391792,0.0119153257501713,0.0182170775855295,8.46665483177412e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0591737416271662,0.00633156279272317,-0.0715836047009036,-0.0467638785534288,1.05137754766904e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0588824164021047,0.00630896695974845,-0.0712479916432117,-0.0465168411609977,1.18520982433977e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,39929,-0.0226428767113348,0.00242693331438355,-0.0273996660075265,-0.017886087415143,1.25709884987279e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,39958,-0.0545603781625373,0.00585362312596632,-0.0660334794894313,-0.0430872768356434,1.3675257739571e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0314559416937951,0.00337604979715258,-0.0380729992962142,-0.0248388840913761,1.4113622748208e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,39638,-0.07468079316609,0.00802603746241081,-0.0904118265924152,-0.0589497597397648,1.59541660584448e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0428038169864547,0.00460327834670659,-0.0518262425459996,-0.0337813914269098,1.63873663017042e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0727291771028581,0.00782032075660966,-0.088057005785813,-0.0574013484199032,1.66585394576848e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0918508751875024,0.00989023395349098,0.0724660166386601,0.111235733736345,1.8325752469151e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0445639922911771,0.00479817741911384,-0.0539684200326403,-0.035159564549714,1.86355159989797e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0300351048451,0.00323512651131229,0.0236942568829279,0.0363759528072721,1.87517789443755e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0727374554830483,0.00784312963707648,-0.0881099895717182,-0.0573649213943784,2.06259216057728e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0314857288543298,0.00340171338808969,-0.0381530870949855,-0.024818370613674,2.5173370086969e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.102261070978285,0.01105274963534,-0.123924460263551,-0.0805976816930188,2.52495096999423e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0331884951806893,0.0035862082070275,-0.0402174632664632,-0.0261595270949154,2.53878840908194e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,41839,-0.0679566408151986,0.00735446924101918,-0.0823714005275961,-0.053541881102801,2.83130891337142e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0664825358145471,0.00719548652195487,-0.0805856893975787,-0.0523793822315156,2.91754083741619e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0681658694708457,0.00737855066764053,-0.0826278287794211,-0.0537039101622703,2.94754856064608e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0284582132179702,0.00308174031873457,-0.0344984242426899,-0.0224180021932504,2.97259901626112e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.101423944843262,0.0109901228947474,-0.122964585716967,-0.0798833039695566,3.14223993854041e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0664386386258079,0.00720079646481117,-0.0805521996968378,-0.052325077554778,3.29788322190937e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0514872974137283,0.00558243140942266,-0.0624288629761967,-0.0405457318512598,3.31770665046466e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.053542243828317,0.00581795323424091,-0.0649454321674292,-0.0421390554892048,4.09204812812663e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0358015291676409,0.00389401160616312,-0.0434337919157206,-0.0281692664195611,4.32980209774255e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.03150324386147,0.00342798288314918,-0.0382220903124424,-0.0247843974104976,4.62992226409391e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0536398235484377,0.00584740253435476,-0.065100732515773,-0.0421789145811024,5.39518316298059e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0480027561917632,0.00524669592829655,-0.0582862802112244,-0.037719232172302,6.56357959504447e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0251979142215689,0.00275549656948153,0.0197971409453851,0.0305986874977527,6.81704578820371e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.144707711005553,0.0158244831871353,-0.175723698052338,-0.113691723958767,7.00744179380804e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0658447833563685,0.00720309382815863,-0.0799628472595594,-0.0517267194531776,7.22138415042835e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.106616284727836,0.0116641401871437,-0.129477999494637,-0.0837545699610339,7.26863452032317e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.028714687861726,0.00314323545204624,-0.0348754293477366,-0.0225539463757153,7.4311432187985e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0786048669036799,0.0086036607234272,-0.0954680419215972,-0.0617416918857626,7.59460998100359e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDK,Midkine,42129,-0.0504684870248312,0.00552749105049281,-0.0613023694837971,-0.0396346045658653,7.77585655795884e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0400385173801027,0.00438712829356788,-0.0486372888354957,-0.0314397459247096,8.28100454829967e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0283048542636804,0.00310484673205907,-0.0343903538585162,-0.0222193546688446,8.84878662251638e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0269849910859689,0.00296050953204835,-0.0327875897687837,-0.0211823924031541,8.95697265215895e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0270002241647791,0.00297174579904005,-0.0328248459308975,-0.0211756023986606,1.17031787809899e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42145,-0.0536118960199847,0.00590771985595214,-0.0651910269376509,-0.0420327651023185,1.29292891913306e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0420400460057105,0.0046346914483706,-0.0511240412445169,-0.0329560507669041,1.3833783730667e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0745929430847535,0.00822506816539141,-0.0907140766889206,-0.0584718094805863,1.39884647622642e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0375038390875643,0.0041405199875835,-0.045619258263228,-0.0293884199119007,1.50954373777285e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0558544658616652,0.00617783603773981,-0.0679630244956352,-0.0437459072276952,1.76297264991766e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0446706914208765,0.00493974141954857,-0.0543525846031917,-0.0349887982385613,1.77036193776784e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0559331358699542,0.00618826141131933,-0.0680621282361401,-0.0438041435037683,1.84848684554124e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0835747286449487,0.00925137306521124,-0.101707419852763,-0.0654420374371347,1.87959204234335e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0773881024464451,0.00857128610451564,-0.0941878232112958,-0.0605883816815944,1.97342720064101e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0893775831464984,0.00989827855998416,-0.108778209124067,-0.0699769571689295,2.00005056384104e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,39866,-0.0932034289792639,0.010335907456844,-0.113461807594678,-0.0729450503638496,2.23604093451443e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0630180426369592,0.00699222999183615,-0.076722813420958,-0.0493132718529603,2.27676945222878e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0435586069097017,0.0048344176479973,0.034083148319627,0.0530340654997764,2.38752728017985e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0383919215638531,0.00426129094790628,-0.0467440518217494,-0.0300397913059568,2.41315010499661e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.106156389899561,0.0117991384212505,-0.129282701205212,-0.0830300785939105,2.62437654251956e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0454895038427003,0.00505769190037606,-0.0554025799674374,-0.0355764277179633,2.76973005627806e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.039559039619784,0.00440014712241575,-0.0481833279797189,-0.0309347512598491,2.85352195029783e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0737584031687357,0.00820421162007637,-0.0898386579440853,-0.057678148393386,2.86681935948156e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.02616008255273,0.00291611600407495,-0.0318756699207169,-0.0204444951847431,3.32395373994586e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0480584483532583,0.0053558136889228,-0.058555843183547,-0.0375610535229696,3.33455585619771e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42137,0.0481048279473685,0.00536511442137279,0.0375892036814778,0.0586204522132592,3.46605056021846e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,41997,-0.0775351017170426,0.00864801644558423,-0.0944852139503877,-0.0605849894836975,3.48847754655413e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.093326167416585,0.0104208758770884,-0.113751084135678,-0.0729012506974917,3.81550321209505e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0556944450950979,0.00622552400524862,-0.0678964721453852,-0.0434924180448106,4.15810361406766e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0275103349432169,0.00307540326264392,-0.033538125337999,-0.0214825445484348,4.18982777696511e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0493070546867995,0.0055126162338984,-0.0601117825052403,-0.0385023268683586,4.32999004390391e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0281383176255942,0.00314716704570456,-0.0343067650351752,-0.0219698702160133,4.46031624509585e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0453380156351499,0.00507196355156781,-0.0552790641962229,-0.035396967074077,4.53625085169821e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0962043537110261,0.0107800184610911,-0.117333189894765,-0.0750755175272876,5.17087982100405e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0458116394872126,0.00514808776402816,-0.0559018915047078,-0.0357213874697174,6.3738575938562e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0370240863215242,0.00416914253732592,-0.045195605694683,-0.0288525669483654,7.48836096060413e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0940759207902565,0.0106010646707269,-0.114854007544881,-0.0732978340356317,7.91940783222796e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0429063335835703,0.00483935750392712,-0.0523914742912675,-0.0334211928758732,8.53198845226582e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0894884476241362,0.0100916552641348,-0.10926809194184,-0.0697088033064319,8.59308945693839e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0921156943382183,0.0103929978926572,-0.112485970207826,-0.0717454184686102,8.7537579713912e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0861641943500766,0.00973811406070845,-0.105250897909065,-0.0670774907910881,1.00289189160974e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42116,-0.0387209971025303,0.0043765655770928,-0.0472990656336322,-0.0301429285714284,1.00623562082508e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0735037786235396,0.00830827872353712,-0.0897880049216724,-0.0572195523254068,1.03151289754616e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0351067707880916,0.00396956754360224,-0.042887123173552,-0.0273264184026312,1.03728627826181e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0544183504615072,0.0061574816753569,-0.0664870145452068,-0.0423496863778077,1.09409463238283e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0328596689195152,0.00371959830712005,-0.0401500816014705,-0.0255692562375599,1.13160043414213e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0904319358984742,0.0102401413782065,-0.110502612999759,-0.0703612587971895,1.1884172749499e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0629091465622799,0.00713312784419059,-0.0768900771368935,-0.0489282159876664,1.31995530019323e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0691692570877592,0.00785974118648162,-0.0845743498132631,-0.0537641643622552,1.52622807862201e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0314067362217591,0.00357109000324903,0.024407399815391,0.0384060726281272,1.64028673925457e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.036867133946251,0.00419487822978109,-0.0450890952766219,-0.02864517261588,1.69894839302793e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0467539511223628,0.00532042181591003,-0.0571819778815465,-0.0363259243631791,1.75277120878008e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSG,Basigin,42284,-0.0197815336687766,0.00225574883927503,-0.0242028013937556,-0.0153602659437975,2.00616357249451e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0231224511471181,0.0026378557841604,-0.0282926484840725,-0.0179522538101637,2.07704159424781e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42143,-0.0998174445791485,0.0113878343978777,-0.122137599998989,-0.0774972891593082,2.08279750316881e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0302762303065292,0.00346376183559814,0.0234872571087569,0.0370652035043016,2.58173714338813e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42137,0.0265390371070113,0.00303694529172436,0.0205866243352315,0.032491449878791,2.63187611671432e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0631005918638983,0.00722573734838578,-0.0772630370667344,-0.0489381466610622,2.83343546440797e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0534880230734981,0.00612696380724486,-0.065496872135698,-0.0414791740112982,2.84355802232402e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0257171051223243,0.00295028228460892,-0.0314996584001578,-0.0199345518444908,3.18769185245378e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0514924692301507,0.00591049551917951,-0.0630770404477425,-0.0399078980125588,3.3335843384199e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.065584797654577,0.00752813327883791,-0.0803399388810993,-0.0508296564280547,3.4124558025866e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0352748903122017,0.00404983568350697,-0.0432125682518754,-0.0273372123725281,3.46462302953423e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0721814415193626,0.0082885218925052,-0.0884269444286728,-0.0559359386100524,3.50220709091341e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0721221104738193,0.00829825978705575,-0.0883866996564485,-0.05585752129119,4.0008094199309e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0472122514818508,0.00544053454167008,-0.0578756991835242,-0.0365488037801775,4.58255402097477e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.123738687746454,0.0142613317931506,-0.151690898061029,-0.0957864774318791,4.6520393020556e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0430781344655686,0.0049654593087601,-0.0528104347107384,-0.0333458342203988,4.69111026693229e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0647039356024564,0.00745936216522294,-0.0793242854462933,-0.0500835857586194,4.73216489270164e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0523030642563469,0.00604167473755252,-0.0641447467419499,-0.040461381770744,5.38841546679252e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0358545353331642,0.00414411227899801,-0.0439769954000003,-0.0277320752663281,5.63115933209873e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0443467891878602,0.00512757224154792,-0.0543968307812941,-0.0342967475944263,5.80359920909556e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0635805426664698,0.00735526423536284,-0.077996860567781,-0.0491642247651587,6.01349061959543e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0798069241142153,0.00923272024718973,-0.0979030557987072,-0.0617107924297234,6.18070960993406e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.06338507942679,0.0073358701993974,-0.0777633850176089,-0.0490067738359711,6.22402331899872e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0255927288211004,0.00296126256109806,-0.0313968034408526,-0.0197886542013482,6.23481449423059e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0973242125271081,0.0112645716919561,-0.119402773043342,-0.0752456520108741,6.25434411452201e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0415467865826498,0.00481155148169524,-0.0509774274867725,-0.0321161456785272,6.68945387130788e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0281542079569668,0.0032641965937911,-0.0345520332807973,-0.0217563826331362,7.1059467394707e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0323738715342333,0.00375376425382641,-0.0397312494717331,-0.0250164935967336,7.32332525306145e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.062165066632606,0.00721374585433682,-0.0763040085071062,-0.0480261247581059,7.57992923991357e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.110936866259323,0.0128783809846838,-0.136178492989303,-0.0856952395293424,7.97478304633865e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0424710414593135,0.00493163590150443,-0.0521370478262621,-0.0328050350923648,8.13386853816971e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0890616943789002,0.0103458505603646,-0.109339561477215,-0.0687838272805855,8.2166300152814e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0481472791799834,0.00559345623645358,-0.0591104534034324,-0.0371841049565344,8.27184375876864e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0602203117569134,0.00700025686828135,-0.0739408152187449,-0.0464998082950819,8.8208048090672e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0311392547816739,0.00362268558930991,-0.0382397185367213,-0.0240387910266264,9.17234927057552e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0252974492043894,0.00294613726328633,0.0195230201683482,0.0310718782404306,1.01187724145582e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0153506619530561,0.00178824769154054,-0.0188556274284756,-0.0118456964776367,1.03345697497789e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0498416089666154,0.00581000638666954,-0.0612292214844877,-0.0384539964487431,1.06367383589502e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0326218027403903,0.00380275702636623,-0.0400752065120681,-0.0251683989687125,1.06506358164504e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0740815097291472,0.00867438267675208,-0.0910832997755813,-0.0570797196827131,1.48217844988607e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0474920270867552,0.00556713643559004,-0.0584036145005117,-0.0365804396729988,1.60540164474698e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.028686922164179,0.00336591676865439,0.0220897252976164,0.0352841190307417,1.74467382192158e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0327017744631093,0.00383802416459173,-0.0402243018257091,-0.0251792471005095,1.7900248912597e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0609992140674966,0.00716338271960675,-0.0750394441979259,-0.0469589839370674,1.87622432792808e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0580144392031338,0.00682263991683802,-0.0713868134401364,-0.0446420649661313,2.07498521640863e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBN,Nibrin,41913,-0.0498270722653365,0.00586303432854112,-0.0613186195492771,-0.0383355249813959,2.12293688809042e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0765215384959442,0.00900783321229561,-0.0941768915920436,-0.0588661853998448,2.19066520142624e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0591080944912399,0.00695917876871944,-0.07274808487793,-0.0454681041045498,2.25418769843377e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,39649,-0.0397467670708646,0.00468094918121906,-0.0489214274660539,-0.0305721066756752,2.30714728692306e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.051075829530994,0.00602288509625738,-0.0628806843196584,-0.0392709747423295,2.47708618130884e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0262137372684974,0.00309488257189576,-0.0322797071094131,-0.0201477674275817,2.70478380891112e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0243441962214794,0.00287892785025002,0.0187014976349893,0.0299868948079694,3.10436832468055e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0660274201550412,0.00781459585164235,-0.0813440280242602,-0.0507108122858222,3.28968625837743e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0667546781523467,0.00790428605052437,-0.0822470788113745,-0.0512622774933189,3.40956829311511e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0266442134790168,0.00315708187432201,-0.0328320939526879,-0.0204563330053456,3.50503466268763e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPN,Asporin,39958,0.0254420305274768,0.00301520797893195,0.0195322228887701,0.0313518381661834,3.62175269793285e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0497603150262034,0.0059082842718774,-0.0613405521990831,-0.0381800778533237,4.06610575243432e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0257697384001544,0.0030626827482309,0.0197668802136219,0.031772596586687,4.35284911044791e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0363081240515507,0.00431489483061155,-0.0447653179195494,-0.0278509301835521,4.41489374684448e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0770849281023594,0.00917066844368378,-0.0950594382519797,-0.0591104179527392,4.76519783053146e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0480627432064353,0.00572261112972618,-0.0592790610206986,-0.036846425392172,5.06474132959623e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0313803706976313,0.00373966954926165,-0.0387101230141841,-0.0240506183810784,5.28718062324855e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.041190155407676,0.00490934285623664,-0.0508124674058998,-0.0315678434094522,5.44512622930459e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0539045397784821,0.00643554069579976,-0.0665181995422496,-0.0412908800147146,6.11628186898677e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.035648490461743,0.00425696212338454,-0.0439921362235767,-0.0273048446999093,6.21435300391569e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0602583096730706,0.00720234928035578,-0.0743749142625679,-0.0461417050835732,6.65533230604223e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0459107477109106,0.00548826275119776,-0.0566677427032582,-0.0351537527185629,6.71840845353311e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0553479528744276,0.00661892534953786,-0.0683210465595218,-0.0423748591893334,6.9025118179693e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0530359179096257,0.00635202288624077,-0.0654858827666576,-0.0405859530525938,7.6688225770143e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0430518344921703,0.00515922231247693,-0.0531639102246251,-0.0329397587597155,7.83200716343473e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,39929,-0.0258850963540635,0.00310606158377026,-0.0319729770582532,-0.0197972156498738,8.73552273689919e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42181,-0.0384428128802565,0.00461520806307798,-0.0474886206838893,-0.0293970050766236,8.8833956810901e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0389269228195819,0.00467399419634112,-0.0480879514444104,-0.0297658941947533,8.9766386410133e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.070161290550409,0.00843155225108134,-0.0866871329625284,-0.0536354481382895,9.52186048164101e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0251102302239347,0.00301922100080554,-0.0310279033855136,-0.0191925570623559,9.8843287875292e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0448779792628144,0.00539884792189328,-0.0554597211897252,-0.0342962373359035,1.04664585687672e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,39979,-0.0370705789005122,0.00446394083184459,-0.0458199029309276,-0.0283212548700968,1.11615190573392e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0335027826701683,0.0040354100809848,-0.0414121864288985,-0.0255933789114381,1.11729770858607e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.059470043407713,0.00716352701045017,-0.0735105563481953,-0.0454295304672306,1.12238772860316e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.07229102320713,0.00870885390226841,-0.0893603768555761,-0.055221669558684,1.13072864650223e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42099,-0.043126580391216,0.0051965898272552,-0.0533118964526362,-0.0329412643297958,1.14873004694851e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0546879154342611,0.00659051905506602,-0.0676053327821905,-0.0417704980863317,1.1586984907801e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0232851987701228,0.00280758032574689,0.0177823413316589,0.0287880562085867,1.20118719352756e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0398635802631422,0.00481283625693599,-0.0492967393267368,-0.0304304211995477,1.318303532663e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0434089928758208,0.0052412607603682,-0.0536818639661425,-0.0331361217854992,1.34498920366282e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0685753404898755,0.00828616753811181,-0.0848162288645746,-0.0523344521151763,1.39367002087022e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0773442674047177,0.00934745668425839,-0.0956652825058641,-0.0590232523035713,1.40987193017961e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0795481867628184,0.0096241678722189,-0.0984115557923674,-0.0606848177332694,1.54648212150398e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0771688728542451,0.00934160517208746,-0.0954784189915365,-0.0588593267169536,1.61138383387645e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0243567723268782,0.00295224294000256,0.0185703761644732,0.0301431684892832,1.72513330747465e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0590410313747191,0.00715623339151719,-0.0730672488220928,-0.0450148139273454,1.72520020810083e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0398534387435768,0.00482989524027833,-0.0493200334145224,-0.0303868440726313,1.74292594168742e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0325081082234911,0.00394187710616289,-0.0402341873515704,-0.0247820290954118,1.80539839116303e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42016,-0.0383466141738988,0.00465146456641829,-0.0474634847240787,-0.029229743623719,1.81940362370989e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0401405258559363,0.00487302008862271,-0.0496916452296368,-0.0305894064822358,1.92195532859503e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0305054011598274,0.00370644350671665,-0.037770030432992,-0.0232407718866627,2.03628834112227e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0522002844170121,0.00634125712835708,-0.064629148388592,-0.0397714204454322,2.04514468232701e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0519720039713047,0.00632811873446693,-0.0643751166908599,-0.0395688912517495,2.39990123327389e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42196,-0.0261876372900585,0.00319678366881901,-0.0324533332809438,-0.0199219412991732,2.80009814889563e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42119,-0.0423272227140408,0.00516955615539927,-0.0524595527786234,-0.0321948926494583,2.8976469015849e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0776040454366526,0.0095010554536591,-0.0962261141258245,-0.0589819767474808,3.4787348809124e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0441612846119518,0.00541125665632953,-0.0547673476583577,-0.0335552215655459,3.67915322124034e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0488163623939831,0.00598498001899792,-0.060546923231219,-0.0370858015567471,3.75022645188809e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0490201838206136,0.00601086846345291,-0.0608014860089813,-0.0372388816322459,3.79102163577267e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0587361945271931,0.00721197653853749,-0.0728716685427266,-0.0446007205116596,4.22936740140847e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42249,-0.032382798378712,0.00397901693409807,-0.0401816715695442,-0.0245839251878798,4.35009516038246e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0430750211909479,0.00529871701846975,-0.0534605065471486,-0.0326895358347471,4.78054975762608e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0812269999551266,0.0100133279026284,-0.100853122644278,-0.0616008772659749,5.40886636411903e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0730864221460194,0.00902589491944293,-0.0907771761881275,-0.0553956681039113,6.09275664506964e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0680412556514925,0.00840487126647501,-0.0845148033337836,-0.0515677079692015,6.19122570035672e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0368353228915129,0.00455386037774755,0.0279097565511277,0.0457608892318981,6.53284693421945e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0504923874246705,0.00624331460881478,-0.0627292840579474,-0.0382554907913935,6.60830950925385e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,39657,-0.043004121985253,0.00532126963188132,-0.0534338104637404,-0.0325744335067656,7.06013599609436e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0570191470745775,0.00705936344587114,-0.0708554994284849,-0.04318279472067,7.31856981637377e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0733311727910686,0.00909194750104547,-0.0911513898931177,-0.0555109556890195,7.90372801340845e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42217,0.0420648065509527,0.00521753350136129,0.0318384408882845,0.0522911722136208,8.11478838351953e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,39657,-0.0372074278891203,0.00461867057659848,-0.0462600222192533,-0.0281548335589873,8.70171886792911e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0316323114436322,0.00393352735643881,-0.0393420250622523,-0.0239225978250121,9.59153580292434e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0474144891337047,0.00589570170718286,-0.0589700644797831,-0.0358589137876263,9.71926187517779e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0483204096033183,0.00601084830657469,-0.0601016722842046,-0.0365391469224319,9.99041077114467e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42249,0.0324876882070632,0.00404807658667526,0.0245534580971797,0.0404219183169467,1.09358003664299e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.059895782634836,0.00746821382387836,-0.0745334817296376,-0.0452580835400344,1.16238672714965e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0494846054343843,0.00617363625337558,-0.0615849324910004,-0.0373842783777681,1.20782932423331e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0538982311417098,0.00672648844675675,-0.067082148497353,-0.0407143137860665,1.21140555831822e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.023314066063879,0.00291036237598045,-0.0290183763208007,-0.0176097558069573,1.25511532397e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0231538645880865,0.00289216847208585,0.0174852143827983,0.0288225147933748,1.28459597608094e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0499064441312066,0.00623624844525538,-0.0621294910839072,-0.0376833971785061,1.31867103996066e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2,Complement C2,42199,-0.0195287570248228,0.00244079139441728,-0.0243127081578807,-0.014744805891765,1.33355396979064e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0349794168655703,0.00437221596642401,-0.0435489601597614,-0.0264098735713792,1.36110072767107e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0367733222481752,0.00459851738044883,-0.0457864163138549,-0.0277602281824955,1.40464154297056e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0280811870421374,0.00351400545094664,-0.0349686377259928,-0.021193736358282,1.44224681356755e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0922031594713568,0.011560889372723,-0.114862502641894,-0.0695438163008197,1.66421461275139e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0262693418509786,0.00329381568268986,-0.0327252205890507,-0.0198134631129064,1.66475986058616e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0524019639099027,0.0065743375593073,-0.0652876655261451,-0.0395162622936604,1.70325227034596e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0611902679393685,0.0076794686525309,-0.0762420264983291,-0.046138509380408,1.73998519043834e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0559302434772454,0.0070319172015198,-0.0697128011922242,-0.0421476857622666,1.98063304081029e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0200461014345745,0.00252097346841917,-0.024987209432676,-0.0151049934364729,1.98241918321121e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42145,-0.0210435580138513,0.00264667482117113,-0.0262310406633467,-0.0158560753643559,1.99683602647189e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0708504621175086,0.00890956808801481,-0.0883132155700176,-0.0533877086649996,2.01117527105012e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0289559462848366,0.00364270404780075,-0.0360956462185261,-0.0218162463511471,2.02930009638161e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0482471373965248,0.0060722974109302,-0.060148840321948,-0.0363454344711016,2.08719854747814e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.109640473714785,0.0138001908240527,-0.136688847729928,-0.0825920996996417,2.09648086244747e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0283320632358525,0.00356585923566653,-0.0353211473377589,-0.0213429791339461,2.11845074350328e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0313019967907232,0.00394450846951136,0.0235707601904809,0.0390332333909655,2.26040159603045e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0396945992172171,0.00500396617365869,-0.0495023729175882,-0.0298868255168461,2.31173180796672e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0242033525372227,0.00305546499634702,-0.0301920639300628,-0.0182146411443825,2.57668956623161e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0430280760627101,0.00543374045048371,-0.0536782073456582,-0.032377944779762,2.63215406899812e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0674469779867388,0.00852188591890854,-0.0841498743877996,-0.0507440815856781,2.67508712364273e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0830282807927183,0.0104908665268782,-0.1035903791854,-0.062466182400037,2.68009334592244e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0459520441566377,0.00580577136323521,-0.0573313560285787,-0.0345727322846967,2.70511593932019e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0447134262929824,0.00565593160849122,-0.0557990522456251,-0.0336278003403396,2.91419124932069e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0742980120217247,0.00941002628285188,-0.0927416635361144,-0.055854360507335,3.11120281382152e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.028598740911352,0.00362250059237312,-0.0356988420724033,-0.0214986397503007,3.12965069628905e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0960308773450625,0.0121695607235365,-0.119883216363194,-0.072178538326931,3.22569630734794e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0575433619270712,0.00729438092054382,-0.071840348531337,-0.0432463753228053,3.34272909517059e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42145,-0.0365368681193829,0.00463338640066973,-0.0456183054646956,-0.0274554307740702,3.36971102342076e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0409106924435558,0.00519117670688534,-0.0510853987890511,-0.0307359860980605,3.5484320732659e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0397925372116128,0.00504953445276583,-0.0496896247390338,-0.0298954496841918,3.56837885319261e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0268309454131906,0.00341214908641468,0.0201431332038178,0.0335187576225634,4.02156697437953e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0210916955172862,0.00268786698582661,-0.0263599148095064,-0.0158234762250661,4.57826545405512e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0262157623039995,0.00334392860079955,0.0196616622464324,0.0327698623615666,4.84385242008262e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.109406381123711,0.0139603144190078,-0.136768597384966,-0.0820441648624556,4.95888115266512e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,39850,-0.083724827470368,0.0106828112048688,-0.104663137431911,-0.0627865175088251,5.01638259584846e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0526809341225199,0.00672350958962951,-0.0658590129181938,-0.0395028553268461,5.0314081343604e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0776056579300363,0.00990763065415338,-0.0970246140121769,-0.0581867018478957,5.20366013919456e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0737543856755852,0.00942855728944828,-0.0922343579629038,-0.0552744133882665,5.56200191259988e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,39914,-0.0825040519523666,0.0105542181536215,-0.103190319533465,-0.0618177843712685,5.88134469335847e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0923016849314563,0.0118102809171976,-0.115449835529164,-0.069153534333749,5.97344101495681e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42299,-0.0286474195926758,0.00366852437593732,-0.0358377273695129,-0.0214571118158386,6.18265114786203e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0428296123094768,0.00548844599265354,-0.0535869664550777,-0.0320722581638758,6.45260875617596e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0604400424543882,0.00775820266838398,-0.0756461196844208,-0.0452339652243556,7.15412861129034e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0530569758355861,0.00680909666137753,-0.0664028052918861,-0.0397111463792861,7.1704950120374e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42296,-0.0407754840419787,0.00523538306403514,-0.0510368348474875,-0.0305141332364698,7.26977901656631e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,39870,-0.0274542249522788,0.00352606327397275,-0.0343653089692654,-0.0205431409352922,7.5166972400453e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,39934,-0.0436610256688272,0.0056211767485421,-0.0546785320959697,-0.0326435192416847,8.71252144095494e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0946490718096261,0.0121999187719168,-0.118560912602583,-0.0707372310166692,9.22566838313338e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0734515499887015,0.00947629685680531,-0.0920250918280399,-0.0548780081493631,9.76161253510076e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0306242443851221,0.00395167623849121,-0.0383695298125649,-0.0228789589576793,9.87245645719246e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0738129907876542,0.0095250276238132,-0.0924820449303281,-0.0551439366449803,1.00254841519378e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.052463882623792,0.00677388904661576,-0.0657407051551589,-0.0391870600924251,1.03706196176745e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0198012673580216,0.00256015132034216,-0.0248191639458923,-0.014783370770151,1.11138331108693e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0229426937404787,0.00296577968106561,-0.0287556219153673,-0.0171297655655902,1.11679583637214e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0657141221679904,0.00849719599085857,-0.0823686263100732,-0.0490596180259076,1.13373143873602e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0372685248983382,0.00482031353003785,0.027820710379464,0.0467163394172124,1.1369708920219e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0269905003692229,0.00349083419619225,0.0201484653446861,0.0338325353937597,1.15149345088291e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0287159187902738,0.0037152467117795,-0.0359978023453616,-0.0214340352351859,1.17522311514316e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0463583647970145,0.00600227029391591,-0.0581228145730896,-0.0345939150209393,1.21173843008314e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00767387448104634,0.000994104761083537,0.00572542914932261,0.00962231981277008,1.24968098055092e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0757490400737334,0.00981285463511436,-0.0949822351585576,-0.0565158449889093,1.26730500744639e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0253212685568404,0.00328202781421742,-0.0317540430727066,-0.0188884940409743,1.29233373999462e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0293527557044835,0.00380715834551561,-0.0368147860616941,-0.0218907253472728,1.34614906541245e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0394685111622639,0.00512146970593341,-0.0495065917858934,-0.0294304305386345,1.38496685184571e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0424265184160831,0.00550958464984053,-0.0532253043297706,-0.0316277325023957,1.44843304070914e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0543163141701859,0.00706025650498192,-0.0681544169199504,-0.0404782114204213,1.53560407645604e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0258864779153801,0.00336672150350072,0.0192877037685187,0.0324852520622415,1.58567679637571e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0348391671759797,0.00453950581383189,-0.0437365985710902,-0.0259417357808692,1.77823816096559e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.02238340658302,0.00291786705595119,-0.0281024260126843,-0.0166643871533556,1.82029132991495e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0298986429253258,0.00389755486185433,-0.0375378504545603,-0.0222594353960913,1.82107456489443e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0411991369669801,0.00537281762180309,-0.0517298595057142,-0.0306684144282461,1.86460735305482e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0370742581794369,0.00483490274425941,0.0275978488006885,0.0465506675581854,1.86516319006766e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,39930,-0.0480549591721062,0.00626838612870863,-0.0603409959843751,-0.0357689223598373,1.91577391396e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0200437305382381,0.00261576689747548,0.0149168274191861,0.02517063365729,1.94539813268502e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0189346944952048,0.00247361977700852,-0.0237829892581415,-0.0140863997322681,2.06762384192346e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,39657,-0.0377269275847437,0.00492822568690309,-0.0473862499310738,-0.0280676052384137,2.08963599724508e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,41900,-0.0411369516076392,0.005377852610766,-0.0516775427247406,-0.0305963604905378,2.15892962310577e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0391339867744536,0.00511614684427654,-0.0491616345892357,-0.0291063389596716,2.16083154104579e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0608574449175218,0.00796065022092197,-0.0764603193505289,-0.0452545704845148,2.23353158761227e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0272994962418125,0.00357205348887667,-0.0343007210800108,-0.0202982714036143,2.27377523358681e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0356898787637126,0.00468036199513708,-0.0448633882741813,-0.0265163692532439,2.59633642868754e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0624580545333674,0.00819280380763744,-0.0785159499963368,-0.046400159070398,2.66546385910015e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0301404608486535,0.00395465622403998,-0.0378915870477718,-0.0223893346495351,2.71229122720964e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42016,0.0214789826448818,0.00281960421035247,0.015952558392591,0.0270054068971727,2.75435837817648e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.101751372382431,0.0133697098800522,-0.127956003747333,-0.0755467410175288,2.91430641714809e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0500519390886852,0.0065782522330353,-0.0629453134654344,-0.037158564711936,2.95537618369855e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42070,-0.0485053634848983,0.00637741635965418,-0.0610050995498205,-0.0360056274199761,3.01874482045418e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.094217493176866,0.0124065622529069,-0.118534355192563,-0.0699006311611685,3.34119702462413e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAT,Catalase,39827,-0.043076636050388,0.00567745270358577,-0.0542044433494162,-0.0319488287513599,3.52413930392624e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,39966,-0.0699292673808239,0.00923069144325858,-0.0880214226096108,-0.0518371121520371,3.84800503886216e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.041428832852079,0.00546982214345367,-0.0521496842532482,-0.0307079814509098,3.85106729715641e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0859888017643407,0.0113675802496106,-0.108269259053577,-0.063708344475104,4.20376150824758e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,39736,0.0384697151867068,0.00508826794419847,0.0284967100160778,0.0484427203573358,4.33160894885536e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42170,0.0302231675103727,0.00400096633866579,0.0223812734865878,0.0380650615341576,4.491579560654e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,39930,-0.0644660116054781,0.00853458954285718,-0.0811938071094782,-0.0477382161014781,4.56300159884177e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFP,Properdin,39979,-0.019357590003111,0.00256336733493278,-0.0243817899795793,-0.0143333900266428,4.62732649595409e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0646489681735212,0.00856512491203671,-0.0814366130011132,-0.0478613233459293,4.70709392306032e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42145,-0.0285783546837324,0.00378645847672392,-0.0359998132981112,-0.0211568960693535,4.71924749573765e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0739513559760997,0.00981460400511142,-0.0931879798261181,-0.0547147321260813,5.20668872111121e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0263902387788099,0.00350377413367806,-0.0332576360808189,-0.0195228414768009,5.32829332473562e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0327403462075105,0.00434722545789587,-0.0412609081049864,-0.0242197843100346,5.33767806101469e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0345023805875796,0.0045883227653169,-0.0434954932076007,-0.0255092679675585,5.83495790375315e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0945494157369041,0.0126311102632136,-0.119306391852803,-0.0697924396210054,7.57300694787464e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,41913,-0.0358570750108132,0.00479531535857758,-0.0452558931136252,-0.0264582569080011,8.04706628734824e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.040823393837533,0.00547392026362629,-0.0515522775542406,-0.0300945101208255,9.44032593894356e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0712016034636519,0.00954929703192024,-0.0899182256462156,-0.0524849812810883,9.57048379674087e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0515532467461799,0.00691679627390441,-0.0651101674430325,-0.0379963260493272,9.76335546194744e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,39929,-0.110863700028122,0.0148793255369397,-0.140027178080524,-0.0817002219757204,9.9482543261302e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42137,0.0210147507246077,0.00282521173684956,0.0154773357203826,0.0265521657288329,1.08129475562246e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0643182346010589,0.00865221445168706,0.0473598942757522,0.0812765749263655,1.11906717838136e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0238154426125703,0.00320426626182874,-0.0300958044857546,-0.017535080739386,1.12941004113169e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0481514466038696,0.00648044702799769,0.0354497704289941,0.060853122778745,1.14960549561407e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0166917528956186,0.00224731809315674,-0.0210964963582058,-0.0122870094330314,1.17399720405757e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0188071386302604,0.00253310385239729,0.0138422550795617,0.0237720221809591,1.19903140186691e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,39979,-0.0219032807770509,0.00295062911746353,-0.0276865138472794,-0.0161200477068224,1.22424469605349e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,39757,-0.0434010119099329,0.00585703691700291,-0.0548808042672586,-0.0319212195526072,1.3536218313841e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0596219685169798,0.0080465212862614,-0.0753931502380521,-0.0438507867959074,1.35792139652395e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0350539609118869,0.00473449773576911,-0.0443335764739944,-0.0257743453497795,1.41814409056726e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0214983468987231,0.00290676386564767,-0.0271956040753925,-0.0158010897220537,1.48667734646712e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.018749018528659,0.00253636958826599,0.0137777341356577,0.0237203029216603,1.52930108326366e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0672812410134617,0.00910003103016422,-0.0851173018325835,-0.0494451801943398,1.53083242525086e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42137,-0.0345486885931556,0.00467390172331158,-0.0437095359708463,-0.0253878412154649,1.53313517908983e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0608118133255752,0.00822855527409871,-0.0769397816628087,-0.0446838449883418,1.55017151733521e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0613115453942689,0.00830009550157538,-0.0775797325773566,-0.0450433582111812,1.59142618599142e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0426982639196848,0.00578573579752329,-0.0540383060828304,-0.0313582217565391,1.6779678322385e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0360085719250597,0.00489857887073995,-0.04560978651171,-0.0264073573384094,2.08546907656566e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0425714840461735,0.00579901502702016,-0.053937553499133,-0.031205414593214,2.23892871621028e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0236501555071114,0.00322407830287756,-0.0299693489807514,-0.0173309620334714,2.33778923956577e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.019006303979218,0.00259160509176682,0.013926757999355,0.024085849959081,2.36360458477066e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0246771913356642,0.00336690020226482,-0.0312763157321032,-0.0180780669392251,2.44266721608557e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAYN,Layilin,41997,-0.0282656298440102,0.00386278208936413,-0.0358366827391639,-0.0206945769488565,2.67150529997154e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0531294982291798,0.00726485157976159,-0.0673686073255125,-0.0388903891328471,2.75443643180482e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0409626841009551,0.00561300286657318,-0.0519641697194385,-0.0299611984824716,3.08575589631848e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPART,Spartin,39736,-0.0616185395610155,0.00844192570262921,-0.0781647139381688,-0.0450723651838623,3.09407346196518e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0598811011468174,0.00821254955896497,-0.0759776982823888,-0.0437845040112461,3.23738347782319e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0709580581377215,0.00973817816875029,-0.090044887348472,-0.0518712289269709,3.35595522681089e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.044448698840152,0.00610218546689291,-0.0564089823552621,-0.0324884153250419,3.42158150614342e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,39990,-0.0551679060778397,0.00757420374730185,-0.0700133454225513,-0.040322466733128,3.46323250241729e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42137,-0.0354021770811355,0.00486145386901062,-0.0449306266643963,-0.0258737274978747,3.46500212773481e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0338859280603294,0.0046548463129503,-0.043009426833712,-0.0247624292869468,3.57079868495493e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,41900,0.0182777191791891,0.00251178177544209,0.0133546268993226,0.0232008114590556,3.61006487732984e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0627930587297835,0.00863219164077686,-0.0797121543457062,-0.0458739631138609,3.67721915965043e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0358957135666587,0.00493500324328834,-0.0455683199235038,-0.0262231072098135,3.68774751089853e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.093268867007914,0.0128197963493715,-0.118395667852682,-0.0681420661631458,3.68882262234601e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0371985010974329,0.00512622272497908,-0.0472458976383919,-0.0271511045564739,4.23276938143907e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RETN,Resistin,42105,-0.0336077448694201,0.00463529785620627,-0.0426929286675843,-0.0245225610712558,4.38151372017359e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42077,-0.019644710893302,0.00271339467172578,-0.0249629644498845,-0.0143264573367194,4.7333502440493e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0230888551245504,0.00319031387034,-0.0293418703104168,-0.016835839938684,4.82851565137223e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAX,Protein max,41839,-0.0830869269445306,0.011483816257023,-0.105595206808296,-0.0605786470807655,4.90668020485149e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0269507703672984,0.00372498655802838,-0.034251744021034,-0.0196497967135628,4.94969221558705e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42137,-0.0497759404074452,0.00688621242070906,-0.0632729167520349,-0.0362789640628554,5.15101593949469e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42119,-0.0256982546763199,0.00356124893969788,-0.0326783025981277,-0.0187182067545121,5.6359364185073e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0811225776906064,0.0112478632874676,-0.103168389734043,-0.05907676564717,5.79632369982354e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0719564500555907,0.0100251728590414,-0.0916057888593119,-0.0523071112518696,7.47172002682987e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0219258416675194,0.00305575813174454,-0.0279151276057387,-0.0159365557293001,7.58964963899916e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,39990,-0.0569590816171263,0.00794709485948338,-0.0725353875417137,-0.0413827756925389,8.1229287482298e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,39908,-0.0664986739831425,0.00927981037106215,-0.0846871023104244,-0.0483102456558607,8.20548687152284e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0334364460874236,0.00467028828386156,-0.0425902111237923,-0.0242826810510549,8.51856404640794e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42296,-0.0452170810752242,0.00631849526461446,-0.0576013317938685,-0.0328328303565798,8.70954720619677e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0368797848694034,0.00515476656523198,-0.0469831273372581,-0.0267764424015487,8.91489354774083e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0600545256706656,0.00839715297359307,-0.076512945498908,-0.0435961058424232,9.00464449994273e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42124,0.0444877590529075,0.00622936968960858,0.0322781944612747,0.0566973236445403,9.69537328582576e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0329013842514104,0.00460995546268571,-0.0419368969582744,-0.0238658715445464,1.00167866472944e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0721110207830312,0.0101048708462525,-0.0919165676416862,-0.0523054739243762,1.00827628939225e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42181,-0.0537718505375391,0.00755736407098171,-0.0685842841166632,-0.0389594169584149,1.17386326501435e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0235400044701633,0.00330845207458627,-0.0300245705363524,-0.0170554384039742,1.18570988037967e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0684230671714591,0.00961784653799013,-0.0872740463859197,-0.0495720879569984,1.1935501582824e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0487992035333505,0.00686293463974043,-0.0622505554272417,-0.0353478516394593,1.21314595095896e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,39930,-0.026891028495861,0.00378628378660266,-0.0343121447176022,-0.0194699122741198,1.30120851733239e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0700983023730718,0.00988730900209309,-0.0894774280171743,-0.0507191767289694,1.4105503482317e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0269525996876727,0.00380204321306135,-0.0344046043852729,-0.0195005949900724,1.41721303569715e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2,Brorin,41973,-0.0313098055771065,0.00441692110556056,-0.0399669709440052,-0.0226526402102078,1.42266580412902e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0673139842273942,0.00949454032558206,-0.085923283265535,-0.0487046851892534,1.42338711917063e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.020618947760648,0.00290892994020314,-0.0263204504434461,-0.0149174450778498,1.4396749070115e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0488747124666934,0.00689781132395911,-0.0623944226616533,-0.0353550022717336,1.45380398392361e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.053179800008097,0.00750431234907249,-0.0678882522122791,-0.0384713478039149,1.45915071241838e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42189,-0.027577489035766,0.00389357277536235,-0.0352088916754762,-0.0199460863960558,1.48193512501457e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0295851455515797,0.00418615147731341,-0.037790002447114,-0.0213802886560454,1.65783109876551e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0399384550789843,0.00566576507467057,-0.0510433546253386,-0.02883355553263,1.9073245039702e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0204479908539404,0.00290244030439517,-0.026136773850555,-0.0147592078573259,1.94296688979874e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0706108147026114,0.0100278997184334,-0.0902654981507409,-0.050956131254482,1.99612079777077e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,41751,-0.0824651658757453,0.0117312391161623,-0.105458394543423,-0.0594719372080672,2.17445960931372e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0397403660436354,0.00565898419868793,-0.0508319750730638,-0.0286487570142071,2.28523544841779e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0837367916158597,0.0119374147883934,0.0603394586306087,0.107134124601111,2.43785045769756e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0257454304813503,0.00367411777961192,-0.0329467013293897,-0.0185441596333109,2.56853868038767e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42035,-0.0513764903568598,0.00733845022123456,-0.0657598527904796,-0.0369931279232401,2.66211897017483e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0498608709955102,0.00712127699442091,-0.0638185739045752,-0.0359031680864452,2.67698560064651e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0467202236453982,0.00667629399538335,-0.0598057598763495,-0.0336346874144468,2.74399661222307e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0391102143348091,0.00559473016757114,-0.0500758854632486,-0.0281445432063697,2.89625346416566e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0281336300441224,0.00403031804962724,-0.0360330534213918,-0.020234206666853,3.08144505183392e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.036683023090038,0.00525779815305801,-0.0469883074700317,-0.0263777387100443,3.160922237757e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42296,-0.0267527598603958,0.00383862029531469,-0.0342764556392126,-0.019229064081579,3.32926147111597e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0487093883782509,0.00698974341797066,-0.0624092854774734,-0.0350094912790284,3.37647105464192e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42167,0.0158780516521696,0.00227999077541953,0.0114092697323473,0.0203468335719919,3.45759697174089e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0621166349183183,0.00892514519008653,-0.0796099194908879,-0.0446233503457487,3.56597318117107e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0330025351188373,0.00474452613852298,-0.0423018063503424,-0.0237032638873323,3.66409069108096e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0503209500855344,0.00723440569380436,-0.064500385245391,-0.0361415149256778,3.66750278556618e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0506076223512459,0.00727600975717892,-0.0648686014753166,-0.0363466432271752,3.71404869799779e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0540535976143865,0.00777591367184532,-0.0692943884112033,-0.0388128068175696,3.81531309617183e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42217,-0.0350478792230314,0.00504391461693667,-0.0449339518722272,-0.0251618065738355,3.85842732933928e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0417746353005588,0.00601644610778535,-0.0535668696718181,-0.0299824009292995,4.03707069721882e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.030011182948337,0.00432679235732777,-0.0384916959686994,-0.0215306699279746,4.21643933080618e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0749119841101693,0.0108011178402952,-0.0960821750771478,-0.0537417931431907,4.23098032131116e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0312270832222115,0.00451340646266373,-0.0400733598890324,-0.0223808065553906,4.81010910827009e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0517851366553922,0.00748672810683423,-0.0664591237447873,-0.0371111495659971,4.82381828177737e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0446362695692829,0.00645353766051849,-0.0572852033838992,-0.0319873357546667,4.87654811578031e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0494148043441849,0.00714896873471725,-0.0634267830642307,-0.0354028256241391,4.98748647237493e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0307958951737527,0.00445601418952387,-0.0395296829852195,-0.0220621073622859,5.02511032032809e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.020144391182445,0.00291653428402183,-0.0258607983791278,-0.0144279839857622,5.17192746020004e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0257855717323744,0.00373349402407158,-0.0331032200195547,-0.0184679234451941,5.23577951056246e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0408299386651427,0.00591884562252481,-0.0524308760852913,-0.029229001244994,5.5524413015731e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0628622918038961,0.00912138443041773,-0.0807402052875149,-0.0449843783202773,5.80875129963657e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0379056978699075,0.00550149069997904,-0.0486886196418664,-0.0271227760979485,5.8271879583334e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0499432921367496,0.00725273624612327,-0.0641586551791512,-0.035727929094348,6.04109603913799e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0628192988556918,0.00913293522679919,-0.0807198519002182,-0.0449187458111654,6.32676224013836e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0320541736070609,0.00466084655733316,0.0229189143546879,0.0411894328594339,6.42816756081476e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,39929,-0.0630223781328362,0.00916772635168731,-0.0809911217821434,-0.0450536344835291,6.55340674079952e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0388124672253936,0.00564905136427345,-0.0498846078993695,-0.0277403265514176,6.67823425955409e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0478319204266538,0.00696684434474376,-0.0614869353423516,-0.034176905510956,6.91398074728567e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0338803568408018,0.00493730834471755,-0.0435574811964482,-0.0242032324851554,7.14007552020537e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,39979,-0.0159252054858317,0.00232127459454968,-0.0204749036911491,-0.0113755072805143,7.21581706089496e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0357799969322006,0.00522306114596633,-0.0460171967782946,-0.0255427970861066,7.74689477835146e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0785191946407608,0.0114651044484011,-0.100990799359627,-0.0560475899218946,7.85310116870732e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0354531700402735,0.00517788884326177,-0.0456018321730665,-0.0253045079074804,7.92947437554202e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0892549204931898,0.0130896402657279,-0.114910615414017,-0.063599225572363,9.66637745991937e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0367311928549301,0.00539297175755575,-0.0473014174997394,-0.0261609682101209,1.01067842248946e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42137,-0.0279456477293549,0.00410374420134161,-0.0359889863639844,-0.0199023090947253,1.01862456622785e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.05267162008725,0.00774246416836342,-0.0678468498572423,-0.0374963903172577,1.06774446338044e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0613035437065416,0.0090247498231222,-0.0789920533598611,-0.0436150340532221,1.15695376324709e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0437958375542494,0.00645562545378825,-0.0564488634436744,-0.0311428116648245,1.22587620174811e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.030638596738061,0.0045201024958624,-0.0394979976299513,-0.0217791958461706,1.26600539245755e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,39946,-0.0350177031767904,0.00516892320512285,-0.0451487926588312,-0.0248866136947497,1.30867459372519e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0276271199933669,0.00408244906902701,-0.0356287201686598,-0.0196255198180739,1.37903031853937e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0512087539115395,0.00759067851992326,-0.066086483810589,-0.0363310240124899,1.57914779761721e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,39657,-0.0420456817228124,0.00624090606021859,-0.0542778576008408,-0.0298135058447839,1.69591882967259e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGN,Biglycan,41820,0.0861446257950786,0.0127902765024806,0.0610756838502166,0.111213567739941,1.70515142573077e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0661069659658262,0.00981359088692721,-0.0853416041042036,-0.0468723278274489,1.70576559020087e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0663450750702999,0.00985934297365577,-0.0856693872986652,-0.0470207628419346,1.79099820140259e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0414529816149153,0.00617168438366124,-0.0535494830068914,-0.0293564802229393,1.94865064073378e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0341181863697179,0.00508261523217787,-0.0440801122247865,-0.0241562605146493,1.98713372613945e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0241688693020513,0.00360371723270193,0.0171055835259555,0.0312321550781471,2.07104436865887e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0444204057168891,0.00662886180645846,-0.0574129748575477,-0.0314278365762305,2.15070216485077e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0632625220165791,0.00944170120838105,-0.081768256385006,-0.0447567876481522,2.17980989394859e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42166,-0.0222527737479415,0.00332472498455254,-0.0287692347176645,-0.0157363127782185,2.27048925811385e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0172459615784747,0.00257825067549399,-0.0222993329024429,-0.0121925902545064,2.33515557842135e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,39934,0.0355209966933931,0.00531302925380594,0.0251074593559335,0.0459345340308528,2.40718611546555e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,39930,-0.074984795724882,0.0112173229472751,-0.0969707487015413,-0.0529988427482227,2.42212808136402e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0636469668670968,0.00953067763627642,-0.0823270950341986,-0.044966838699995,2.53661727553663e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0340879451938826,0.00511241674316641,-0.0441082820104887,-0.0240676083772764,2.69877300501017e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0167716564953539,0.00251554134231099,-0.0217021175262834,-0.0118411954644243,2.72778469523192e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0600539298090132,0.00902448190215097,-0.0777419143372291,-0.0423659452807974,2.97493042759704e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,41751,-0.0538989699544526,0.0081248965281649,-0.0698237671496558,-0.0379741727592494,3.39947051948736e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0283457460747196,0.00427369219999485,-0.0367221827867095,-0.0199693093627297,3.44808302206473e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0175552210774806,0.002648630034446,0.0123639062099664,0.0227465359449947,3.52894229375806e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0643710480805688,0.00971921090520824,-0.0834207014547769,-0.0453213947063606,3.67687031215858e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0481415204732117,0.0072757545778464,-0.0624019994457907,-0.0338810415006328,3.81420044796038e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0416321705986782,0.0062940443725163,-0.0539684975688102,-0.0292958436285463,3.89521531095445e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0429146910500914,0.00649557949878398,0.0301833552324748,0.055646026867708,4.07390319113278e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0743924774868799,0.0112681042233386,-0.0964779617646237,-0.0523069932091362,4.24019154313298e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0241949119608167,0.00367219616410285,0.0169974074791751,0.0313924164424583,4.63964836290318e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,41839,-0.0583067305655121,0.008852261585856,-0.0756571632737899,-0.0409562978572344,4.66863580005733e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0400657573992564,0.00608382109938065,-0.0519900467540425,-0.0281414680444703,4.73244010218055e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0482447501711333,0.00735488133430096,-0.0626603175863632,-0.0338291827559034,5.59282638077138e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0308159544594244,0.00470046143396208,-0.0400288588699901,-0.0216030500488588,5.76862800950217e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,39586,-0.0456420501495736,0.00697787426495004,-0.0593186837088757,-0.0319654165902715,6.38377052799686e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0707010742006212,0.0108111520122887,-0.0918909321447071,-0.0495112162565354,6.43190551887936e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0879694545719599,0.0134536796379667,-0.114338666662375,-0.0616002424815452,6.48755107826726e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0168682487270472,0.00258454126075466,0.0118025478559681,0.0219339495981264,6.96775134478541e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0410524575883843,0.00629434745953248,-0.053389378609068,-0.0287155365677007,7.22734575058428e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0181161043612738,0.00277808696180985,-0.0235611548064211,-0.0126710539161265,7.28561272839956e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0260117523867159,0.00398977018857998,-0.0338317019563327,-0.0181918028170992,7.30346249764689e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0395478109028108,0.00606670532981084,-0.05143855334924,-0.0276570684563815,7.33493781169927e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0333148707784201,0.00511138345288848,-0.0433331823460815,-0.0232965592107586,7.44633050712842e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0400402675220278,0.00614452419771865,-0.0520835349495563,-0.0279970000944992,7.51387862774735e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0334577979329224,0.00513539831023746,-0.0435231786209878,-0.0233924172448569,7.57040356200912e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0168345284159135,0.00258638248095729,-0.0219038380785898,-0.0117652187532372,7.83899373502633e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0155845682293254,0.00239449869816435,-0.0202777856777276,-0.0108913507809233,7.85754911500593e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0602370455627339,0.00925644957072791,-0.0783796867213606,-0.0420944044041072,7.95940341939428e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0281069787514833,0.00433031432838618,-0.0365943948351202,-0.0196195626678463,8.83912610454726e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42185,0.0467304109912481,0.00720131213870264,0.0326158391993909,0.0608449827831053,8.93146205347445e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0505184916651013,0.00779255425316924,-0.065791898001313,-0.0352450853288896,9.31382144793443e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.031496344814622,0.00485831579136492,-0.0410186437656972,-0.0219740458635467,9.37267620208905e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0616978120179295,0.0095200333217484,-0.0803570773285564,-0.0430385467073027,9.50038029844176e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0503086683864947,0.00777209099268176,-0.065541966732151,-0.0350753700408385,9.93828480863949e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0509128023622538,0.0078720131506524,-0.0663419481375325,-0.035483656586975,1.0307381193056e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0566193042578752,0.00877441221783664,-0.073817152204835,-0.0394214563109153,1.1441257854232e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0682669353089645,0.0105885055145487,-0.0890204061174801,-0.047513464500449,1.17834663706547e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0471310746207081,0.00731568897494969,-0.0614698250116095,-0.0327923242298067,1.21521611480868e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0691621412352404,0.0107339008112559,-0.090200586825302,-0.0481236956451788,1.21614483723382e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0187093862080865,0.00290371850512527,-0.024400674478132,-0.0130180979380409,1.21657688744208e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0357573424841699,0.00555203366447057,-0.0466393284665322,-0.0248753565018076,1.23172940524231e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0280304840963065,0.00436037597625059,-0.0365768210097576,-0.0194841471828553,1.34073100281128e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0216605157315177,0.00337058993156987,-0.0282668719973947,-0.0150541594656408,1.35971129237735e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.062175676148625,0.00967667108474331,-0.0811419514747219,-0.0432094008225281,1.36014107866887e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0227616714750728,0.00354617076874522,-0.0297121661818135,-0.0158111767683322,1.42082648785182e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0251953907196179,0.00392745714215264,-0.0328932067182371,-0.0174975747209987,1.46434943185103e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0317686796152343,0.00495923148192508,0.0220485859106611,0.0414887733198074,1.54411667099315e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0252635026659018,0.00394495760465945,-0.0329956195710344,-0.0175313857607693,1.57555250631091e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0387470862080236,0.00605255159042993,-0.0506100873252663,-0.026884085090781,1.59845540402085e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0472575398495314,0.00739029328315761,-0.0617425146845203,-0.0327725650145425,1.66437830806172e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42174,0.0180623188163001,0.00282983986469329,0.0125158326815012,0.0236088049510989,1.79524386920845e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0724369766767865,0.0113551448474402,-0.0946930605777693,-0.0501808927758037,1.838334350363e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,39934,-0.053301041774781,0.00835501794962577,-0.0696768769560476,-0.0369252065935145,1.84559721174236e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0310120498412101,0.00486503784353027,-0.0405475240145295,-0.0214765756678908,1.89577694874376e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C3,Complement C3,39445,-0.0318359572454846,0.00500041520804996,-0.0416367710532626,-0.0220351434377067,2.00994442404847e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0580348626146209,0.00912789776066786,-0.0759255422255299,-0.0401441830037119,2.11152785104596e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.048174743881869,0.00759139399859244,-0.0630538761191102,-0.0332956116446278,2.28173336484563e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0196959204644806,0.00310451512567852,-0.0257807701108104,-0.0136110708181507,2.30550943695861e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42119,-0.0592863238309451,0.00935043480195521,-0.0776131760427774,-0.0409594716191129,2.36319494251172e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0681612656472486,0.0107508850172808,-0.089233000281119,-0.0470895310133782,2.38685926127198e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0300730096418675,0.00474572568662514,-0.0393746319876527,-0.0207713872960822,2.43613723982938e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0194286567638032,0.00306743244333652,0.0134164891748636,0.0254408243527427,2.4658182554644e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.039778453532257,0.00629016016034709,-0.0521071674465373,-0.0274497396179767,2.6306742093015e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0743652266678215,0.0117635299558178,-0.0974217453812243,-0.0513087079544187,2.67049657224044e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0209893272998293,0.00331979046459672,-0.0274961166104388,-0.0144825379892197,2.67240410428264e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0372985058616674,0.00589954710597913,-0.0488616181893865,-0.0257353935339484,2.67423314046346e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,41992,0.0225234220055967,0.00356391881572185,0.0155381411267818,0.0295087028844115,2.70118254719147e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.039154870262665,0.00619787236516548,-0.0513027000983893,-0.0270070404269406,2.74183441717082e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0281464565856891,0.00445484870502238,-0.036877960047533,-0.0194149531238453,2.74795513504491e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42087,-0.0452080838905789,0.00716145005517394,-0.0592445259987199,-0.031171641782438,2.82797097367568e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0250173644335894,0.00397984462311601,-0.0328178598948968,-0.017216868972282,3.37689038940342e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0375986075015078,0.00599094593905233,-0.0493408615420503,-0.0258563534609652,3.60259964820539e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0317037165564431,0.00505725103195775,-0.0416159285790803,-0.0217915045338059,3.74693598805495e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0245367926877727,0.00391933809248294,-0.0322186953490393,-0.0168548900265062,3.95739614450013e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0813882513959616,0.0130049559995903,-0.106877965155159,-0.0558985376367646,4.03632705450867e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0669046407067966,0.010691754297798,-0.0878604791304807,-0.0459488022831124,4.0504378824916e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0362021438898537,0.00580102843558154,-0.0475721596235935,-0.0248321281561139,4.51300915148241e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0403687773277009,0.00647010756027011,-0.0530501881458303,-0.0276873665095715,4.52711983099177e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0412305221986027,0.00661126583496699,-0.054188603235138,-0.0282724411620674,4.60901979955615e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0295988081589746,0.00474718866461363,-0.0389032979416173,-0.0202943183763319,4.68327700212596e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0219663420199875,0.00352754741359157,0.015052349089348,0.0288803349506269,4.92435403807992e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42310,0.0204421040085655,0.0032833438950792,0.0140067499742102,0.0268774580429207,4.92442942404955e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0574620359599932,0.009229837228886,-0.0755525169286097,-0.0393715549913766,4.93942622742198e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.050169871255974,0.00806807733839519,-0.0659833028392286,-0.0343564396727194,5.20482803146242e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0233574524817441,0.0037575752506905,-0.0307222999730975,-0.0159926049903907,5.24625626962706e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0263663064218993,0.00424176282909156,-0.0346801615669187,-0.0180524512768798,5.25793442401548e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0597798919762789,0.00962262382530751,-0.0786402346738816,-0.0409195492786762,5.4046701619227e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.029106100958294,0.0046903336564616,-0.0382991549249587,-0.0199130469916293,5.64604302676595e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0250351231768603,0.00403666458543971,-0.0329469857643221,-0.0171232605893985,5.77189649758082e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,41846,-0.0376178216284032,0.00607569476328189,-0.0495261833644357,-0.0257094598923707,6.13446629493688e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0472653937521572,0.00763981312634598,0.0322913600245191,0.0622394274797953,6.31970757582748e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0440987670783383,0.00713336088017037,-0.0580801544034722,-0.0301173797532044,6.5092328495991e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0189256977947109,0.00306839588119243,-0.024939753721848,-0.0129116418675737,7.11362776914951e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0437830471942632,0.00712193020711616,-0.0577420304002109,-0.0298240639883155,8.08926131119538e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0376195795105246,0.00613820805748797,-0.049650467303201,-0.0255886917178482,9.10824121946026e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0202059176748049,0.00329693624277497,-0.0266679127106438,-0.0137439226389659,9.15476581853282e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,39575,-0.0389314121823015,0.00635611223100044,-0.0513893921550623,-0.0264734322095406,9.37685575568132e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0318557310048947,0.0052052413495651,-0.0420580040500423,-0.0216534579597471,9.67073440983661e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0285240330904212,0.00466374087088434,-0.0376649651973545,-0.0193831009834879,9.85764372977644e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0776216445288439,0.0126997029207938,-0.1025130622536,-0.0527302268040881,1.01074596801013e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0300051177740421,0.00491515033050688,-0.0396388124218356,-0.0203714231262486,1.05878324313944e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0405421609207081,0.00664407182869884,-0.0535645417049578,-0.0275197801364583,1.07668609197602e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0223714750059759,0.00367300404560656,-0.0295705629353647,-0.015172387076587,1.16094213640919e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.022652256141784,0.00372195708008703,0.0153572202648134,0.0299472920187546,1.18795419513064e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0479789196810453,0.00788311074615264,-0.0634298167435045,-0.0325280226185861,1.19282509369148e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0436795196323862,0.00717706527702969,-0.0577465675753644,-0.029612471689408,1.19616203652705e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0341969716216961,0.00562233484929171,-0.0452167479263078,-0.0231771953170843,1.21700359422732e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0210721768656105,0.00346546427331969,-0.0278644868413171,-0.014279866889904,1.23678126072215e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0187587137890636,0.00308845283580624,0.0127053462308833,0.0248120813472438,1.28246610159412e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0230714393258472,0.00380057086869627,-0.0305205582284919,-0.0156223204232025,1.30966531159866e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0300214574720351,0.00494833341820072,-0.0397201909717085,-0.0203227239723617,1.33808580794142e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,39966,0.0327197862176093,0.00539556189668426,0.0221444849001081,0.0432950875351104,1.36822464320433e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0578724918684788,0.00954601041861199,-0.0765826722889583,-0.0391623114479993,1.38306727509826e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42144,-0.0213554048519152,0.0035284277004902,-0.028271123144876,-0.0144396865589544,1.46484352091656e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0313649807783486,0.00518584329284956,-0.0415292336323337,-0.0212007279243634,1.50403923928023e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0390959592471543,0.00646644670311508,-0.0517701947852598,-0.0264217237090487,1.53271849586423e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0222172566643427,0.0036763102505273,-0.0294228247553762,-0.0150116885733091,1.54964895050712e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0350349376155896,0.00580155926967111,-0.046405993784145,-0.0236638814470342,1.59210459154677e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0347377420714625,0.0057544958714856,-0.0460165539795742,-0.0234589301633507,1.61483893422735e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0296307974559467,0.00491722475195012,-0.039268557969769,-0.0199930369421245,1.73379347379766e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0251282952482716,0.00417434929495945,0.0169465706301511,0.0333100198663921,1.79222164570459e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0481741880639079,0.00800578802122967,-0.063865532585518,-0.0324828435422977,1.82783651550104e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,39886,-0.0186215565697382,0.00309499037945761,-0.0246877377134751,-0.0125553754260013,1.8355696133117e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0193890179596615,0.00322456704933473,-0.0257091693763576,-0.0130688665429654,1.87829622310772e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.040408613141796,0.00673103467935843,-0.0536014411133385,-0.0272157851702535,1.98212216156159e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0494979491270306,0.00824643057111721,-0.0656609530464203,-0.0333349452076408,1.99567370306348e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0563836479243106,0.00939904378800348,-0.0748057737487974,-0.0379615220998238,2.04760384089719e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.010016922913642,0.00167020061690391,0.00674332970451032,0.0132905161227736,2.06545488055972e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42119,-0.0443251992185739,0.00739219460843322,-0.058813900651103,-0.0298364977860448,2.07117119263979e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASN,Vasorin,41975,0.0177933475518213,0.00296755799291224,0.0119769338857133,0.0236097612179293,2.07504518482398e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42310,0.0173058577518871,0.00288692470957595,0.0116474853211183,0.022964230182656,2.09154052989125e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0243137707273575,0.00406051410523363,-0.0322723783736154,-0.0163551630810995,2.19233907040748e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0152850840302558,0.00255559594425802,-0.0202940520810015,-0.0102761159795101,2.2754339444204e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0576768921246754,0.00964917726252342,-0.0765892795592213,-0.0387645046901295,2.32443569540165e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.043049745566488,0.00721557560057061,-0.0571922737436064,-0.0289072173893696,2.50060230117478e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0342830073096203,0.00575240993733857,-0.0455577307868039,-0.0230082838324367,2.6011958748607e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0142716839249633,0.00239506363882487,-0.0189660086570601,-0.00957735919286661,2.60364716047091e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0285797293819374,0.00479680531015121,-0.0379814677898338,-0.019177990974041,2.61568959979941e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.022180548979378,0.00372751097597302,-0.0294864704922852,-0.0148746274664709,2.73931189109084e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42286,0.02828469131365,0.00475460859431226,0.018965658468798,0.037603724158502,2.76539274202188e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,39638,-0.0189778519060238,0.00319067188775139,-0.0252315688060166,-0.0127241350060311,2.79809909766472e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.0207059370772873,0.00348332117111199,-0.0275332465726669,-0.0138786275819078,2.84415832440905e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0482741824765006,0.00813023206362653,-0.0642094373212086,-0.0323389276317926,2.96318968186166e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0487667762074454,0.00821794323695363,-0.0648739449518746,-0.0326596074630163,3.04227624695585e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0462620171965053,0.00780347545820009,-0.0615568290945775,-0.0309672052984331,3.13543478524513e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,39990,-0.0482780262615138,0.00814429992524419,-0.0642408541149924,-0.0323151984080352,3.15859834395094e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.044101822925781,0.00744316828656328,-0.058690432767445,-0.0295132130841169,3.21246682205201e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0331655158778284,0.00560350616098786,-0.0441483879533646,-0.0221826438022922,3.32471132809426e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0498892371812351,0.00843196472472043,0.0333625863207831,0.0664158880416872,3.36480447681419e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42216,-0.0374455222336029,0.00633141322086853,-0.0498550921465052,-0.0250359523207006,3.41397297374807e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0293230833995224,0.00496014940885971,-0.0390449762408874,-0.0196011905581573,3.46671100528567e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0268050155680838,0.00453436838281002,-0.0356923775983914,-0.0179176535377761,3.47055463066148e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0392934199956303,0.00664677375504053,-0.0523210965555098,-0.0262657434357509,3.48705107733094e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0363118109708746,0.0061452244232384,-0.0483564508404218,-0.0242671711013273,3.52615643730065e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0461930960098771,0.00781828519420554,-0.0615169349905199,-0.0308692570292342,3.54060337705728e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0714261106593891,0.0120992629190748,-0.0951406659807757,-0.0477115553380025,3.64888835352877e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0187867539567221,0.00318292023379442,-0.0250252776149592,-0.0125482302984851,3.66918728236836e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0389479570905273,0.00660719693775273,-0.0518980630885227,-0.025997851092532,3.8622924021886e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,41913,-0.0726987301888044,0.0123372749601234,-0.0968797891106462,-0.0485176712669626,3.89337119007614e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0437202285211426,0.00742543749871112,-0.0582740860186164,-0.0291663710236688,4.00416676815769e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0794559774664184,0.0134947760304786,-0.105905738486156,-0.0530062164466802,4.02577807450856e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.027610273008914,0.00469090554897816,-0.0368044478849112,-0.0184160981329168,4.07083180995254e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0148214970584794,0.0025203794982222,-0.0197614408749949,-0.00988155324196391,4.18156240297463e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42016,0.0212142659355348,0.00361077352808583,0.0141371498204866,0.028291382050583,4.32167477151597e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0365423292269203,0.00622323201432356,-0.0487398639749945,-0.0243447944788461,4.43187218774437e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0580325960151056,0.00988531239312069,-0.0774078083056221,-0.038657383724589,4.44344691037589e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.0126432769984039,0.00215647133949012,-0.0168699608238046,-0.0084165931730033,4.65374166873819e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0436111930482274,0.00744173737260063,-0.0581969982985246,-0.0290253877979301,4.75084343775706e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0328076111115957,0.00560044080618496,-0.0437844750917182,-0.0218307471314732,4.81731440819545e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0712962091243119,0.0121780369282596,0.0474272567449231,0.0951651615037008,4.89661408992697e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.060196594873416,0.0102899515858982,-0.0803648999817764,-0.0400282897650555,5.05070157752311e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,39638,-0.0326645202209195,0.00558844680505855,-0.0436178759588342,-0.0217111644830047,5.20877510415785e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,41647,-0.0388688004391208,0.00665848475876949,-0.051919430566309,-0.0258181703119326,5.42550138434545e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0301919028793348,0.00517386979417351,-0.0403326876759149,-0.0200511180827548,5.48979692769493e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0241505546159769,0.0041456934443727,-0.0322761137669473,-0.0160249954650064,5.82806044305221e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.022599112995207,0.00388219875563881,-0.030208222556259,-0.0149900034341549,6.00339572910041e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.026344565484076,0.00452835374165757,0.0174689921504272,0.0352201388177248,6.12899385355838e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0398710808927547,0.00686364500941948,0.0264183366742926,0.0533238251112169,6.45838282354235e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0308094374000418,0.00530792201321791,-0.0412129645459489,-0.0204059102541347,6.63265932123222e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0754968845991059,0.0130312408631998,-0.101038116690978,-0.0499556525072343,7.07568416316038e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0260477332934421,0.0044980021017669,-0.0348638174129053,-0.017231649173979,7.15349805433394e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42185,-0.0227453719289352,0.00392809747694833,-0.0304444429837539,-0.0150463008741164,7.17590899957716e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0407112461573379,0.00703177337824282,-0.0544935219786938,-0.026928970335982,7.24699581322082e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0378202392139266,0.00655599171175189,-0.0506699829689603,-0.0249704954588929,8.19461128697222e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0261610586505659,0.00454117104250437,-0.0350617538938745,-0.0172603634072574,8.54929332678711e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0430469389213952,0.00747580102996405,-0.0576995089401248,-0.0283943689026657,8.68788323400766e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0273873041005648,0.00475715106110092,-0.0367113201803226,-0.018063288020807,8.74459293920314e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,41839,-0.0183274188336673,0.00318548817741695,-0.0245709756614045,-0.0120838620059301,8.93967857629403e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0227152607483536,0.00395666730190374,-0.0304703286600849,-0.0149601928366223,9.65316317233888e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,39575,-0.0244453321605171,0.00426061485278186,-0.0327961372719695,-0.0160945270490646,9.86191116644741e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0240278741595295,0.00419492665364818,-0.03224993040068,-0.0158058179183791,1.04305707526228e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.051808662562619,0.00905139005927678,-0.0695493870788015,-0.0340679380464365,1.06347296095579e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0461587672778136,0.00807369548915305,-0.0619832104365536,-0.0303343241190736,1.11085935003376e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0460955844463637,0.00806968875790163,-0.0619121744118508,-0.0302789944808765,1.14384636541188e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0147770938629103,0.00259161277671793,-0.0198566549052774,-0.00969753282054313,1.20959285843101e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0186736986002616,0.00327622395989481,0.0122522996388678,0.0250950975616554,1.22956474383014e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0324808862649747,0.00570152042013757,-0.0436558662884443,-0.0213059062415051,1.25140016578464e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42113,-0.0147707966203982,0.00259704379468625,-0.0198610024579832,-0.00968059078281313,1.315511405523e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0215315453250918,0.00378735356858539,-0.0289547583195191,-0.0141083323306644,1.34059915881431e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.0133446628422813,0.00234776160847977,0.00874305008966098,0.0179462755949017,1.34921141458125e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0250158317390821,0.00440215969662585,-0.0336440647444688,-0.0163875987336955,1.35350311113108e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPL,Periplakin,39657,-0.0199099643830032,0.0035060013289197,-0.0267817269876859,-0.0130382017783206,1.39044370243404e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0226667923064846,0.0039965801335929,-0.0305000893683266,-0.0148334952446425,1.44474325647795e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0453031770357609,0.00798816841296326,-0.0609599871251689,-0.0296463669463529,1.4529265476955e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42310,-0.0537958681015866,0.00951547798753573,-0.0724462049571566,-0.0351455312460165,1.6033770214e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0265326207291284,0.00469472514492692,-0.0357342820131852,-0.0173309594450716,1.62817079622904e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0366906438320375,0.00649891479154805,-0.0494285168234717,-0.0239527708406033,1.67827418028138e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0154517709446845,0.00274219764321362,-0.0208264783253833,-0.0100770635639858,1.78698720058169e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0173008175010581,0.00307098521478969,0.0112816864800703,0.0233199485220459,1.80729270667091e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0341035040712205,0.0060546124534344,-0.045970544479952,-0.0222364636624891,1.81835917335213e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0156454290021505,0.00278166231932882,-0.0210974871480349,-0.010193370856266,1.89781960095896e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.065968027079374,0.0117280023570039,-0.0889549116991016,-0.0429811424596465,1.90095180244142e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.014921418969374,0.00265531332272842,-0.0201258330819217,-0.00971700485682626,1.96151463015873e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0249319204167192,0.00443955785021819,-0.0336334538031469,-0.0162303870302916,1.99452731513738e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.025125498346093,0.00449004291435333,-0.0339259824582255,-0.0163250142339605,2.24800463265926e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0284402372358333,0.00511117217755888,-0.0384581347038487,-0.0184223397678179,2.69143274938632e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0318479261544553,0.00573023930931783,0.0206166571081923,0.0430791952007182,2.7824749709392e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0154341822272526,0.00277858911545721,-0.0208802168935487,-0.00998814756095644,2.83356592920071e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0308844389529297,0.00556171512304468,-0.0417854005940973,-0.0199834773117622,2.86122146207045e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42310,-0.0152135668371289,0.0027451188518009,-0.0205939997866587,-0.00983313388759914,3.04478369273608e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0446449139699094,0.00806232316107918,-0.0604470673656246,-0.0288427605741942,3.12639232787016e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0242174200497419,0.00437375997746216,-0.0327899896055677,-0.0156448504939161,3.14600349357369e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42070,-0.0270793458766428,0.00489758394630506,-0.0366786104114007,-0.0174800813418848,3.27824171144139e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0403565940654158,0.00729809961256213,-0.0546608693060376,-0.026052318824794,3.28056823868379e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0182359214091909,0.00329880445412057,0.0117702646791146,0.0247015781392672,3.30998658590975e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0430401943574581,0.00778798311145572,-0.0583046412559113,-0.0277757474590049,3.34043148713964e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0364462457698533,0.00659974997883614,0.0235107358113344,0.0493817557283721,3.41797751061508e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0678877550927256,0.0122975185937769,-0.0919908915365283,-0.0437846186489228,3.4433837351976e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0361951249848365,0.00655956512059899,-0.0490518726212105,-0.0233383773484624,3.4929898396141e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0757048630553622,0.013719264674529,-0.102594621817439,-0.0488151042932853,3.50265308380226e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0378464981437558,0.00685999857556056,-0.0512920953518545,-0.0244009009356571,3.51342819425724e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42070,0.0270983615704807,0.00491201068863935,0.0174708206207475,0.0367259025202138,3.51685611413462e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0293668097580601,0.00532413792862143,-0.0398021200981581,-0.0189314994179621,3.54843912558809e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0471909894816363,0.00855973414482624,-0.0639680684054957,-0.0304139105577768,3.60421303871931e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0664947515130948,0.0120759035152754,-0.0901635224030346,-0.0428259806231549,3.73071168454308e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0250490513979413,0.00454909936571684,-0.0339652861547463,-0.0161328166411363,3.74534183234115e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0367640909642317,0.00668080393362788,-0.0498584666741423,-0.023669715254321,3.80441450929654e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0280401896182108,0.00509517958706815,-0.0380267416088644,-0.0180536376275572,3.80900758279619e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LXN,Latexin,41960,0.0407118991184207,0.00740795317836326,0.0261923108888287,0.0552314873480127,3.96291431737745e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0297565076532962,0.00541563937963405,-0.040371160837379,-0.0191418544692135,3.98734562318545e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0490690263410768,0.00893349192171971,-0.0665786705076474,-0.0315593821745062,4.03004213692934e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0575457168263158,0.0104759029066792,-0.078078486523407,-0.0370129471292246,4.03352109460581e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0427506111805156,0.00779079706558072,-0.0580205734290538,-0.0274806489319774,4.16858569192165e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42224,-0.0411156685167126,0.00751836396126961,-0.055851661880801,-0.0263796751526242,4.61340985506089e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42137,-0.0431128964358557,0.00788596360597158,-0.05856938510356,-0.0276564077681514,4.65714327558911e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0550031173833945,0.0100667604088567,-0.0747339677847537,-0.0352722669820353,4.7420548077878e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0265503726471267,0.00485986880653692,-0.0360757155079391,-0.0170250297863144,4.77813250263506e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0463100531127497,0.00847864767033655,-0.0629282025466094,-0.0296919036788901,4.80842872295508e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0214587910443562,0.00393203206611404,-0.0291655738939397,-0.0137520081947727,4.93513292273236e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0351741046567185,0.00644721381269219,-0.0478106437295952,-0.0225375655838419,4.96503313076471e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0141572694936726,0.00259816603172709,-0.0192496749158577,-0.00906486407148747,5.15561836817934e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0228029231493726,0.0041892185443373,-0.0310137914962737,-0.0145920548024715,5.34458954066247e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0486911761031792,0.00894783194590922,-0.0662289267171613,-0.0311534254891971,5.37020107461198e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,41843,-0.033639988825548,0.00618423773414202,-0.0457610947844664,-0.0215188828666297,5.43384450632279e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0296357224162003,0.00544841712825256,-0.0403146199875753,-0.0189568248448253,5.44321826471902e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0350475629408495,0.00644699011343957,0.0224114623185079,0.047683663563191,5.53424765486205e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0425014841868518,0.00781799523408289,-0.0578247548456543,-0.0271782135280494,5.55029895620505e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0279349057481412,0.00514830840187311,-0.0380255902158125,-0.0178442212804699,5.86112399903412e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.02565043596631,0.00472726473110895,-0.0349158748392836,-0.0163849970933365,5.88281133908298e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0556833929083231,0.0102686109922928,-0.0758098704532171,-0.0355569153634292,5.97246489113418e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0260047435531028,0.00479654671346494,-0.0354059751114941,-0.0166035119947115,6.03344163839003e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0285503207382895,0.00527141601692342,-0.0388822961314594,-0.0182183453451196,6.19676906148063e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0329976944551113,0.00609544290458937,-0.0449447625481065,-0.0210506263621162,6.31055644113561e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0629223437032563,0.0116241138261503,-0.085705606802511,-0.0401390806040017,6.32105537375226e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42016,-0.0191379900178939,0.00354758512028339,-0.0260912568536493,-0.0121847231821385,6.98213280866457e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0260347036366134,0.00482646679507612,-0.0354945785549626,-0.0165748287182642,7.00255040097374e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0385563422548678,0.00715316944642403,-0.0525765543698589,-0.0245361301398767,7.18277941841439e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI3,Elafin,41966,-0.0327103924275806,0.0060794714909495,-0.0446261565498416,-0.0207946283053196,7.55457017238865e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0225217997300219,0.00418667384681038,-0.0307276804697703,-0.0143159189902736,7.59785853578061e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0400531580284958,0.00745064727729457,0.0254498893649984,0.0546564266919931,7.75164056209216e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0337693135695968,0.00628628923665096,-0.0460904404734327,-0.0214481866657609,7.92292545275581e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,39929,-0.0221591493049763,0.00413714198683305,-0.0302679475991691,-0.0140503510107835,8.66778867787377e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0437342803836128,0.00817688761480632,-0.0597609801086331,-0.0277075806585924,9.01526129393905e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0308467820402371,0.0057760157879452,-0.0421677729846097,-0.0195257910958645,9.42254910214065e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.035458485647416,0.00664977031997434,-0.0484920354745657,-0.0224249358202662,9.88421455550542e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.0148042791887097,0.00277665635301366,-0.0202465256406165,-0.00936203273680294,9.9172224077864e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,41654,0.0181371518715113,0.00340726023503238,0.0114589218108478,0.0248153819321748,1.03708735732405e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0360860905664946,0.00677916631236557,-0.0493732565387311,-0.0227989245942581,1.04019422322209e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.018766134137561,0.00353974697951374,-0.0257040382174079,-0.011828230057714,1.1662609509663e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0249333693011627,0.00471229161813035,-0.0341694608726981,-0.0156972777296272,1.2349779611105e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0219949822237438,0.00416268407160335,0.0138361214434012,0.0301538430040863,1.28489807777837e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0417584697265934,0.0079154826741958,-0.0572728157680172,-0.0262441236851697,1.34454184671836e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,41756,-0.0419436664541651,0.00795323447061802,-0.0575320060165764,-0.0263553268917538,1.35754219395475e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.030816575384636,0.00584386975051327,-0.042270560095642,-0.01936259067363,1.36044273779933e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0335948477229964,0.00637625809072978,-0.0460923135808268,-0.021097381865166,1.39489366669438e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,39990,-0.0529228021379121,0.0100440119775891,-0.0726090656139867,-0.0332365386618376,1.39604716189194e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0461517984091818,0.0087759728744841,-0.0633527052431706,-0.028950891575193,1.47178769729192e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0398063753603868,0.00757371112827555,0.0249619015489668,0.0546508491718069,1.49636397757426e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0236519775084674,0.00450041021320207,-0.0324727815263435,-0.0148311734905914,1.4990290629002e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.0114319024712603,0.00217672761837445,-0.0156982886032743,-0.00716551633924643,1.53288346089012e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,39657,-0.023862187725352,0.00454488787452623,-0.0327701679594234,-0.0149542074912806,1.54638460631687e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42144,-0.0168267593698323,0.00320674568748625,-0.0231119809173054,-0.0105415378223593,1.56672606390629e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0403747878522921,0.00771246550340618,-0.0554912202389682,-0.025258355465616,1.67979671040445e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0233510906784252,0.00448118319234884,-0.0321342097354289,-0.0145679716214215,1.90729140458906e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0260251020646413,0.00499484496121136,-0.0358149981886156,-0.016235205940667,1.91193048345754e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0296375957738507,0.00568956196664437,-0.0407891372284737,-0.0184860543192278,1.93074747965926e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0182940372646245,0.00351581143639218,-0.0251850276799532,-0.0114030468492958,1.99127789902624e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0399993858736371,0.00771223313821319,-0.0551153628245349,-0.0248834089227392,2.17988603187709e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,39919,-0.04798380254463,0.00928260447230222,-0.0661777073103424,-0.0297898977789177,2.39084316051277e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0446883190037954,0.00865561337397098,-0.0616533212167785,-0.0277233167908123,2.46637932124937e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.013843579891337,0.00268533719617104,-0.0191068407958322,-0.00858031898684172,2.57678352389401e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42262,-0.0156745977282451,0.00304173399573429,-0.0216363963598843,-0.00971279909660589,2.59678485014597e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0383582469314596,0.0074437109106612,-0.0529479203163556,-0.0237685735465637,2.59797044963173e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,39742,-0.0122019266632844,0.00237019918765749,-0.0168475170710931,-0.00755633625547576,2.67682172225977e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0205934362300588,0.00400129565941501,-0.0284359757225122,-0.0127508967376054,2.68820066988831e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0167404388876669,0.0032539001438557,-0.0231180831696241,-0.0103627946057097,2.71619872648713e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0359453801647123,0.0069891740715188,-0.0496441613448892,-0.0222465989845355,2.75001338852216e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0369116883404458,0.00718219223622564,-0.0509887851234481,-0.0228345915574436,2.802935852368e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.043357460053943,0.00843932725717745,-0.0598985414780108,-0.0268163786298752,2.8221994460488e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0617838153701674,0.0120250420260469,0.0382147329991155,0.0853528977412193,2.82686513189129e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0172647599326427,0.00336145162469361,-0.0238532051170422,-0.0106763147482432,2.84341322019455e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0675638233929208,0.0131804963887213,-0.0933975963148145,-0.041730050471027,2.99969861012965e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.034143304640305,0.00666141725243179,-0.0471996824550713,-0.0210869268255386,3.00785149228939e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0151813573246951,0.00296270265713707,0.00937446011670642,0.0209882545326837,3.03808332262406e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0661209388145677,0.012919555291291,-0.091443267185498,-0.0407986104436374,3.13186548085764e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0135881608200523,0.00265545435037092,0.00838347029332527,0.0187928513467793,3.15368543272082e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0319416985495046,0.0062664308950707,-0.0442239031038431,-0.019659493995166,3.49273497070009e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0190149003926776,0.00373217042916053,-0.0263299544338323,-0.011699846351523,3.53747707064907e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0121567493078939,0.00238648514070428,0.00747923843211351,0.0168342601836743,3.56214422140131e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,39794,-0.0180778188120838,0.00355188888370755,-0.0250395210241506,-0.011116116600017,3.64576401503285e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0239272505367294,0.00471083014012752,-0.0331604776113793,-0.0146940234620794,3.84180754742173e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.013838565050923,0.00272695572047142,0.00849373183879898,0.0191833982630469,3.93152197538159e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0481497794264862,0.00950218495399248,-0.0667740619363115,-0.0295254969166609,4.10115849730479e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0221156327368725,0.00436477119418447,-0.0306705842774741,-0.0135606811962709,4.10830612116468e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0183939931419854,0.00363458746553688,-0.0255177845744377,-0.0112702017095331,4.24006040301463e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0125202258234889,0.00247440738909413,-0.0173700643061134,-0.00767038734086438,4.26077766448745e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0269839419273645,0.00533559126845312,0.0165261830411964,0.0374417008135326,4.31908648066244e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0182328904318959,0.0036074019588375,-0.0253033982712174,-0.0111623825925744,4.37618596658474e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0223863395580273,0.00443572610805179,-0.0310803627298088,-0.0136923163862458,4.56143322211455e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.029182886918583,0.0057951303654251,-0.0405413424348162,-0.0178244314023498,4.83474472361712e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0116817363942157,0.00232042078534475,-0.0162297611334914,-0.00713371165493996,4.85746272065139e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.069960207600591,0.0138957584636442,-0.0971958941893336,-0.0427245210118485,4.86093033730614e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0341019209728647,0.00678311036932005,-0.047396817296732,-0.0208070246489974,5.04577210078742e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42119,-0.0270254113868891,0.0053808825101626,-0.0375719411068078,-0.0164788816669704,5.16571018772434e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0545317661313977,0.0108834671663375,-0.0758633617774193,-0.0332001704853761,5.51036440514704e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,39990,-0.0118585576906306,0.00236677040075546,-0.0164974276761113,-0.00721968770514987,5.51211901084137e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,41814,-0.0198001459984067,0.00395847237257198,-0.0275587518486478,-0.0120415401481656,5.7477206772365e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELL,L-selectin,39979,0.0126249330695634,0.00252474551301608,0.00767643186405189,0.0175734342750749,5.8041050228413e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.046254301848383,0.00927049492378578,-0.0644244718990032,-0.0280841317977629,6.14852790098503e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42145,-0.0218616173534941,0.00438441028368481,-0.0304550615095163,-0.0132681731974719,6.23351624452406e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0251967122912189,0.00505937063356334,0.0152803458494347,0.035113078733003,6.44829315885938e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0655163348935768,0.0131595827805478,-0.0913091171434505,-0.0397235526437032,6.48342758215209e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0335667038288261,0.00674266645516517,-0.0467823300809498,-0.0203510775767023,6.49496757325501e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.024284896630809,0.00488389977887992,-0.0338573401974136,-0.0147124530642043,6.70850678402372e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,-0.00720728842175431,0.00145223282869671,-0.0100536647659999,-0.00436091207750875,7.04707097713754e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0257093806499184,0.00518732380052654,-0.0358765352989504,-0.0155422260008864,7.2927525643865e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0515654035116905,0.0104091016074861,-0.0719672426623632,-0.0311635643610178,7.38181846955539e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0286732930239013,0.00579731964683207,-0.0400360395316921,-0.0173105465161104,7.6857963792925e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0200402736838956,0.00405553929494849,-0.0279891307019947,-0.0120914166657966,7.86491764897479e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,39736,-0.0211236305488001,0.00427490430165662,-0.0295024429800471,-0.0127448181175531,7.87279770323674e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,39638,-0.0159809348212204,0.00323694430565407,-0.0223253456603023,-0.00963652398213838,8.04760302063948e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0391093808375828,0.00792508068380784,-0.0546425389778462,-0.0235762226973195,8.11521411685433e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0441581381222764,0.00895678555884011,-0.061713437817603,-0.0266028384269498,8.31490312579262e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0376646905910833,0.0076443595251805,-0.0526476352604371,-0.0226817459217295,8.46679563380058e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),39775,0.0973228420267151,0.0197732331855175,0.0585673049831008,0.136078379070329,8.69099924573335e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0554881551999298,0.0112819128312903,-0.0776007043492589,-0.0333756060506008,8.83162184521271e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0211410298934036,0.00430153910241375,-0.0295720465341345,-0.0127100132526726,9.0155550264597e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FST,Follistatin,42166,0.0259125373198534,0.00527306305805349,0.0155773337260686,0.0362477409136383,9.02171593367329e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0156267450054942,0.00318218258278124,-0.0218638228677455,-0.00938966714324298,9.20178305624903e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42148,-0.0501614172865147,0.0102178521222802,-0.0701884074461839,-0.0301344271268456,9.25166837926779e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0541490788148464,0.0110369432250889,-0.0757814875360207,-0.0325166700936722,9.39645037454986e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,39897,-0.0493202384049651,0.0100523362465278,-0.0690228174481595,-0.0296176593617706,9.40832055613604e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0143897596852192,0.00293690800479726,-0.0201460993746219,-0.00863341999581662,9.73391592223522e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0446310083650239,0.0091122399383501,-0.0624909986441901,-0.0267710180858577,9.81911544495241e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.010188660531607,0.00208105423085502,0.00610979423913115,0.0142675268240828,9.89713225557088e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0187403261989601,0.00383130584960351,-0.026249685664183,-0.0112309667337373,1.01293821166258e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,41910,-0.0388441804798625,0.00795391511164394,-0.0544338540986846,-0.0232545068610403,1.05347035412672e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0165211305211222,0.0033833228299794,0.00988981777436259,0.0231524432678818,1.05899033114449e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0296148254419985,0.0060877968810288,-0.0415469073288149,-0.017682743555182,1.16236942417047e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0363638221286616,0.00749748446210977,-0.0510588916743968,-0.0216687525829265,1.25017888310867e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0143182003763769,0.00296232582667564,-0.0201243589966612,-0.00851204175609268,1.35959935913875e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0196224136748939,0.00406175670478635,-0.0275834568162751,-0.0116613705335126,1.37612494816262e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0302075005505182,0.0062578822660936,-0.0424729497920616,-0.0179420513089747,1.400735700414e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42083,-0.0183587300977925,0.00380757212182457,-0.0258215714565687,-0.0108958887390164,1.43939363363982e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0251832865780663,0.00523018091978243,-0.0354344411808398,-0.0149321319752927,1.48832318014571e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0204904088373365,0.0042589439024181,-0.0288379388860759,-0.012142878788597,1.52000036280056e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0319077339993722,0.00664501159775983,-0.0449319567309815,-0.018883511267763,1.59345152741112e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0156424347771794,0.00326226028005089,-0.0220364649260792,-0.00924840462827969,1.64447751281597e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.034060249940916,0.00710884020860271,-0.0479935767497773,-0.0201269231320547,1.67899902237545e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0205666709341207,0.00429999614984786,-0.0289946633878225,-0.0121386784804189,1.74573960536806e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,41984,-0.0181774151063185,0.00380194044552828,-0.0256292183795539,-0.0107256118330831,1.76204188157794e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,41913,-0.0365993391917502,0.0076619088569563,-0.0516166805513845,-0.0215819978321158,1.80014059656451e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0327304593394351,0.00685502149155604,-0.046166301462885,-0.0192946172159853,1.8232969850845e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0484136161168142,0.0101513359050918,-0.0683102344907941,-0.0285169977428344,1.86908815398318e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0275334701262588,0.00578132347288158,-0.0388648641331067,-0.0162020761194109,1.9321507307004e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,39736,0.0501949272106617,0.0105387807288433,0.0295389169821289,0.0708509374391946,1.93259195328607e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0168481538823078,0.00354131905433887,-0.023789139228812,-0.00990716853580361,1.97959452150892e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0392599802037378,0.00825943966171213,-0.0554484819406936,-0.0230714784667821,2.02622181813221e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0301212344474796,0.00635048263082322,-0.0425681804038931,-0.0176742884910661,2.12596492448223e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.04911730611763,0.0103699926475406,-0.0694424917068095,-0.0287921205284505,2.19661994170765e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.045075574457022,0.00954520787543529,-0.0637841818928751,-0.0263669670211688,2.35494785848146e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0224274801613245,0.00475517719744758,-0.0317476274683218,-0.0131073328543272,2.42879654248065e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0151198133117012,0.00320815343732507,-0.0214077940488583,-0.00883183257454406,2.47155216588559e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.013833576225938,0.00294349561068003,0.00806432482900511,0.0196028276228708,2.63100542637516e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0179433981490258,0.00382185670173425,-0.0254342372844249,-0.0104525590136267,2.69812985454995e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0228933747199628,0.00487683678886329,-0.0324519748261349,-0.0133347746137908,2.70650111532481e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0504356965519351,0.0107505037489378,-0.0715066838998531,-0.0293647092040171,2.7390245585198e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0333864605392217,0.00712172090576113,0.0194278875639299,0.0473450335145135,2.78606291460151e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00881837602116158,0.00188480829140653,0.00512415177000479,0.0125126002723184,2.91559686960326e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,38503,-0.0542696347127064,0.0116061388711977,-0.0770176669002539,-0.031521602525159,2.96475743711832e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,41839,0.0377635354483497,0.00809535144020593,0.0218966466255461,0.0536304242711533,3.11877066281075e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0604778083061053,0.0129951606429795,-0.0859483231663451,-0.0350072934458656,3.28853602182607e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42119,-0.0160474058810849,0.003449116137727,-0.0228076735110299,-0.00928713825114002,3.3086300427967e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0279386427014082,0.00601682306537833,-0.0397316159095497,-0.0161456694932667,3.46635173826298e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0268029698402088,0.00578158516633089,-0.0381348767662173,-0.0154710629142002,3.58746894896371e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0220967131014345,0.0047690884312092,-0.0314441264266045,-0.0127492997762645,3.63863177081123e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0286841631252331,0.00619138357443072,0.0165490513193489,0.0408192749311173,3.63950554807749e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIM,Vimentin,41900,-0.0575102427015012,0.0124215533359272,-0.0818564872399185,-0.0331639981630839,3.6934875159805e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,39854,-0.0216503781051058,0.0046775116257056,-0.0308183008914887,-0.0124824553187228,3.7224362809761e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,39657,-0.025647239882453,0.00554489403829148,-0.0365152321975043,-0.0147792475674017,3.78156685939113e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0246316570676551,0.00533959122328723,0.0141660582700121,0.035097255865298,4.00528160047866e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0350493281232785,0.00761101894262063,-0.0499669252508149,-0.0201317309957421,4.16881496353775e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42249,-0.0139472248049369,0.00303363442897826,-0.0198931482857343,-0.00800130132413955,4.31366741153539e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0313810496808501,0.0068303265641391,-0.0447684897465627,-0.0179936096151374,4.38866632337825e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0613286052379082,0.0133528818177076,-0.0875002536006151,-0.0351569568752012,4.41932513787811e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0181914875111988,0.00396107745141445,-0.0259551993159711,-0.0104277757064264,4.42718552527688e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0226188935632723,0.00492646168941405,-0.0322747584745238,-0.0129630286520208,4.44536028336034e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0294139717054443,0.00640746419655876,-0.0419726015306994,-0.0168553418801891,4.46894192379877e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0318589531358912,0.00694059881700333,-0.0454625268172177,-0.0182553794545647,4.47643387702057e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0345865829260883,0.007543122152853,-0.0493711023456801,-0.0198020635064964,4.58607849916026e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0288288049460898,0.00629127343138697,-0.0411597008716082,-0.0164979090205713,4.63929313467538e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00405031784883592,0.000884587225436068,0.00231652688698122,0.00578410881069061,4.7276949474945e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42137,0.0116064664734265,0.00254322625074112,0.00662174302197389,0.0165911899248791,5.07072375495263e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0146675940753861,0.0032221359010831,-0.020982980441509,-0.00835220770926323,5.36575978981871e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42070,-0.0209770875002517,0.00461077723630602,-0.0300142108834115,-0.0119399641170919,5.42233686642737e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42249,0.0148077738609984,0.00325558477196901,0.00842682770793917,0.0211887200140577,5.45151360425929e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0436606393012613,0.0096034617023991,-0.0624834242379636,-0.0248378543645591,5.51515586360164e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0261343353377878,0.00574934334044733,0.014865622390511,0.0374030482850646,5.52437148901653e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,41960,-0.0198546685774666,0.00437293911077631,-0.0284256292345881,-0.011283707920345,5.66520835023559e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0450472306678627,0.00994295884138522,-0.0645354299969778,-0.0255590313387477,5.93414127316897e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0150385605088282,0.00332289314376354,-0.0215514310706048,-0.0085256899470517,6.06946993018049e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0416857220259606,0.009215963972723,-0.0597490114124977,-0.0236224326394235,6.1429671651746e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0242615652469315,0.00537049835059902,-0.0347877420141056,-0.0137353884797574,6.32042320212027e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,39934,-0.0125187886826458,0.002772365296889,-0.0179526246645483,-0.00708495270074341,6.3786310073643e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0214567512038445,0.00475191504610222,-0.0307705046942048,-0.0121429977134841,6.3838283576803e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,39713,0.0142051683905001,0.00314688062042129,0.00803728237447433,0.0203730544065258,6.42559097566071e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0535220971212804,0.0118628177582041,-0.0767732199273605,-0.0302709743152003,6.48366414303705e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42138,-0.0199584610404732,0.00442735813586817,-0.0286360829867749,-0.0112808390941716,6.59955425838308e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.058717831632519,0.013029711618015,-0.0842560664038285,-0.0331795968612096,6.64695793887091e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.036258061721159,0.00804600876017218,-0.0520282388910964,-0.0204878845512215,6.65199398110151e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0230967643213092,0.00513329854742142,-0.0331580294742552,-0.0130354991683633,6.88346808204102e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0118634824775176,0.00263791291961111,-0.0170337917999553,-0.0066931731550798,6.93973678854265e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.024963472558607,0.00556446692557306,0.0140571173844837,0.0358698277327302,7.32064463276507e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0168350723375386,0.00376398825214079,0.0094576553633427,0.0242124893117346,7.80257371525145e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0112908707196615,0.00252622564141662,-0.0162422729768381,-0.00633946846248495,7.91977850601808e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.019304896223148,0.00432046174478689,-0.0277730012429303,-0.0108367912033657,7.96386002090207e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0280945626662035,0.00629349325318655,-0.0404298094424492,-0.0157593158899579,8.10861922182912e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.018112289929675,0.00406636250352654,-0.026082360436587,-0.010142219422763,8.50239816187307e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0321435175387248,0.00722630639909321,-0.0463070780809475,-0.0179799569965021,8.73300588204133e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0159508531156055,0.00358656389314615,-0.0229805183461719,-0.00892118788503903,8.77617010919033e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0284776054452142,0.0064041169983026,-0.0410296747618873,-0.0159255361285411,8.80296995351384e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42107,-0.0193452265420297,0.00435268109195773,-0.0278764814822669,-0.0108139716017925,8.88232132511167e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0277564946655005,0.00624819086172912,-0.0400029487544895,-0.0155100405765114,8.98584117537683e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0491430552342227,0.0110765116338246,-0.070853018036519,-0.0274330924319264,9.22373607904723e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0195896159801348,0.0044197083151955,-0.028252244277918,-0.0109269876823517,9.39698646920367e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0150322429703921,0.00339723821295332,-0.0216908298677806,-0.0083736560730036,9.72795680120434e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0174406428592712,0.00394541882482688,-0.0251736637559319,-0.00970762196261049,9.9400289437903e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0235888666926732,0.00534487263302378,-0.0340648170533999,-0.0131129163319466,1.02563635515076e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0151166967480328,0.00343288867361959,-0.0218451585483272,-0.00838823494773837,1.07343393854662e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0226703069168038,0.00516823163633139,-0.0328000409240133,-0.0125405729095943,1.16240986029417e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0131219216845654,0.00299510861964611,-0.0189923345790718,-0.00725150879005902,1.19134070512175e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,41843,-0.0310999148348612,0.00711140037250084,-0.0450382595649629,-0.0171615701047596,1.23346451292655e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0189700215588417,0.00434037801985485,-0.0274771624777572,-0.0104628806399262,1.25015066960237e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.034831383026018,0.00797337686888668,-0.0504592016890359,-0.0192035643630001,1.26077087321156e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.00683038412161192,0.00156867306500975,-0.00990498332903102,-0.00375578491419282,1.34696961081594e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCT,Secretin,39649,-0.0227659623673783,0.00523193945036894,-0.0330205636901014,-0.0125113610446552,1.36521711711069e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0158368773132271,0.00365598798131853,-0.0230026137566114,-0.00867114086984274,1.4900877199657e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0539622597576153,0.012458159364803,-0.0783802521126291,-0.0295442674026014,1.49385680199919e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0141878891126162,0.00328218148469017,-0.020620964822609,-0.00775481340262351,1.55446482719588e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0458321308335259,0.0106150294874785,-0.0666375886289838,-0.025026673038068,1.59073513104945e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0136996354204611,0.003174668450108,-0.0199219855826727,-0.0074772852582494,1.60764901196375e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0363834014605334,0.0084478472812129,-0.0529411821317107,-0.0198256207893561,1.67009077061189e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0249296013372367,0.005800949678363,-0.0362994627068282,-0.0135597399676452,1.73936884428682e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.0189206028678924,0.00440306601608675,-0.0275506122594224,-0.0102905934763623,1.74494135789084e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0199717863373359,0.00465286371724052,-0.0290913992231274,-0.0108521734515445,1.78030760313234e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0119842449020992,0.00279218291377477,0.00651156639110067,0.0174569234130978,1.78485750931984e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0211847809109,0.00493692087902406,0.0115084159880129,0.0308611458337872,1.79061584956985e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,41900,-0.0365220713384132,0.00851297960792511,-0.0532075113699465,-0.01983663130688,1.79803338721609e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.0106696861025566,0.00249261807889551,-0.0155552175371918,-0.00578415466792145,1.87993631014928e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.033043892297735,0.00772039112529478,0.0179119256921572,0.0481758589033128,1.88362496253166e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0341419290096039,0.0079816848324309,-0.0497860312811685,-0.0184978267380393,1.90566590367952e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0207972043146132,0.00486714547856556,-0.0303368094526017,-0.0112575991766247,1.94457279728169e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,41839,-0.0318770578141816,0.00746708192241475,-0.0465125383821145,-0.0172415772462487,1.97708761469297e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0217234151383306,0.00508894455186262,-0.0316977464599813,-0.0117490838166799,1.97945153701825e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0135145064908893,0.00316640088612858,-0.0197206522277013,-0.00730836075407725,1.98750814344504e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0185915457439527,0.00435712713765956,0.0100515765541399,0.0271315149337654,1.99790140803252e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42262,-0.0146609061706494,0.00343649419501959,-0.0213964347928878,-0.00792537754841099,2.00133971467043e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.138104473860869,0.0324115195229452,-0.201631052125842,-0.0745778955958966,2.04920511477899e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42145,-0.0136343425340131,0.00320211009443793,-0.0199104783191114,-0.00735820674891475,2.07724437982954e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0228918493951087,0.00538300230647886,0.0123411648744101,0.0334425339158072,2.12706405097484e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.015044732638772,0.00354192310184346,0.00810256335915879,0.0219869019183852,2.17491540866916e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.022543386091602,0.00531681762998446,-0.0329643486463716,-0.0121224235368325,2.25325003752116e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00990188229015178,0.00233649703878295,-0.0144814164861664,-0.0053223480941372,2.27388667256121e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0247453289033342,0.00584044914878759,-0.0361926092349578,-0.0132980485717105,2.28172326728839e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0399148583870734,0.00946763930316299,-0.0584714314212728,-0.0213582853528739,2.50370673960537e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0211401390303838,0.00501774100500958,-0.0309749114002026,-0.0113053666605651,2.53926581742359e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0149989106406006,0.00356505809209281,-0.0219864245011025,-0.00801139678009868,2.6059883441966e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42119,0.0201238864660189,0.00478537753760014,0.0107445464923226,0.0295032264397152,2.62430159323399e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42062,-0.0146756004778683,0.00348994541243279,-0.0215158934862366,-0.00783530746950006,2.62643898024282e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0334430424950796,0.00796734968778454,-0.0490590478831373,-0.0178270371070219,2.71567212473892e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.018335432693694,0.00437391293189676,0.00976256334717635,0.0269083020402117,2.78295504707326e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0339971027050914,0.00812877629036509,-0.049929504234207,-0.0180647011759758,2.90722931837729e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0219856285868025,0.00526064583490667,-0.0322964944232195,-0.0116747627503854,2.94651656483642e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0275496513927103,0.00659339892558736,-0.0404727132868616,-0.0146265894985591,2.95483022188714e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0314582551965317,0.00753150701964794,-0.0462200089550417,-0.0166965014380218,2.97738653760293e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.032799141314095,0.00785446993138111,0.0174043802485881,0.048193902379602,2.99088493735495e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.0130996553653511,0.00314227574112752,-0.019258515817961,-0.00694079491274119,3.08461425999842e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00962027382321524,0.00230995267864813,0.00509276657306491,0.0141477810733656,3.14104014488921e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42261,-0.0155756031490904,0.00374409990034096,-0.0229140389537587,-0.00823716734442214,3.20138574833706e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0129864943170314,0.00312228303511197,-0.0191061690658509,-0.00686681956821194,3.21579790205644e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0189593855221568,0.00455967858193124,0.0100224155015715,0.027896355542742,3.23334134649012e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42296,-0.0356541740602672,0.00857643710885862,-0.0524639907936301,-0.0188443573269043,3.24097372220497e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0457356276874769,0.0110577526850016,-0.06740882295008,-0.0240624324248738,3.55939532888306e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,41839,-0.0328580184895109,0.00794999711420277,-0.0484400128333483,-0.0172760241456735,3.60128946410125e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0118325120994989,0.00286756362260455,0.00621208739919401,0.0174529367998038,3.71221449247014e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0149344710633037,0.00362099457642904,-0.0220316204331046,-0.00783732169350281,3.73907084303169e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0132513710058287,0.00321418754650494,0.006951563414679,0.0195511785969784,3.76561032036296e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,41913,-0.0342475140353833,0.00831429488511506,-0.0505435320102088,-0.0179514960605578,3.82633505703802e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0153418488235136,0.0037266859179135,-0.022646153222624,-0.00803754442440313,3.86527849480646e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0226431400523469,0.0055113162784617,-0.0334453199581319,-0.011840960146562,4.01162002882466e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.043947626882555,0.0107355197320962,-0.0649892455574636,-0.0229060082076463,4.27545693932399e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0422402317489067,0.0103218306065409,-0.0624710197377268,-0.0220094437600866,4.29556730313133e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,39657,-0.0158114296932209,0.00386926664353564,-0.0233951923145507,-0.00822766707189101,4.41183774919586e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42264,-0.0090762147695709,0.00222942379937047,-0.013445885416337,-0.00470654412280478,4.70544800252845e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0180019514005178,0.00443554665003954,-0.0266956228345953,-0.00930827996644033,4.96541166926174e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0221149761453441,0.00546253018133355,0.0114084169899303,0.0328215353007578,5.18929645115832e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0477639416372106,0.0118053184283107,-0.0709023657566994,-0.0246255175177217,5.23978491681426e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0156080683440303,0.00385837913669495,-0.0231704914519524,-0.00804564523610822,5.25648161293946e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0202681914536436,0.00501473314796231,-0.0300970684236498,-0.0104393144836375,5.33585247635687e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0309491995178311,0.00766767403862399,-0.0459778406335341,-0.0159205584021281,5.46583649246618e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0381828500163805,0.00947871806028027,-0.0567611374145298,-0.0196045626182311,5.65608584711932e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.04938776833042,0.0122753593315564,-0.0734474726202705,-0.0253280640405695,5.77613474274261e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0282546966861714,0.00703784891387853,-0.0420488805573733,-0.0144605128149694,5.98533444682194e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0107222087934283,0.00267095740469987,-0.0159572853066401,-0.00548713228021659,5.99225194460353e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0430858914040778,0.0107513540875244,-0.0641585454156255,-0.02201323739253,6.17614783301315e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0132628089686578,0.003311914819051,-0.0197541620139977,-0.0067714559233178,6.24585279588467e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0243253115708141,0.00607883763839139,-0.0362398333420612,-0.012410789799567,6.33155852251554e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0335765328350431,0.0084002657122091,-0.0500410536309729,-0.0171120120391132,6.45458307054414e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42119,-0.023838287048257,0.00599282797317003,-0.0355842298756702,-0.0120923442208437,6.99176174193504e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0248611102416998,0.00625973085849664,-0.0371301827243532,-0.0125920377590464,7.17629533576432e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0212456646112133,0.00536077127192451,-0.0317527763041854,-0.0107385529182413,7.44254564235967e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.01716081825915,0.00433096897393566,-0.0256495174480639,-0.00867211907023614,7.46708282637265e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00872790432614401,0.00220576067777213,0.00440461339771064,0.0130511952545774,7.63249028183889e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0257966774880727,0.00652335270011432,-0.0385824487802968,-0.0130109061958486,7.7172755264272e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.031469616744806,0.0079706552258505,-0.047092100987473,-0.0158471325021391,7.92198788749101e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.0151119426896929,0.00384507484025564,-0.0226482893765939,-0.00757559600279182,8.53848711683224e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0139033857540127,0.00354159470280471,-0.0208449113715099,-0.00696186013651544,8.68856927550099e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,39958,-0.0115907910339529,0.00295444491956911,-0.0173815030763084,-0.00580007899159747,8.79059692734881e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0227092527226735,0.00579523032266681,-0.0340679041551004,-0.0113506012902465,8.95829738349746e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0359749399526341,0.00921700520164538,-0.054040270147859,-0.0179096097574091,9.54271656231966e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0124418415839032,0.00320812731881512,-0.0187297711287808,-0.00615391203902555,0.000105724721196873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0117009445718471,0.00302199004547272,0.00577784408272061,0.0176240450609737,0.00010849011533416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.020532639595471,0.00531552565408965,-0.0309510698774867,-0.0101142093134552,0.000112643732558707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0146951200823649,0.00381169892493645,-0.0221660499752404,-0.00722419018948946,0.000116131382613624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42119,-0.0269403826014608,0.00699161696947835,-0.0406439518616384,-0.0132368133412833,0.000117103406916997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0122684440109669,0.00318927969868117,0.00601745580155181,0.018519432220382,0.000120224304847497
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.00975440676143929,0.00253610071458967,-0.014725164162035,-0.00478364936084353,0.000120505547224799
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0365942310759699,0.00953312413842214,-0.0552791543872773,-0.0179093077646625,0.000124281456677583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0216384991233488,0.00563817390895573,-0.032689319984902,-0.0105876782617955,0.000124671524022802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0196155613306249,0.00512148128711023,-0.0296536646533609,-0.00957745800788881,0.000128694795459324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0295812126742483,0.0077563648869324,-0.0447836878526358,-0.0143787374958608,0.000137468075536571
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,39657,-0.0264211048951862,0.00693948938239492,-0.0400225040846802,-0.0128197057056922,0.000141219414625507
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0162360081443933,0.00426942630549204,0.00786793258562886,0.0246040837031576,0.000143676947854031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,39649,-0.0188602794510222,0.00496439323248598,-0.0285904901866947,-0.00913006871534966,0.000145994889583702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0153255370666842,0.00404010287984156,0.00740693542219473,0.0232441387111737,0.000149424289941038
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00499472365691913,0.00131710221864563,0.00241320330837369,0.00757624400546457,0.000149969308671511
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0193284460875803,0.00509908606010846,-0.0293226547653929,-0.0093342374097677,0.000150968086554329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0130565681504433,0.00344932643362578,-0.0198172479603498,-0.00629588834053677,0.000154369953641152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0221278964630876,0.00586258655175085,-0.0336185661045192,-0.0106372268216559,0.000161195819663612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,41913,-0.0138634595715638,0.00368566966361462,-0.0210873721122485,-0.00663954703087919,0.000169655521312166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0263478988722236,0.00702268994625445,0.0125834265775649,0.0401123711668823,0.000176456454840695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.014012330920785,0.00374193698881591,0.00667813442270581,0.0213465274188642,0.000181542236617849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0202873609009013,0.0054268036307595,-0.0309238960171899,-0.00965082578461263,0.000186002327288711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0225684408723956,0.00604203274999366,-0.0344108250623832,-0.0107260566824081,0.000188456425430449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0266414856294546,0.00713425791434104,-0.0406246311415631,-0.0126583401173462,0.000189157714097667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.027479849908724,0.00737757628195089,-0.0419398994213478,-0.0130198003961003,0.000196278945812649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42070,-0.030014549551694,0.00808791957501392,-0.0458668719187213,-0.0141622271846667,0.000207244716725256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,39966,-0.0339175452758598,0.00914200164201254,-0.0518358684942044,-0.0159992220575153,0.000208182518358464
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0226306095755349,0.00611282140516703,-0.0346117395296623,-0.0106494796214076,0.000214823271377661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.0116362830020796,0.00314723558455247,-0.0178048647478025,-0.00546770125635679,0.000218931933235831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0216249902738513,0.00586563258318441,-0.0331216301368928,-0.0101283504108099,0.000228243964861313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0236439356356621,0.00644004698523543,-0.0362664277267236,-0.0110214435446007,0.00024215038889746
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.00979551723885401,0.00267186543536712,-0.0150323734921736,-0.00455866098553446,0.000247354205390978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0351876036632609,0.0096230421096132,-0.0540487661981027,-0.016326441128419,0.000256569639928375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42137,0.0176901808539903,0.0048408381567747,0.00820213806671191,0.0271782236412687,0.00025879568761848
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,39934,-0.0240811448244101,0.00659605154191246,-0.0370094058465585,-0.0111528838022617,0.000262557714375369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0169737891165271,0.0046510242376873,-0.0260897966223942,-0.00785778161065996,0.000263779355722387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0118552932085468,0.00325182299153851,0.00548172014513129,0.0182288662719623,0.000267840687160711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0282070832036339,0.00779642100876105,-0.0434880683808055,-0.0129260980264622,0.000298034954994427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0326966814410059,0.00905473906571227,-0.0504439700098019,-0.0149493928722098,0.000306112681834583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.014704653900349,0.00407283035392166,-0.0226874013940355,-0.00672190640666257,0.000306803952517703
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.024012425305952,0.00665242532333332,-0.0370511789396853,-0.0109736716722187,0.000307816559798993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0222687654354677,0.00618748153820521,-0.0343962292503499,-0.0101413016205855,0.000320805270059124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42015,-0.0196894917748325,0.0054719654641358,-0.0304145440845387,-0.00896443946512634,0.000321520555005853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0117212450083942,0.00325803386229296,0.00533549863830003,0.0181069913784884,0.000322263490535181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.0106960091373693,0.00297326329596226,-0.0165236051974553,-0.00486841307728326,0.000322548451157397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.02744900069741,0.00763054737746341,-0.0424048735572383,-0.0124931278375817,0.000322968856765886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.0356597755896543,0.00991578115020554,-0.0550947066440572,-0.0162248445352514,0.000323969747610657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0121378573530297,0.00338197314032998,-0.0187665247080764,-0.00550918999798291,0.000333401665065614
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,39699,-0.01731749419765,0.0048289621155413,-0.026782259944111,-0.00785272845118909,0.000337008214089829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0346435048935969,0.00970070128147312,-0.0536568794052842,-0.0156301303819096,0.000356797103550779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0153733993924745,0.00431466029729131,-0.0238301335751655,-0.00691666520978355,0.00036806251428993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0241154815715646,0.00678011749532986,-0.0374045118624111,-0.010826451280718,0.000376942062867986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42137,0.00767137105066646,0.0021573564164501,0.00344295247442426,0.0118997896269087,0.00037795452398986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0151344495218588,0.00426976011244151,-0.0235031793422442,-0.00676571970147344,0.000394883994258892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0162998453979941,0.00460782513729938,-0.0253311826671009,-0.00726850812888728,0.000405420681286658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0277382199789798,0.00784275447726115,-0.0431100187544117,-0.012366421203548,0.000406374131688589
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0287605188469732,0.00814222678617345,-0.0447192833478732,-0.0128017543460732,0.000413680522340717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.0119638331276682,0.00338743864822218,0.00532445337715271,0.0186032128781837,0.00041440200198554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42027,-0.017711449912951,0.0050151486651891,-0.0275411412967216,-0.00788175852918034,0.000414454060528595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0313406560030564,0.00891323704894873,-0.0488106006189959,-0.0138707113871169,0.000439549198122089
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0351760568227672,0.010008105423552,-0.0547919434529291,-0.0155601701926052,0.000441920861231431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,41881,-0.0215895800040502,0.00614871062021007,-0.033641052819662,-0.00953810718843848,0.000447506402846292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.0120196314325588,0.0034241541791362,0.00530828924145186,0.0187309736236657,0.000449472247090376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42200,0.0152074643582257,0.00433499731759049,0.00671086961574833,0.0237040591007031,0.000452831492291324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,39575,-0.0287787929081963,0.00824470605908882,-0.0449384167840104,-0.0126191690323822,0.000483869443698044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0152371880454911,0.00436556872097131,-0.0237937027385948,-0.00668067335238731,0.000484010149569165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0182827800223525,0.0052410868062096,-0.0285553101625233,-0.00801024988218167,0.000487580124965735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42123,-0.00883485652350073,0.00253444543482834,-0.0138023695757643,-0.00386734347123719,0.000492015757243287
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0174531398126367,0.00503304891771299,0.00758836393391928,0.0273179156913542,0.000526930943576438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.0173659593894995,0.00500986846950701,-0.0271853015897332,-0.00754661718926571,0.000529226774096369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0166333217399607,0.00480292778604695,-0.0260470602006128,-0.00721958327930871,0.000535515436682048
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,41749,0.0252263513418532,0.00729867042712085,0.0109209573046963,0.03953174537901,0.000549387815058952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.0170527676461786,0.00493758342675891,-0.0267304311626261,-0.00737510412973114,0.000555049507449791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0199895177119136,0.00579025504003439,-0.031338417590381,-0.00864061783344622,0.000557620501713755
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0134095093428845,0.0039047957047409,-0.0210629089241767,-0.00575610976159237,0.000596307686135086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0270851998560853,0.00788761738417344,-0.0425449299290653,-0.0116254697831054,0.000597187293262405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0173459697875078,0.00505707042099737,-0.0272578278126627,-0.00743411176235298,0.00060526892057595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42181,-0.012476474223697,0.00364053084250002,-0.0196119146749971,-0.00534103377239698,0.000611865660537797
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42249,-0.0272579119162541,0.00796561426881849,-0.0428705158831384,-0.0116453079493699,0.000623566993805302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0112174380922394,0.00328862711617903,-0.0176631472399503,-0.0047717289445285,0.000649616575241831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,39959,-0.00825932849892864,0.0024379401800559,-0.0130376912518382,-0.00348096574601908,0.000706869394891814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.0340728951981517,0.0100783720329166,-0.0538265043826684,-0.0143192860136351,0.000725208790116623
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42249,-0.0238157041844996,0.00704665526281274,-0.0376271484996126,-0.0100042598693866,0.000727635460449026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.0214050005335312,0.00634565370434719,0.00896751927301075,0.0338424817940517,0.000745137676200429
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0231390241246597,0.00686291656403214,-0.0365903405901627,-0.00968770765915668,0.000749860960660008
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0141928164059857,0.00421414579393577,-0.0224525421620998,-0.00593309064987155,0.000760023255657856
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42310,-0.00716815637798373,0.00212949891327626,-0.0113419742480052,-0.00299433850796227,0.000764419167885485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.0145348549204829,0.00433443584449116,0.00603936066528025,0.0230303491756856,0.000800577840080427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0313234195915842,0.00938258056373976,-0.0497132774965141,-0.0129335616866543,0.000845238183414041
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.015429226993435,0.00462679885475583,-0.0244977527487564,-0.00636070123811358,0.000856584278698932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0160864530138241,0.00482829389372511,0.00662299698212292,0.0255499090455254,0.000865469625096859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0535924628485939,0.0161249502574937,-0.0851973653532816,-0.0219875603439063,0.000891129896428199
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0170294775733295,0.00513475018541652,-0.0270935879367458,-0.00696536720991308,0.000913937069991636
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGN,Cingulin,39649,-0.013462779612747,0.00406833636267368,-0.0214367188835874,-0.0054888403419066,0.000938754074140899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.0199913187570889,0.00604351524716292,-0.0318366086415283,-0.00814602887264962,0.00094247784820613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42016,0.0149711148155241,0.00452854018362292,0.00609517605562314,0.023847053575425,0.000949043701940756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0174514378628006,0.00530727070342924,-0.0278536884415219,-0.0070491872840793,0.00101132696747348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.0101427554849815,0.00308737116230708,-0.0161940029631033,-0.00409150800685959,0.00102203982946822
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.0093593502956081,0.00285107347626788,0.00377124628212306,0.0149474543090931,0.00103117974520569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,41668,-0.013003102994627,0.00396904318655873,-0.0207824276402822,-0.00522377834897192,0.00105514202044816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0135516129069013,0.00413642434500452,-0.0216590046231102,-0.00544422119069245,0.00105550817949079
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0278265119514636,0.00851831971507422,-0.044522418593009,-0.0111306053099181,0.0010909853464914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.016167049371165,0.00495200493996714,0.00646111968882946,0.0258729790535006,0.00109832608213011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0210026854339593,0.00644132012949957,0.00837769798014016,0.0336276728877785,0.00111498015398313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.019792860209075,0.00608467230494114,-0.0317188179267597,-0.00786690249139041,0.00114516609119773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0111045492464178,0.00341670859006305,-0.0178012980829414,-0.00440780040989422,0.00115712353478996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0241160540901952,0.0074208892119343,-0.0386609969455865,-0.00957111123480399,0.00115785635458068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0229946429606065,0.00707664588354625,0.00912441702885589,0.0368648688923572,0.00115943373841934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0374548791975927,0.0115513302496924,-0.0600954864869899,-0.0148142719081955,0.00118848396604044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.0166749076574991,0.00514469420917745,-0.0267585083074869,-0.00659130700751133,0.00119327930367605
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.00919325980664504,0.00283774947509611,0.00363127083545667,0.0147552487778334,0.0012003836889752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0134725273908321,0.00415948745173137,-0.0216251227962256,-0.00531993198543864,0.00120301301221554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.0199102369549491,0.00616288180079669,0.0078309886253876,0.0319894852845106,0.00123795882847494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,39586,-0.0372109427202845,0.0115267760557801,-0.0598034237896134,-0.0146184616509555,0.00124929823216488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,41839,-0.0156688418480246,0.00486191930672365,-0.0251982036892029,-0.00613948000684622,0.00127265307552541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0219903657496773,0.00684812959427412,-0.0354126997544546,-0.00856803174490001,0.00132586268810984
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00842461371498195,0.0026248296680519,0.00327994756560022,0.0135692798643637,0.00133232821682404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42016,-0.0147389808000662,0.00459951988078154,-0.023754039766398,-0.00572392183373439,0.00135632258784884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42070,-0.0193167313543525,0.00602850557907297,-0.0311326022893355,-0.00750086041936945,0.00135738640478864
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0376516769716268,0.0117887849067564,-0.0607576953888693,-0.0145456585543843,0.00140788427100912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0123503225756926,0.00387284594143052,-0.0199411006208965,-0.00475954453048882,0.00143114364342999
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00953787803575746,0.00299198719699372,0.00367358312964977,0.0154021729418652,0.0014368107051195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0112766633255138,0.00354763379989516,-0.0182300255733083,-0.00432330107771927,0.00148299044972025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0221617446290733,0.00698195939045778,-0.0358463850343705,-0.00847710422377606,0.00150679770430963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0255504636045077,0.00805029984885498,-0.0413290513082635,-0.00977187590075197,0.00150774228905457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0103546842242708,0.00326464413111522,-0.0167533867212566,-0.00395598172728497,0.00151919508808806
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0199100012142223,0.00631479949006964,0.00753299421368581,0.0322870082147588,0.00162086499048211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00695866365903032,0.00221777529543607,-0.011305503238085,-0.00261182407997562,0.00170739411923644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0170386801643817,0.0054323153380426,-0.0276860182269452,-0.00639134210181824,0.00171327849032652
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00736581985248173,0.00235492144495083,0.00275017382037811,0.0119814658845854,0.00176471459951445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.0258520154003322,0.00826797590041745,-0.0420572481651504,-0.00964678263551405,0.00177115384579145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00940869331515594,0.00300963733526139,0.00350980413804362,0.0153075824922683,0.00177461630391006
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.0131394326093085,0.00420866011951522,-0.0213884064435583,-0.00489045877505863,0.00180014366767503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.0124100432991522,0.00397767231490676,-0.0202062810363695,-0.00461380556193497,0.00181365283930093
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0134774085451978,0.00434009379676787,0.00497082470353275,0.0219839923868628,0.00190550452983653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0197436325880295,0.00636375910349146,-0.0322166004308728,-0.00727066474518628,0.00192277005567375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0223200382900501,0.00720474717590613,-0.0364413427548261,-0.0081987338252741,0.00195256785906643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.0103489916312573,0.00334356841839341,-0.0169023857313084,-0.00379559753120618,0.00197080689072842
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0161916714733534,0.0052351282490104,-0.0264525228414138,-0.00593082010529303,0.0019870008634408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.00955245302587619,0.00309073916028661,-0.0156103017800379,-0.00349460427171445,0.00200187561741379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0190647386493102,0.00617085895862793,-0.0311596222082209,-0.00696985509039943,0.00201009878107719
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.0122669515643424,0.00397752593508772,-0.0200629023971143,-0.00447100073157045,0.00204692306656436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0207689269033161,0.00673972122185698,0.00755907330847638,0.0339787804981557,0.00206421061239224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,39575,0.0233707223718405,0.00759964191599292,0.00847542421649441,0.0382660205271867,0.00210850248696706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.0139247216799989,0.00453974824239894,0.00502681512489698,0.0228226282351008,0.00216535530405254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0126343423409486,0.00412263821907256,-0.0207147132503308,-0.00455397143156636,0.00218371469823467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0440931983956209,0.0144861637284143,-0.0724860793033128,-0.0157003174879289,0.00234049445872926
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0176635553944252,0.00580945262607592,0.00627702824731644,0.029050082541534,0.00236733785138725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00892727291798539,0.00294962355333208,-0.0147085350825163,-0.00314601075345451,0.00247799137653708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0131356666868162,0.00434260963010853,-0.0216471815618289,-0.0046241518118035,0.00249342562673661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0105106819470027,0.00347734386752445,-0.0173262759273507,-0.00369508796665481,0.00251067150604735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.0157824642627222,0.00523577356729972,-0.0260445804546297,-0.00552034807081475,0.00258116577316225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.0209366664034111,0.00694766878402165,-0.0345540972200935,-0.00731923558672866,0.00258850235577101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00898688847748494,0.00298395962987333,-0.0148354493520367,-0.00313832760293321,0.00260249373464981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.00803126699279793,0.00267907450667406,0.00278028095971677,0.0132822530258791,0.00272448883769523
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,39966,-0.0140529828478677,0.00469351527139297,-0.0232522727797979,-0.00485369291593744,0.00275823309933553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.012353994638616,0.0041367621808127,0.0042459407642231,0.0204620485130089,0.00282793901563293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.020429889652376,0.00684178165498428,-0.0338397816961452,-0.00701999760860678,0.00283210370932221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00782630427940067,0.00262592126433082,0.00267949860131227,0.0129731099574891,0.00288477115839749
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.0110754752411461,0.00371640937922021,0.00379131285787453,0.0183596376244178,0.0028871230980067
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42016,-0.0181529826391358,0.00609183352664482,-0.0300929763513597,-0.00621298892691201,0.00288870286491798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.00898038081401994,0.00301638727829989,0.00306826174855216,0.0148924998794877,0.0029141391340422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42070,0.00487352628690316,0.00163936785830739,0.00166036528462067,0.00808668728918565,0.00295610791458492
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.00828647371591846,0.0028002698391011,-0.0137750026005566,-0.00279794483128029,0.0030900284035337
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.0108923226018269,0.00369548715558068,-0.018135477426765,-0.00364916777688876,0.00320937634653704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0146667500276676,0.00497609688285655,-0.0244198999180664,-0.00491360013726875,0.00321069323945979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0215294603933538,0.00732370163093025,-0.0358839155899771,-0.00717500519673046,0.00329201735826473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.00763938726887789,0.00259886631692359,-0.0127331652500481,-0.00254560928770766,0.00329298016889193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0117821434648896,0.00400869252251746,-0.0196391808090239,-0.00392510612075543,0.00329777161570875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.017823726133077,0.00607743340445896,-0.0297354956058166,-0.00591195666033745,0.00336623235480891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42158,-0.00980248038332085,0.00334544020294719,-0.0163595431810973,-0.00324541758554436,0.00339415970811303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0230531857992125,0.007872283847688,-0.038482862140681,-0.00762350945774405,0.00341275423984033
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0128541282885934,0.0044070418353654,-0.0214919302859096,-0.00421632629127723,0.00354312828802067
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0141451526464246,0.00486022640504713,-0.023671196400317,-0.00461910889253223,0.00361561797353187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,41830,-0.0270521926596522,0.00929782178114256,-0.0452759233506916,-0.00882846196861274,0.00362587840426827
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.0124749658359841,0.00429189504126175,0.00406285155511104,0.0208870801168571,0.00366071919704711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0143086364178237,0.00492394711028004,0.00465770008167483,0.0239595727539726,0.00366892048470013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0129561358949693,0.00446733302288988,-0.0217121086198335,-0.00420016317010516,0.00373540071244312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,41913,-0.0155369663085068,0.0053588862289694,-0.0260403833172869,-0.00503354929972681,0.00374619723607459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0302781461768346,0.0104648470981521,-0.0507892464892126,-0.00976704586445657,0.00381939072706802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00982559670442388,0.00340079341089974,-0.0164911517897874,-0.0031600416190604,0.00386841011999887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0179920795185358,0.00623684315982792,-0.0302162921117985,-0.00576786692527312,0.0039240551785906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.0105739837671817,0.0036666716577431,-0.0177606602163582,-0.00338730731800527,0.00393655458943348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.0127129569308691,0.00441644640427797,-0.0213691918832539,-0.00405672197848425,0.00400142391785584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.0134471928555954,0.00467892992800017,-0.0226178955144757,-0.00427649019671504,0.00406101509801855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,39657,0.00936933516293481,0.00326145527341416,0.00297688282704305,0.0157617874988266,0.00407694522807102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0452497792405222,0.0157682811235819,0.0143439482383016,0.0761556102427428,0.00411655234114056
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00860675927973937,0.00301174306991781,-0.0145097756967783,-0.00270374286270047,0.00427343847329978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0147063130398027,0.00514816118522556,-0.0247967089628448,-0.00461591711676058,0.00428985019894327
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0125745086401456,0.0044022009517984,0.00394619477462072,0.0212028225056704,0.00429111571461673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00940498597295548,0.00329597754968343,-0.015865101970335,-0.00294486997557597,0.00433105416513387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.00887457070769214,0.00311185487560529,-0.0149738062638785,-0.00277533515150578,0.00435312692228597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0149205977804803,0.00525023802819297,0.00463013124522205,0.0252110643157385,0.00449141195639759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.0163710115997129,0.00576101461263463,-0.0276626002404767,-0.00507942295894901,0.00449426406287904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0180833703035224,0.006369281692005,-0.0305671624198522,-0.00559957818719263,0.00453158415789544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.0103644480538676,0.0036515014527403,-0.0175213909012386,-0.00320750520649662,0.00454219660901195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.00814703640849371,0.00287422870007774,0.00251354815634134,0.0137805246606461,0.00459630358925516
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0255102208905231,0.00900212859293444,-0.0431543929326746,-0.00786604884837157,0.00460662946084718
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0181730547507328,0.00643540782777413,-0.0307864540931701,-0.00555965540829551,0.00475262174515335
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0114108219408768,0.00406032737867636,-0.0193690636030824,-0.0034525802786711,0.00495628795231768
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00533810763384574,0.00190216518035796,-0.00906635138734734,-0.00160986388034414,0.00501805055429409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,39560,0.012155395585708,0.00434073718145071,0.00364755071006463,0.0206632404613514,0.00511434366022974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,41780,-0.00922507464543126,0.00329531002395767,-0.0156838822923883,-0.00276626699847423,0.0051263254579108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.0102645380055247,0.00367102035972459,0.00306933810046454,0.0174597379105849,0.00518134092214905
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0199827435415107,0.00715812071848665,-0.0340126601497446,-0.0059528269332769,0.00525202677891273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00809707679606255,0.00290887792883169,-0.0137984775365727,-0.00239567605555243,0.00538548969074121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.00938180453005187,0.00337402856193127,0.00276870854866658,0.0159949005114372,0.00543506353357268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42137,-0.0162243008475586,0.00584102694981254,-0.0276727136691912,-0.00477588802592604,0.00548297119272381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0251704664483665,0.00908641299213681,-0.0429798359129546,-0.00736109698377835,0.0056113141629685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.0120618234648191,0.00435529089761039,-0.0205981936241355,-0.00352545330550278,0.00562266776262928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,41883,-0.0265333310082795,0.00959242982528811,-0.0453344934658442,-0.00773216855071477,0.00568147648654534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00847539012381499,0.00306668091351507,-0.0144860847143045,-0.00246469553332546,0.00572283596336585
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0256995615116726,0.00931289029703733,-0.0439528264938658,-0.00744629652947948,0.00579730237212235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.0315314111693822,0.0114275642826453,-0.0539294371633669,-0.00913338517539748,0.00580145132798717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.0178073569170597,0.00647766799955876,-0.0305035861961949,-0.00511112763792453,0.00598650706442353
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42070,-0.00854985318450791,0.00311502509955392,-0.0146553023796336,-0.00244440398938223,0.00606438835916239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00872537106058199,0.00318745870495037,-0.0149727901222847,-0.00247795199887926,0.00620066130861254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0129468584291437,0.00474402211508515,0.00364857508357681,0.0222451417747106,0.00636075776124979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0711197187433631,0.026200201212194,-0.122472113119263,-0.0197673243674628,0.00664819594573764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0120381448459696,0.00443929175971185,0.00333713299693439,0.0207391566950049,0.00670348593048785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,39575,0.0103903418243207,0.0038367456177937,0.00287032041344507,0.0179103632351964,0.00677717780993209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0190645587638204,0.00705125469265622,0.00524409956621423,0.0328850179614266,0.00686715746562831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0191176655019431,0.00709222848898679,-0.0330184333403572,-0.00521689766352896,0.00703701502348976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0122556948230106,0.00454742037918892,0.00334275087980029,0.0211686387662209,0.00704758247988322
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,41913,-0.0140420840734971,0.00521093131220726,-0.0242555094454234,-0.00382865870157092,0.00705328292447613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00912361223383088,0.00338670775346268,-0.0157615594306177,-0.00248566503704404,0.00707180974898024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0188826360234283,0.0070096817337922,-0.032621612221661,-0.00514365982519557,0.00707505038276331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.017538753885506,0.00651227628357286,-0.0303028154013087,-0.00477469236970315,0.00708595151590269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.00927841255157642,0.00344902630868492,0.00251832098655398,0.0160385041165989,0.00715270784850962
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0254914808765557,0.00949691012179779,0.00687753703783208,0.0441054247152794,0.00728147998381664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,0.0113993205401753,0.00425639102311083,0.00305679413487804,0.0197418469454725,0.00741158936184357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0156000426788383,0.00583658359689111,-0.0270397465287449,-0.00416033882893173,0.00753125961718567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.0190970798064447,0.00714955388213882,-0.0331102054154368,-0.00508395419745258,0.00756954285983549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0119825598584534,0.00449588397682432,-0.020794492453029,-0.00317062726387772,0.00770263838001028
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00985441237412177,0.00370037637861141,0.00260167467204341,0.0171071500762001,0.00775196767247304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0147170806356356,0.00553800845238465,0.00386258406896169,0.0255715772023095,0.00788222230248132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,41839,-0.011079733036906,0.00417067742900615,-0.0192542607977581,-0.00290520527605398,0.00790326699303166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00741987259139269,0.00280184871484211,-0.0129114960724832,-0.00192824911030216,0.00810318331300913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.0152304318401181,0.00576437434459576,-0.0265286055555258,-0.00393225812471047,0.00824910771007296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0168208711023309,0.00637156212320835,-0.0293091328638193,-0.00433260934084255,0.00830052773816813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIT,Vitrin,39958,-0.011023171367244,0.00417688870762597,-0.0192098732341909,-0.00283646950029713,0.0083243209934308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.042831552528996,0.0162470175281381,-0.0746757068841467,-0.0109873981738452,0.00839183559800215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00755315452646072,0.00287209587562848,0.0019238466102289,0.0131824624426925,0.00855440855028407
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0165077739438946,0.00630685817863093,-0.0288692159740112,-0.00414633191377794,0.00887140233941437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0148320453802713,0.00566898718723647,-0.0259432602672548,-0.00372083049328784,0.00889938785646508
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,39934,-0.0104046606073425,0.00397809092933298,-0.0182017188288351,-0.00260760238584981,0.00892173482424585
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,41843,-0.0207884816526461,0.007956413382524,-0.0363830518823931,-0.00519391142289905,0.00899064581345699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.0131959078258226,0.00505166893805333,-0.0230971789444072,-0.0032946367072381,0.00900663801389604
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,39966,-0.0262751926958253,0.0100724947381665,-0.0460172823826317,-0.00653310300901891,0.00910302477227476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00774363858876351,0.00297610531911476,-0.0135768050142284,-0.00191047216329859,0.00928194970463083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42210,-0.0119019773226987,0.00457464095675491,-0.0208682735979383,-0.00293568104745906,0.0092855473495775
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0110079537100754,0.00423160250544371,-0.019301894620745,-0.00271401279940569,0.00929775183921914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.0106021007099216,0.00407844560609822,-0.0185958540978741,-0.0026083473219691,0.00934720929239971
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00857360828410263,0.00332461406495051,0.00205736471679963,0.0150898518514056,0.00992610638040797
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0159397711903663,0.00618247242711927,-0.0280574171475201,-0.00382212523321252,0.00994173196870938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00583708708035439,0.00226395409468886,0.00139973705476423,0.0102744371059446,0.00994252129422485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42119,0.0187684706285025,0.00728002373093571,0.00449962411586846,0.0330373171411364,0.00994563438434802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0152557316662878,0.00591910090923641,-0.0268571694483912,-0.00365429388418442,0.0099679651257764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.0131883727029372,0.00511846999354668,0.00315617151558569,0.0232205738902887,0.00998764750471946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0188494679904014,0.00732540376712758,-0.0332072593739715,-0.00449167660683135,0.0100877964082871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,39586,-0.0120239267437006,0.00468369174792393,-0.0212039625696315,-0.00284389091776964,0.0102657562397104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0329099560780666,0.0128268579623602,-0.0580505976842926,-0.00776931447184054,0.0103093245311687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,39649,-0.016711625740106,0.00653146223200258,-0.0295132917148311,-0.00390995976538097,0.0105216191787265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,39475,-0.0110258458964156,0.00431514877059267,-0.0194835374867772,-0.00256815430605394,0.010627739948929
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.010071791040403,0.00394828974149344,-0.0178104389337302,-0.0023331431470759,0.0107570947166052
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.00764859279067398,0.00300241217385737,-0.0135333206514344,-0.00176386492991353,0.0108612360838802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.00745181620603742,0.00293006757583763,0.00170888375739566,0.0131947486546792,0.0109943898865061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.0110548615204062,0.00436931641832673,-0.0196187217003266,-0.00249100134048579,0.0114164669241738
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0109598109295238,0.0043347369635699,-0.0194558953781208,-0.00246372648092677,0.011472890845979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.0121561047420627,0.00481715489166908,-0.0215977283297341,-0.00271448115439131,0.0116331035632245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.0138671366344298,0.00551517682966555,-0.0246768832205743,-0.00305739004828532,0.0119363996269194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0397820994650925,0.0159402474409933,-0.0710249844494393,-0.0085392144807457,0.0125854183326473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0130588035378828,0.00523438616344249,-0.02331820041823,-0.00279940665753549,0.0126165676827557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0100621962790437,0.00404485944444545,-0.0179901207901568,-0.00213427176793061,0.0128734957919212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.030204918994969,0.0121810818270159,-0.0540798393759201,-0.00632999861401789,0.0131657331624937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0255908412895095,0.0103397559057627,-0.0458567628648044,-0.00532491971421455,0.0133388251456262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00710543447072853,0.00287132231717012,-0.012733226212382,-0.00147764272907509,0.0133522148529327
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00925946487176419,0.00374436282079121,-0.016598416000515,-0.00192051374301341,0.0134139512753591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.0079509057548033,0.00321637458604261,-0.0142549999434468,-0.00164681156615978,0.0134478967122282
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0091520804868098,0.00370385554627111,-0.0164116373575012,-0.00189252361611843,0.0134872498303707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.0174996141849779,0.0070968547018915,-0.0314094494006853,-0.00358977896927061,0.0136822565685025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00601406487400225,0.00245038827747971,-0.0108168258978625,-0.00121130385014201,0.0141270807040604
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00915101284307845,0.00375334987018735,-0.0165075785886457,-0.00179444709751124,0.0147779983675678
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0105004358356972,0.0043075015733446,0.00205773275194179,0.0189431389194526,0.0147934560041817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.0105355257416367,0.00432269200953452,-0.0190080020803243,-0.00206304940294899,0.0148120966447051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_A,,39934,-0.00869513676877933,0.00357066096253668,-0.0156936322553512,-0.00169664128220744,0.0149004530531483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,39575,0.0106539412077862,0.00437687607225225,0.00207526410617179,0.0192326183094006,0.0149429450768808
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0312762525494325,0.0128612940572372,-0.0564843889016174,-0.0060681161972476,0.0150363723500207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0162523507464926,0.006696267939789,-0.029377035908479,-0.00312766558450612,0.0152370782184681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42262,-0.00644941803337489,0.00266150207436602,-0.0116659620991323,-0.00123287396761749,0.0153963074387276
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0164098518815119,0.00677963643294806,-0.0296979392900901,-0.00312176447293373,0.015516422145799
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.00517349798645969,0.00213937313107305,-0.00936666932336287,-0.000980326649556503,0.0156118077321646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0161811951400256,0.00669646174082026,-0.0293062601520333,-0.00305613012801786,0.0156918015053497
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.0106995655579662,0.00443434516493346,0.00200824903469659,0.0193908820812358,0.0158425302274173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0215211079236714,0.0089282333014054,-0.039020445194426,-0.00402177065291682,0.0159488463525791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0132145383712132,0.00548251979368456,-0.0239602771668349,-0.00246879957559145,0.0159554702732482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.0081991847285092,0.00340600977334437,0.00152340557275425,0.0148749638842642,0.0160886902052065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.0114125683506289,0.00474441973177863,0.00211350567634281,0.0207116310249151,0.0161675204122032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0106290418142862,0.00442406462714761,-0.0193002084834955,-0.00195787514507686,0.0162975341654617
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.00787986761979119,0.00328593281729662,-0.0143202959416926,-0.00143943929788981,0.0164981939391245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,39934,-0.00589344843574217,0.00245782077949771,-0.0107107771635577,-0.00107611970792666,0.0165083722396811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0118582246351209,0.00494982518220873,-0.02155988199225,-0.0021565672779918,0.0166057212891303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.00538698107474708,0.0022616126603461,-0.00981974188902544,-0.000954220260468722,0.0172364245398451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,39930,-0.029914783792346,0.0125800002062667,-0.0545715841966288,-0.00525798338806326,0.017425027001502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0111813931497879,0.0047202772838434,-0.0204331366261209,-0.00192964967345478,0.0178601023515232
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00861814247718532,0.00364452647766777,-0.0157614143734142,-0.0014748705809565,0.0180623257318196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,41839,0.00825696753425912,0.00349887924471597,0.00139916421461582,0.0151147708539024,0.018294818063157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.00881390131405323,0.00374163079760217,-0.0161474976773535,-0.00148030495075298,0.0185082399651452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,39875,0.0185880374805791,0.00792334581284741,0.0030582796873982,0.0341177952737601,0.0189941813157587
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0191023380259817,0.00816362187836478,-0.0351030369075767,-0.00310163914438673,0.01930498820947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00798351847124976,0.00342033421842566,-0.0146873735393641,-0.00127966340313546,0.0196065341714366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.02215515632221,0.00949317381470382,-0.0407617769990295,-0.00354853564539055,0.0196242233165981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0123086628836094,0.00527436867375885,0.00197090028304205,0.0226464254841768,0.0196272550256149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.0131789058309099,0.00565490930714906,-0.024262528072922,-0.00209528358889771,0.0197959137672324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0145629488192446,0.00624916918843214,0.00231457720991764,0.0268113204285716,0.0198040026762961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42181,0.00968716427626922,0.0041621152694415,0.00152941834816389,0.0178449102043746,0.019955319016817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42310,0.0105190054030089,0.0045202006963379,0.00165941203818666,0.0193785987678312,0.0199738850547571
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0225954363407628,0.00972508980639978,-0.0416566123613063,-0.00353426032021919,0.0201715318884228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.0113963155574568,0.00491293060338153,-0.0210256595400846,-0.001766971574829,0.0203773793079958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,39586,0.0117861074334391,0.00508491671014735,0.00181967068155034,0.021752544185328,0.0204753952110665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00799148618762401,0.00344976045126233,0.00122995570314983,0.0147530166720982,0.0205443331155369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00465178830594409,0.00200816018761157,0.000715794338225411,0.00858778227366278,0.0205518061654028
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.0075725030212249,0.00327972394917939,0.00114424408083329,0.0140007619616165,0.0209653227268962
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,39934,0.0086639848262986,0.00377462489915685,0.00126572002395117,0.016062249628646,0.0217327748310189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,39657,0.0254163554820201,0.0110759421597091,0.00370750884899032,0.0471252021150498,0.0217669429357913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.00609023599177433,0.00265791274944535,0.000880727002861446,0.0112997449806872,0.0219578649168488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00917322341086616,0.00400372837106395,-0.0170205310181515,-0.00132591580358082,0.0219691146693939
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0119686996974236,0.00525633151638712,0.0016662899253048,0.0222711094695423,0.0228050372639252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0225177343055414,0.00992141456357501,-0.0419637068501485,-0.00307176176093439,0.0232504866665583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0281042646933647,0.0124339851200002,0.00373365385816436,0.0524748755285651,0.0238228336429147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0208956693702978,0.00927545482775698,-0.0390755608327015,-0.00271577790789412,0.0242917380937572
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,39575,0.0124747735509714,0.00553775205839995,0.00162077951650752,0.0233287675854353,0.0242991144128243
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00729363095373699,0.00324715088854001,0.000929215212198561,0.0136580466952754,0.0247132140527287
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0135846754079783,0.00606137651199985,-0.025464973371498,-0.00170437744445865,0.0250304088970108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0126716537232509,0.0057085180034296,-0.0238603490099729,-0.00148295843652889,0.0264533803621132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0087704084909303,0.00395370606986498,-0.0165196723878657,-0.00102114459399495,0.0265527462937956
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00908199506576724,0.00410327737140094,-0.0171244187137131,-0.0010395714178214,0.0268939412645908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00968606208029576,0.00438750470993483,-0.018285571311768,-0.00108655284882349,0.0272857714715672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00863567634068375,0.00391939650364258,-0.0163176934878232,-0.000953659193544286,0.0275895055564834
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42224,-0.0145854578264866,0.00662147073012647,-0.0275635404575345,-0.00160737519543874,0.0276289163348742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00828914620232983,0.00376651903442976,-0.0156715235098122,-0.00090676889484749,0.0277742340341908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00622763952081884,0.00283332810040536,0.000674316444024336,0.0117809625976133,0.0279703355322755
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0140670390702531,0.00640262444116105,-0.0266161829749288,-0.00151789516557747,0.028032053241729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00660255785562942,0.00301142281068405,-0.0125049465645702,-0.000700169146688678,0.028363904555863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0200437856627312,0.00918721889234406,0.00203683663373684,0.0380507346917255,0.0291525584961057
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00456783923378524,0.00210110936484506,0.000449664878688923,0.00868601358888156,0.0297246951354545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00950104900821828,0.00437916090560247,-0.0180842043831991,-0.000917893633237445,0.0300578277723409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00804730949044443,0.00371916421498076,0.000757747629082146,0.0153368713518067,0.0305057395391949
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0187547485469379,0.00867096058231987,0.00175966580559099,0.0357498312882849,0.0305675147683092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.00519657113129722,0.00240664696727404,-0.00991359918715433,-0.000479543075440113,0.0308476988933818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00694529451345638,0.00321772162782706,-0.0132520289039974,-0.000638560122915355,0.0309144257278393
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.023379133592727,0.0108522820307458,-0.0446496063729888,-0.00210866081246519,0.0312378986655385
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00656554562739055,0.00304868153119123,-0.0125409614285254,-0.000590129826255734,0.0312950309121836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00761112083504717,0.00354610147749999,-0.0145614797309471,-0.000660761939147192,0.0318640885233297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.004273579640507,0.00199172592891027,-0.00817736246117114,-0.000369796819842868,0.0319206873036597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,41877,-0.00994690991063328,0.00464296184171657,-0.0190471151203977,-0.000846704700868811,0.0321824105525444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,39586,0.0215844276995687,0.010077840041165,0.00183186121888541,0.0413369941802521,0.032233822252628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,39919,-0.0163900551391493,0.00765670508549032,-0.0313971971067103,-0.00138291317158824,0.032326428337899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.015579052438191,0.00728954880101461,-0.0298665680881796,-0.00129153678820234,0.0326014950407125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0162550465545878,0.00763705721755478,-0.0312236787009951,-0.00128641440818039,0.0333223735198646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0122412114371993,0.00575745490390926,0.000956599825537117,0.0235258230488614,0.0335127218352757
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0193529879052357,0.009111425144966,0.00149459462110238,0.0372113811893691,0.0336894971837928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0116267912914247,0.00549121353553427,-0.0223895698210719,-0.000864012761777526,0.0342528923955133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C5,Complement C5,39979,-0.00344691431160962,0.00163036654433437,-0.00664243273850499,-0.000251395884714254,0.0345202291405326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,39575,0.0105216067767014,0.00498314448307349,0.00075464358987733,0.0202885699635254,0.0347571207412521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0191650380387258,0.00909807341431567,-0.0369972619307846,-0.00133281414666713,0.0351841265867581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0178918448108205,0.00849736850230074,-0.03454668707533,-0.00123700254631107,0.0352600835301556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42119,-0.0154618858509028,0.00734726657692523,-0.0298625283416762,-0.00106124336012931,0.0353584463990176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.00601849952808252,0.00286043364114264,-0.0116249494647221,-0.000412049591442941,0.0353929475381359
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00733007815629229,0.00349401625738621,0.000481806291815323,0.0141783500207693,0.0359329288315542
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00974844764839218,0.00464912355651337,-0.0188607298191584,-0.000636165477625978,0.0360266653397753
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,39657,0.0124562963971916,0.00594483563107488,0.000804418560284847,0.0241081742340984,0.0361657901086086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00765171937198686,0.00365331595218954,0.000491220105695364,0.0148122186382784,0.0362416388865429
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,39757,0.0377745884051362,0.0180701758009307,0.00235704383531214,0.0731921329749604,0.0366010173951101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0143988808473306,0.00689820111185461,-0.0279193550265656,-0.000878406668095541,0.0368760826736227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00506666386156641,0.00243071027120597,-0.00983085599313012,-0.000302471730002696,0.0371432919077488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.00926439100012087,0.00444547932145516,-0.017977530470173,-0.000551251530068752,0.0371785078250193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.00844543618363426,0.00405911823347197,-0.0164013079212393,-0.00048956444602921,0.037492551851612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0104376597775338,0.00501907438245101,-0.0202750455671378,-0.000600273987929847,0.0375848235433308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.00362688907208491,0.00174607847949783,-0.00704920289190065,-0.000204575252269167,0.03780511991452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0155363514328751,0.00748152690704542,0.00087255869506607,0.0302001441706841,0.0378589246992411
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0225777679743979,0.0109046001722358,-0.04395078431198,-0.00120475163681571,0.0384299386195682
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.00853987196898447,0.0041249551921845,0.000454959792302846,0.0166247841456661,0.0384441120411593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0133634301663382,0.00646470696401402,-0.0260342558158057,-0.000692604516870723,0.0387447394903966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERVV_1,,39575,0.00978735140669251,0.00473932896145686,0.000498266642237061,0.019076436171148,0.0389337111355205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00585903303819409,0.00284436253145021,-0.0114339835998365,-0.000284082476551681,0.0394332219085249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0114594510248578,0.00556766311005377,-0.0223720707205632,-0.000546831329152434,0.0395928418041951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00975565540959533,0.00474064291524855,-0.0190473155234825,-0.000463995295708175,0.0396256311071061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0168754754205394,0.00820077096974345,-0.0329489865212366,-0.000801964319842242,0.0396337097885782
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00992786709010246,0.00483951513391007,-0.0194133167525662,-0.00044241742763873,0.0402499438483581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.006016526793423,0.00293319590500719,-0.0117655907672371,-0.000267462819608915,0.0402718274904957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00734535645384657,0.00358292475442072,-0.0143678889725112,-0.000322823935181963,0.0403783142994448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0217490954394473,0.0106480033875271,-0.0426191820790004,-0.000879008799894204,0.0411199544722235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0182112360866402,0.00891914025189428,-0.035692750980353,-0.000729721192927395,0.0411891675671672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.00638776882829067,0.00313606176216885,-0.0125344498821416,-0.000241087774439719,0.0416818196623545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0130285381924949,0.00639887698206227,-0.025570337077337,-0.000486739307652865,0.0417676298165625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00855768440448196,0.00421612659737024,-0.0168212925353276,-0.000294076273636283,0.0424059985268284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.015092666142881,0.00744413391044068,-0.0296831686073447,-0.000502163678417268,0.0426356250085215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0100973622967828,0.0049899179874838,-0.0198776015522511,-0.000317123041314591,0.0430357872155238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00690906910118953,0.00342202027883246,-0.0136162288477012,-0.000201909354677899,0.0435110393161069
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.012579435862741,0.00623478222045863,0.000359262710642048,0.0247996090148399,0.0436549001472263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.00789330016454003,0.003916835200075,-0.015570297156687,-0.000216303172393039,0.0439047501883548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0252352363562977,0.0125270696327142,-0.0497882928364175,-0.000682179876177889,0.0439817026745358
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.00793784376870215,0.00394610065083291,-0.0156722010443346,-0.000203486493069656,0.044289873215374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0135783019376855,0.00676164511300568,-0.0268311263591766,-0.000325477516194349,0.044653151543107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00723631536294912,0.00361692708859153,0.000147138269309717,0.0143254924565885,0.0454513981246539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00534355973773828,0.00267469702788661,-0.010585965912396,-0.000101153563080519,0.0457601831553161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,39757,-0.0152508291105042,0.00765036207040398,-0.030245538768496,-0.00025611945251241,0.0462334281563279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00635988413282054,0.00319953469136202,8.87961377509829e-05,0.0126309721278901,0.0468638155058302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALLD,Palladin,39657,0.00822631898465378,0.00414483249726854,0.000102447290007442,0.0163501906793001,0.0472006548217764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0108559462272316,0.00549070316521157,9.41680234169302e-05,0.0216177244310463,0.0480492527509451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,39966,0.00689406735926093,0.00348919161639152,5.52517911335459e-05,0.0137328829273883,0.0481976002382287
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,39726,0.00448557112734758,0.00227988858611221,1.69894985676544e-05,0.00895415275612751,0.0491559400056305
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.0119837540630062,0.00609951665126993,-0.0239388066994953,-2.87014265171921e-05,0.0494692343721225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00484816988040162,0.00247285703434239,-0.00969496966771271,-1.37009309052888e-06,0.0499512854046319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0171685574682668,0.00880257454937211,-0.0344216035850362,8.44886485025301e-05,0.051153494509269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,41900,-0.0102418694627905,0.00527000782729273,-0.0205710848042842,8.73458787032447e-05,0.0519857933282431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00785331530223374,0.00404251010492582,-7.00045034208695e-05,0.0157766351078884,0.0520796076334908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.0120732059474528,0.00623859900781989,-0.0243008600027797,0.000154448107874234,0.0529861590215216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00828557041099027,0.00428374346220748,-0.0166817075969169,0.000110566774936394,0.053115542041128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42088,-0.0151578890550125,0.00785109851305252,-0.0305460421405955,0.000230264030570431,0.0535446729502825
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00981900928795549,0.00508793331314666,-0.000153340005811966,0.0197913585817229,0.0536497118015137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,39930,-0.0064777177954238,0.00336065194446741,-0.0130645956065799,0.000109160015732321,0.053940050721915
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00926763968565961,0.00482168893912374,-0.000182870635022927,0.0187181500063421,0.054617249132932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0161503648812128,0.00841957488358314,-0.0326527316530357,0.000352001890610167,0.0551123583581295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.0102731138982762,0.00536112788613807,-0.0207809245551068,0.000234696758554443,0.0553619050446581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00809446917217694,0.00422707516415523,-0.000190598149567307,0.0163795364939212,0.0555299283318369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42189,-0.00941937749998948,0.00491991063298962,-0.0190624023406491,0.000223647340670177,0.0555718628270118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,39649,-0.0153238596804495,0.00801653694508477,-0.0310362720928156,0.000388552731916667,0.055962206148992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00928564009265186,0.00485895440242348,-0.0188091907214019,0.00023791053609817,0.0560256977725634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00870693503934391,0.00455718899561057,-0.000225155392052798,0.0176390254707406,0.0560826952283044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00624292739391675,0.00327092123572978,-0.0126539330159471,0.000168078228113618,0.0563370324107823
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.0054813590038618,0.00287574101704205,-0.0111178113972642,0.000155093389540616,0.0566664807581461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00488865933135704,0.00256757406924423,-0.000143785844361653,0.00992110450707573,0.0569362475169859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.0128348574544558,0.00674484808744984,-0.0260547597058574,0.000385044796945937,0.057078108316192
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,39575,0.0115336230363251,0.00606162168411267,-0.000347155464535761,0.0234144015371859,0.0571020677241795
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,41864,-0.0101957229709122,0.00538172181246273,-0.0207438977233391,0.000352451781514787,0.0581791481363651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.011031218434287,0.00584205031851463,-0.00041920019000166,0.0224816370585757,0.0590195937909936
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00939934467082404,0.00500147501738686,-0.000403546363254207,0.0192022357049023,0.0602271950096014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.0106652145416755,0.00570008719235591,-0.021837385438693,0.000506956355342123,0.0613585698717951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0109095844175446,0.00583257360451979,-0.000522259847314212,0.0223414286824034,0.0614464270643671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.0157798692802016,0.00844465053355314,-0.000771645765562601,0.0323313843259657,0.0617019217020391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.00496457524635868,0.00266943699005889,-0.0101966717468741,0.000267521254156748,0.0629380843376389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0139737512904234,0.0075330046938296,-0.0287384404903294,0.000790937909482661,0.0636220643874385
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,41913,0.00929697180671037,0.00504642704670919,-0.000594025204839633,0.0191879688182604,0.0654552636629633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42018,0.00954712328961069,0.00519255702686518,-0.000630288483045055,0.0197245350622664,0.0659936359052626
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,39560,0.00611886626186031,0.00333084361830445,-0.000409587230016401,0.012647319753737,0.0662322342725017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,39757,0.00827269454694212,0.00451172848454514,-0.000570293282766367,0.0171156823766506,0.0667403716711584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0124895308120728,0.00681566342576211,-0.0258482311265665,0.000869169502420959,0.0669028165982979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.0104680124368219,0.00571729065866636,-0.021673902127808,0.00073787725416417,0.0671362515877248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42079,0.0056838674366356,0.00310668048031854,-0.000405226304788733,0.0117729611780599,0.0673373982601534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,39657,0.0110194695436871,0.00604384745462592,-0.000826471467379733,0.0228654105547539,0.0682919042941704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,39649,0.0133040080310444,0.00730401250588987,-0.00101185648049977,0.0276198725425885,0.0685631278565456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0125830218474922,0.00691173459222706,-0.000963977953272837,0.0261300216482572,0.0687007351172029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00591088770907917,0.00324985029160713,-0.000458818862470807,0.0122805942806291,0.0689609368308361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00682185208175974,0.00375275188105748,-0.000533541605112925,0.0141772457686324,0.0691178710620668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00828969910176473,0.00457044440039007,-0.000668371922999803,0.0172477701265293,0.0697412036278405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0129969054244537,0.00717484006317417,-0.00106578109936767,0.0270595919482751,0.0700976542247317
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0137567466360546,0.00761568453665167,-0.0286834883278919,0.00116999505578269,0.0708870258592897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00701408060973247,0.00388343017224583,-0.000597442527869362,0.0146256037473343,0.0709160500220641
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00949851718551551,0.00526940703755056,-0.000829520608083589,0.0198265549791146,0.0714819106651551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.0130663465527557,0.00724900957414637,-0.0272744053180826,0.0011417122125712,0.0714893614488586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.0111619901318965,0.00619891365675275,-0.0233118608991319,0.000987880635338884,0.0717876104812358
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.00753378358854134,0.00418838959971632,-0.000675460026902656,0.0157430272039853,0.0720878806143941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2,Prothrombin,39979,-0.00290223266806587,0.00161358726930168,-0.00606486371589717,0.000260398379765425,0.0721050734153989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,39979,0.00440834737015307,0.0024536107359008,-0.000400729672212503,0.00921742441251864,0.0724133331986729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.0107788597203931,0.00600399507506749,-0.0225466900675253,0.000988970626739227,0.0726364044389976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0153874813802716,0.00860015155026351,-0.00146881565824493,0.032243778418788,0.0736080389915881
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00781330427327718,0.0043736941616659,-0.0163857448301423,0.000759136283587978,0.0740568841106208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0118836498764574,0.00666072961043611,-0.00117138015999733,0.0249386799129122,0.0744236968870291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.0100440254192055,0.00563835106433473,-0.0210951935053016,0.00100714266689055,0.0748786682418566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00847827480902402,0.00476407307738006,-0.0178158580406889,0.000859308422640885,0.0751644239638715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,39586,0.0101559877452054,0.00571573838913819,-0.0010468594975055,0.0213588349879162,0.0756212207772583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00701102277696434,0.00399066219388745,-0.0148327206769837,0.000810675123055054,0.0789698839019979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00349082884473959,0.0019912848172291,-0.00739374708650863,0.000412089397029455,0.0796197479141752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00983856432632847,0.00562990638138506,-0.00119605218118625,0.0208731808338432,0.0805643972568925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,39657,-0.00754986096026491,0.0043242087208254,-0.0160253100530827,0.000925588132552883,0.0808470614648138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00718455149838387,0.0041232294182289,-0.000896978161344787,0.0152660811581125,0.081456266676697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.00398626401904752,0.00228958133635717,-0.00847384343830757,0.000501315400212535,0.0817027271416761
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0174565633003413,0.0100415461528046,-0.0371379937598383,0.00222486715915573,0.0821624482400572
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00497797638930854,0.00288979700343134,-0.010641978516034,0.00068602573741688,0.0849830636449031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00867584867151038,0.00505551489023041,-0.018584657856362,0.00123296051334122,0.0861688722997882
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.0071828353929358,0.00419931342784579,-0.00104781892564195,0.0154134897115135,0.0872052238564356
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,41913,-0.00945792783806181,0.0055324703949801,-0.0203015698122228,0.00138571413609919,0.0873759990211899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0212138895209683,0.0124255086874422,-0.045567886548355,0.0031401075064185,0.0877919369547661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00472831840708022,0.0027721411202321,-0.000705078188574686,0.0101617150027351,0.0880995176692747
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0101834357389064,0.00597289203375402,-0.0218903041250643,0.00152343264725146,0.0882334756212579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00582897181000732,0.00342934433860713,-0.00089254309366265,0.0125504867136773,0.0892093535884264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.0053672894757533,0.00315958777901216,-0.0115600815226171,0.000825502571110528,0.0893934555087378
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.01008274700053,0.00594088014570967,-0.0217268720861209,0.00156137808506097,0.0896906702486939
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.00577369831802721,0.00340275685228916,-0.012443101748514,0.000895705112459548,0.0897634086840888
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,39757,-0.00798501520275947,0.00471019027111899,-0.0172169881341527,0.00124695772863375,0.090053286168017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00936110244960884,0.00552305288430066,-0.00146408120362045,0.0201862861028381,0.0901200086133431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00890825886080364,0.00525741897706015,-0.0192128000558415,0.00139628233423426,0.0902136250638465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,39757,0.00614905346652427,0.00363576999218959,-0.000977055718167338,0.0132751626512159,0.0908139762345023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,41538,-0.00517766117289684,0.00307321705914694,-0.0112011666088248,0.000845844263031169,0.0920572449032265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0105316540249367,0.00626074257963847,-0.0228027094810281,0.00173940143115466,0.0925582317159813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00485346884590932,0.00288970021320672,-0.000810343571975862,0.0105172812637945,0.0930685454731072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00464995643316622,0.00277577216790195,-0.010090469882254,0.000790557015921597,0.0939237213992235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00537142067441698,0.0032238316896028,-0.0116901307860385,0.000947289437204506,0.0957097979633181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NENF,Neudesin,39919,-0.0202806265820828,0.0122245200178851,-0.0442406858171376,0.00367943265297193,0.0971410599120009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0302821200067194,0.0182721745748531,-0.0055313421599926,0.0660955821734314,0.0974862842784567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.0108028442699818,0.00653148724037626,-0.0236045592611193,0.00199887072115567,0.0981625713818987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0139719490362515,0.00844901267731317,-0.0305320138837853,0.0025881158112823,0.0982212987036584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00530971001204647,0.00321224014939085,-0.0116057007048525,0.000986280680759594,0.0983670441514825
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.012095413017883,0.00733225308855154,-0.026466629071444,0.00227580303567799,0.0990489043531036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0106716446261074,0.00648082549989878,-0.00203077335369422,0.023374062605909,0.0996586579842027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00495312310086155,0.00300952051398836,-0.0108517833082787,0.000945537106555644,0.0998247023007712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42262,-0.0052282277909052,0.00320182805027556,-0.0115038107694453,0.0010473551876349,0.102515520628238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00881073920447348,0.00539965199212104,-0.0193940571090307,0.00177257870008376,0.102766218848327
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.0038022191391064,0.00234270778812318,-0.00839392640382784,0.000789488125615029,0.104612206336109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00642622611895591,0.00396352658353034,-0.00134228598476356,0.0141947382226754,0.104973362769699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,39919,0.0184610251021733,0.0113929394789666,-0.00386913627660123,0.0407911864809479,0.105176007671068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,41913,0.00477488761714447,0.00295913944831786,-0.00102502570155853,0.0105748009358475,0.106636435502147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.0145815562955431,0.00909110401257065,-0.0324001201601816,0.00323700756909538,0.10875634222517
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,39757,-0.0150882895577004,0.00940753241883088,-0.0335270530986089,0.00335047398320815,0.108774987622917
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42196,-0.0060430348072174,0.00380384397985122,-0.0134985690077258,0.001412499393291,0.11215923707461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.00483057173053413,0.00304078798665068,-0.0107905161843695,0.0011293727233012,0.112180350160259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00505408947901022,0.00318747620470805,-0.00119336388221755,0.011301542840238,0.112851912463558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.0190088894963903,0.0119896513725407,-0.00449082719378945,0.04250860618657,0.112889428242778
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00378901160732647,0.00238991744211901,-0.00847324979387973,0.000895226579226799,0.112900610708073
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,39929,0.00657323676668893,0.00414847963507172,-0.00155778331805164,0.0147042568514295,0.113109494473728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00482012036679255,0.00304266114773893,-0.0107837362163609,0.00114349548277576,0.113181553965701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.00499354142944048,0.00315241790295349,-0.0111722805192293,0.00118519766034835,0.113209425014934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00787172543590422,0.00498714956837467,-0.00190308771811013,0.0176465385899186,0.114501957328453
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42286,-0.00516547814536484,0.00327377452052413,-0.0115820762055921,0.00125111991486246,0.114626483278756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00732019400104583,0.00464266496516285,-0.00177942933067335,0.016419817332765,0.114888227888606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00899275777644552,0.00570743205880691,-0.0201793246117071,0.00219380905881603,0.11514076147356
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00486372468352898,0.0030893009349557,-0.0011913051489842,0.0109187545160422,0.115423647183071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.00475078966924965,0.00301934960937296,-0.00116713556512135,0.0106687149036206,0.115638213359677
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0177394239120614,0.0113091809024184,-0.0399054184808015,0.00442657065667864,0.116772340181483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00586886146075588,0.00375510338802033,-0.00149114117976397,0.0132288641012757,0.118104271016627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,39586,-0.00830580291399468,0.00532703157894952,-0.0187467848087357,0.00213517898074638,0.118982507054655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.0132767639949046,0.00852175267115774,-0.00342587124056459,0.0299793992303738,0.119264692179556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00515353161173275,0.00330893211768129,-0.00133197533892257,0.0116390385623881,0.119390026259478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00735700297565647,0.0047315324505381,-0.0019168006273982,0.0166308065787111,0.119996042985166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,39657,-0.0055574258014171,0.00358788038106593,-0.0125896713483063,0.00147481974547213,0.121423801463792
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00780319540535553,0.00505281089079438,-0.0177067047513125,0.00210031394060145,0.122537817316155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42070,-0.0318896046228446,0.020683762165127,-0.0724297784664936,0.00865056922080439,0.12315297782902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,41800,-0.00800592011034365,0.0052022947018172,-0.0182024177259054,0.00219057750521807,0.123847574599282
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42123,-0.00596546711808695,0.00388992472252344,-0.0135897195742329,0.00165878533805899,0.125159166687469
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,39958,0.00500790286280692,0.00326882157691067,-0.001398987427938,0.0114147931535518,0.125545136691352
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,41913,0.00784607524810785,0.00513119972256554,-0.00221107620812061,0.0179032267043363,0.12626545458998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.0108553345535448,0.00711569608478177,-0.024802098879717,0.0030914297726275,0.127151334095446
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,39919,-0.0070808588073435,0.00464289457380807,-0.0161809321720073,0.00201921455732031,0.127263154521612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,39979,-0.00309897116790979,0.00204044145670287,-0.00709823642304742,0.000900294087227839,0.128846960553712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0103967602088059,0.0068486950311921,-0.0238202024699424,0.0030266820523306,0.12902121874454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00784560969893783,0.0052084710377188,-0.0180542129328667,0.00236299353499103,0.132014535609824
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00448525253813444,0.00297777579012955,-0.00135118801051949,0.0103216930867884,0.132033235875642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,39750,-0.0162181540817336,0.0107906896114237,-0.0373679057201239,0.0049315975566568,0.132873396617427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00807561694550013,0.00537708171605055,-0.00246346321795896,0.0186146971089592,0.133161463405239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0140912719450948,0.00939422350837713,-0.0325039500215139,0.00432140613132441,0.133644699894551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.00649102630030923,0.00435210004763762,-0.015021142393679,0.0020390897930605,0.13586643560092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00397734538517301,0.00267228330369309,-0.00126032989006545,0.00921502066041146,0.136681302161064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,39822,-0.00506241870063877,0.00341174528811926,-0.0117494394653525,0.00162460206407498,0.137884546052802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0116964546433568,0.00791956867293475,-0.0272188092423089,0.00382589995559533,0.139729630179876
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.0113425547855638,0.0076954821598746,-0.00374059024779044,0.026425699818918,0.140530744511941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00997412939725736,0.00678088105406334,-0.0232646562632215,0.00331639746870679,0.141341627799999
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00836471503053621,0.00569000904564201,-0.0195171327599946,0.00278770269892213,0.141566396899964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,39908,-0.00968327028829158,0.00664189911691709,-0.0227013925574491,0.00333485198086592,0.144893988276053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00768842528320038,0.00527620399492609,-0.0180297851132555,0.00265293454685476,0.14509285728544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,39560,0.00740036514717458,0.00508264623008551,-0.00256162146379302,0.0173623517581422,0.145419510083532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.0117407289666992,0.00807946611679503,-0.0275764825556175,0.00409502462221904,0.146203953093156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00396387975668006,0.00273309159030083,-0.00139297976030956,0.00932073927366969,0.146990178950859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00368948897798696,0.00254695293675009,-0.00868151673401715,0.00130253877804322,0.147475474170634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,39649,-0.00565581460918258,0.00391051684988816,-0.0133204276349634,0.0020087984165982,0.148118997368891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00446597822878357,0.00310111991041251,-0.0105441732531921,0.00161221679562494,0.149861613623228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0121502312676665,0.0084415930846267,-0.0286957537135349,0.00439529117820178,0.150084931484917
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0130223670041918,0.00905556091095766,-0.00472653238128522,0.0307712663896688,0.150447799366115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42016,0.00529703122185438,0.00368712466247823,-0.00192973311660294,0.0125237955603117,0.150846679777163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00410172488514312,0.00285914629528941,-0.00150220185362413,0.00970565162391036,0.151430244959554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7,Complement component C7,39722,-0.00518758932749236,0.00361757855348765,-0.0122780432923282,0.00190286463734343,0.151601820980299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00557288659139116,0.00388922662109838,-0.00204999758596166,0.013195770768744,0.151913888970441
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.00670288830222515,0.004681715157507,-0.00247327340648857,0.0158790500109389,0.152253270419815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.00598294058288397,0.00418295718721044,-0.0141815366698164,0.00221565550404848,0.152655095307637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.0107065577896014,0.00751857797302535,-0.00402985503752833,0.025442970616731,0.15447073490974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0216167019089363,0.0151811743136239,-0.0513718035636392,0.00813839974576661,0.154494537057667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00691558086441534,0.00485755862716883,-0.0164363957736662,0.00260523404483557,0.154568771303146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00518827728879243,0.00364844480137055,-0.0123392290994787,0.00196267452189384,0.155034519274442
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00559188885544349,0.00393632329319684,-0.00212330479922231,0.0133070825101093,0.155460341633697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00571757388994372,0.00407400388939625,-0.00226747373327294,0.0137026215131604,0.160517309891759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00635000562228082,0.00452480975871826,-0.00251862150480698,0.0152186327493686,0.160533259089614
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.0091996314857503,0.00656025916158578,-0.0220577394424584,0.00365847647095783,0.160840804477901
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.0055233037049873,0.00394270291718569,-0.00220439401269665,0.0132510014226713,0.161273542190519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42016,0.019360212945302,0.0138470575819671,-0.00778001991535342,0.0465004458059575,0.162092237842894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00847953725147925,0.00607183536207029,-0.00342126005817852,0.020380334561137,0.162581331548741
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00519434256198662,0.00373376359244422,-0.00212383407920406,0.0125125192031773,0.164198408888473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0113857526539591,0.00820511104997268,-0.0274677703119055,0.0046962650039874,0.165269590662429
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00683242063333511,0.00492916683067565,-0.0164935876214594,0.00282874635478917,0.165738154362772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.0101062517976202,0.00729165160951847,-0.00418538535703603,0.0243978889522764,0.165774152085955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,-0.00920119638629315,0.00664194930996981,-0.022219417033834,0.00381702426124768,0.165978823496041
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_DRA,,42060,0.00545992727861131,0.00394137789315626,-0.00226517339197496,0.0131850279491976,0.165988635307165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,39649,-0.00604490422627678,0.00436630528805533,-0.0146028625908652,0.00251305413831167,0.166250567585438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00638382162260004,0.00463044745271451,-0.0026918553847204,0.0154594986299205,0.168027150099
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.00764927616730996,0.00554886591948026,-0.00322650103487134,0.0185250533694913,0.168062807310466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.0079010505225486,0.00573504622638099,-0.00333964008115814,0.0191417411262553,0.168330667213404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.0104490920407593,0.00758499685395056,-0.0253156858745024,0.00441750179298375,0.168349292378284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00450256471809868,0.00327502397562649,-0.0109216117103266,0.00191648227412923,0.169210877694635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.0100057314695416,0.00730142958590881,-0.0243165334579229,0.0043050705188397,0.170596284446441
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESPL1,Separin,39560,0.00791883048383223,0.00579933162002893,-0.00344785949142447,0.0192855204590889,0.172132471054013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00554851383312906,0.00407195528353733,-0.0135295461888622,0.00243251852260411,0.173030450426065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.00412264980280009,0.00302615095407207,-0.00180860606718116,0.0100539056727813,0.173112744093681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.00573386559222997,0.00420969213521525,-0.0139848621772518,0.00251713099279192,0.173205821450123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0155539708639282,0.0114765203520927,-0.0380479507540298,0.00694000902617345,0.175354061062825
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0177588830552718,0.0131152430763309,-0.0434647594848803,0.00794699337433673,0.17574285571932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00833646678555753,0.00616783951200157,-0.0204254322290806,0.00375249865796555,0.176525501367047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,39649,-0.00850261923155604,0.00629070472703847,-0.0208324004965514,0.00382716203343936,0.176525753670149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.015361637191365,0.0113766844105927,-0.0376599386361268,0.00693666425339678,0.176955858085545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,-0.0126092136508272,0.00935647804390614,-0.0309479106168832,0.00572948331522887,0.177795130379891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00498189283798603,0.00370029640732163,-0.00227068812036436,0.0122344737963364,0.178217580242303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00571132660967265,0.00424413388198532,-0.00260717579901858,0.0140298290183639,0.17842745434249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.00786520988736424,0.00587367482107315,-0.00364719276193913,0.0193776125366676,0.180573742550351
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0112127334337393,0.00838768714419231,-0.0276526002363562,0.00522713336887762,0.181312601223837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00761122581475897,0.00570350349970451,-0.0187900926741798,0.00356764104466187,0.182073051603615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.0150206828828218,0.0112799525104085,-0.0371293898032225,0.00708802403757887,0.183010446040771
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00563736158763709,0.00423690354008478,-0.0139416925262033,0.00266696935092909,0.183363951555506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.0051819086606779,0.00389741366035532,-0.00245702211361854,0.0128208394349743,0.183685374559509
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00554482007921153,0.00417199842709252,-0.0137219369963129,0.0026322968378898,0.183856217736139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.00685794202966905,0.00516582625560321,-0.0169829614906514,0.00326707743131324,0.184351264139651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00827234322482919,0.00624530291615317,-0.00396845049083101,0.0205131369404894,0.185341062969849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00466992005023639,0.00352715285781495,-0.00224329955108091,0.0115831396515537,0.185533447330044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00490373514012144,0.00370931888281587,-0.0121740001504405,0.00236652987019766,0.186189201605935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00503468675449334,0.00381088644659651,-0.0125040241898225,0.00243465068083582,0.18648463203997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.0107162505737681,0.0081273457128989,-0.00521334702351371,0.02664584817105,0.187349628618793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0101992845367605,0.00773552150317467,-0.0253609066829828,0.00496233760946185,0.187363900979679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0155422026474721,0.0118194313187607,-0.038708288032243,0.00762388273729885,0.188547288521294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,41843,-0.00539809427544232,0.0041084047492484,-0.0134505675839692,0.00265437903308454,0.188897598378773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00697989069488096,0.00531821408304556,-0.0174035902976503,0.00344380890788833,0.189391059019007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,39560,-0.0103862612857497,0.00794281159836059,-0.0259541720185365,0.00518164944703705,0.191026155416168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00411646847570287,0.00314888949772966,-0.010288291891253,0.00205535493984725,0.19114160828663
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0115558065191062,0.00891569921850619,-0.00591896394916595,0.0290305769873783,0.194961324725833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00675519936783998,0.00525482820202001,-0.0170546626437992,0.00354426390811923,0.19863700259562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00651257098164191,0.00508784150107909,-0.00345959836047311,0.0164847403237569,0.200562975025313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00392027806534745,0.00307981553862875,-0.0021161603903649,0.0099567165210598,0.20307741477591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00393376851767443,0.00311380208381502,-0.00216928356660301,0.0100368206019519,0.20649638804684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0149605744709556,0.0118920608829818,-0.0083478648596887,0.0382690138015999,0.208402379872224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42310,0.0100817293888776,0.00801409077499153,-0.00562588853010577,0.025789347307861,0.20841303690545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00494215013161386,0.00393643918259585,-0.00277327066627399,0.0126575709295017,0.209328398475219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.0090213243128815,0.0072023821999901,-0.00509534479909909,0.0231379934248621,0.210396760702365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00410231954355449,0.00327576419157061,-0.0105228173590329,0.00231817827192391,0.210478175008231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00851835594630045,0.00680686164806066,-0.0218598047764993,0.00482309288389845,0.210801698391661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,39979,-0.00274865986234962,0.00219691993405944,-0.00705462293310611,0.00155730320840688,0.210908220313404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00950082142859277,0.00759608083466493,-0.024389139864536,0.00538749700735049,0.211050411886417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00835697766581382,0.00669349330311042,-0.0047622692082826,0.0214762245399102,0.211866342687534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.00764889712984451,0.00613018496807928,-0.00436626540759088,0.0196640596672799,0.212146774739712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.0170843788781517,0.0137007371763014,-0.0439378237437025,0.00976906598739913,0.212431336732881
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42310,-0.00755678063201448,0.00607148451100454,-0.0194568902735834,0.00434332900955442,0.21328731469576
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00793884894687794,0.00637865840277046,-0.020441019416308,0.00456332152255217,0.213302080595234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0101767535880308,0.00822231510436927,-0.00593898401653292,0.0262924911925946,0.215853254500723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.0068261686495841,0.00552463952584518,-0.0176544621202407,0.00400212482107246,0.216638667021437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.012508978704982,0.0101306627999887,-0.0323650777929598,0.0073471203829959,0.216939763913217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00599148986290329,0.00486331037002462,-0.00354059846234496,0.0155235781881515,0.217983813040927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00546357581111083,0.00443604786730459,-0.00323107800880617,0.0141582296310278,0.218113020907167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00351084429441563,0.00286171746951116,-0.00209812194582625,0.00911981053465751,0.219912392885035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.00365073173971132,0.00298163093238918,-0.00219326488777148,0.00949472836719411,0.220819721127077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00585794235043765,0.00479352165422842,-0.00353736009185005,0.0152532447927253,0.221712651985018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00817353040861745,0.00669417396972563,-0.00494705057204478,0.0212941113892797,0.222115417303492
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00636443070143023,0.00523038195401728,-0.00388711792844363,0.0166159793313041,0.223699068909488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,-0.00803248545188674,0.00661352549637791,-0.0209949954247875,0.00493002452101397,0.224557526443621
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00840511966007194,0.00693031257279092,-0.00517829298259826,0.0219885323027421,0.225225797253379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00619375330206292,0.00512648173237306,-0.0162416574975141,0.00385415089338827,0.227000228262306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.0112442515006179,0.00931365741290036,-0.0294990200299027,0.00701051702866677,0.227343452891627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00762397850603434,0.00632125247329898,-0.00476567634163165,0.0200136333537003,0.227810037441495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.00470273574000263,0.0039007346045149,-0.0123481755648518,0.00294270408484658,0.22799593748621
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00573419595984313,0.0047598037934285,-0.00359501947527672,0.015063411394963,0.228339404844447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,39586,-0.00510508553801195,0.00424750242154403,-0.0134301902842383,0.00322001920821435,0.229427052296952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.00659075213291703,0.00552886909366531,-0.017427335556501,0.00424583129066697,0.233262895746549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00828215965904548,0.00697579888603969,-0.0219547254756833,0.00539040615759232,0.235146703977487
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,39649,0.00440581371786447,0.00372650923701103,-0.00289814438667715,0.0117097718224061,0.237116188798651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.00425536381722651,0.00360207595561581,-0.0113154326902335,0.00280470505578048,0.237478611053793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00712631757221686,0.00603688894376963,-0.0189586199020053,0.00470598475757162,0.237841709344705
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARTN,Artemin,41913,-0.00577098424091429,0.00488977777064034,-0.0153549486713694,0.00381298018954077,0.237936194498031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,39657,-0.00219744769819052,0.00186327333025177,-0.005849463425484,0.00145456802910295,0.238285002376332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00454078408789729,0.00386948095442305,-0.0121249667585665,0.00304339858277188,0.240625415251922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.00721022024556378,0.00614986824898074,-0.019263962013566,0.00484352152243848,0.241055638630212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.0052128345005446,0.00449743762098789,-0.00360214323659165,0.0140278122376809,0.246453637343244
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,41839,-0.00739388974907292,0.0063848695917431,-0.0199082341488894,0.00512045465074355,0.246871456078108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.00387931358299764,0.00336473920686607,-0.00271557526245986,0.0104742024284551,0.248962793610329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00392477546171407,0.00340512335291014,-0.00274926630998982,0.0105988172334179,0.249095886875908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00604567489151862,0.00526120661993618,-0.0163576398665935,0.00426629008355629,0.250538037548898
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00493355275729697,0.00429510681007287,-0.00348485659044586,0.0133519621050398,0.250727446653695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00474499378082938,0.00413758692640502,-0.0128546641565832,0.00336467659492446,0.25148445626659
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00371413631239858,0.0032430093331939,-0.00264216198066146,0.0100704346054586,0.252116688485213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00511852701761377,0.00447154401118068,-0.0138827532795279,0.00364569924430037,0.252362586118798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,41843,0.0109795870376189,0.0095995286331672,-0.00783548908338885,0.0297946631586266,0.252742552936234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00511733335775218,0.00447715186071597,-0.00365788428925112,0.0138925510047555,0.253068355113762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42070,-0.00236293995525798,0.00207176658043227,-0.00642360245290523,0.00169772254238927,0.254080209119475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00298497466854621,0.0026282630140101,-0.00813637017600602,0.00216642083891359,0.256097177230945
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0192377117641665,0.0169427348975522,-0.0524454721633688,0.0139700486350359,0.25620475748581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00435786505764251,0.00384154258883264,-0.00317155841646946,0.0118872885317545,0.256644796708527
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00471432874490479,0.00415633864453614,-0.0128607524881956,0.00343209499838604,0.256714304152564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,39657,-0.0057796902176073,0.005099789677107,-0.015775277984737,0.00421589754952242,0.257104749989388
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00270035658301003,0.00238530699971324,-0.00197484513642792,0.00737555830244798,0.257625663579461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,39560,0.00372260803211485,0.00330816611658091,-0.00276139755638374,0.0102066136206134,0.260495700986493
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00445615367668082,0.00396274292457962,-0.00331082245549524,0.0122231298088569,0.260815639165643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00819501135390824,0.00729951503938887,-0.0225020608311104,0.00611203812329394,0.261598460966158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,39575,-0.00789652782747937,0.00710545505529263,-0.0218232197358529,0.00603016408089419,0.266449315572506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00822602092346379,0.00741620281465684,-0.00630973659326362,0.0227617784401912,0.267370066723959
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00355345114740305,0.00322035807096064,-0.0027584506716798,0.0098653529664859,0.269862946510349
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00826342753603952,0.00753406397888544,-0.00650333786257594,0.023030192934655,0.272744676793262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00411933517602338,0.00375899584007861,-0.00324829667053069,0.0114869670225775,0.273163836250082
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00862063358993776,0.00787118874480328,-0.00680689634987667,0.0240481635297522,0.273446675518457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00554831526331418,0.00506806111496068,-0.00438508452200875,0.0154817150486371,0.27364539108226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.0056617480942702,0.00517688801088418,-0.0158084485956032,0.0044849524070628,0.274128741158791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00417346450444301,0.0038310255421781,-0.00333534555822607,0.0116822745671121,0.276003650422457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00974161846759751,0.00895202493726242,-0.0272875873446318,0.00780435040943683,0.276529467457503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,41843,0.00640030217150321,0.0058944092634387,-0.00515273998483665,0.0179533443278431,0.277575795222177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLU,Clusterin,39979,0.00353657155703761,0.00326625496188366,-0.00286528816825435,0.00993843128232958,0.278937726241512
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00318297090572472,0.00294434055881963,-0.00895387840101118,0.00258793658956175,0.279699226878401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00468244656872636,0.00433367663056514,-0.00381155962718131,0.013176452764634,0.279952710466656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00670966165035611,0.0062166676373195,-0.00547500691879011,0.0188943302195023,0.280476828348686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,41913,0.00567218086284823,0.00525689180566087,-0.00463132707624707,0.0159756888019435,0.28060773356332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.00566303042219566,0.00525250031371073,-0.00463187019267738,0.0159579310370687,0.280982047672157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,39510,0.0040227106591073,0.0037332729596687,-0.00329450434184335,0.011339925660058,0.281267733168163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00558798583550806,0.0052245919399554,-0.00465221436680454,0.0158281860378207,0.284839377407338
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00536550703895709,0.005023157702514,-0.0152108961358845,0.00447988205797034,0.285470426982837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00335077877065119,0.0031613389160049,-0.00284544550471841,0.00954700304602078,0.289202359926091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00791417865128335,0.00751614752326377,-0.0226458277968803,0.00681747049431363,0.292383817502644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.00432258619997907,0.00410751173722795,-0.0123733092049458,0.00372813680498771,0.29265628355542
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00712665271030525,0.00677298155046355,-0.0204016965492138,0.00614839112860332,0.292722563650126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00685833942091203,0.00651885923302491,-0.0196353035176409,0.00591862467581679,0.292783509563386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00659158868469187,0.00629802171875323,-0.00575253388406447,0.0189357112534482,0.29530097616809
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.00584217544325113,0.00558502657854376,-0.00510447665069463,0.0167888275371969,0.295563632492626
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,39575,0.00661407343389729,0.00634045885651169,-0.00581322592486563,0.0190413727926602,0.296900066541908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00696095237280606,0.00668227277953533,-0.0061363022750832,0.0200582070206953,0.297571037719117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00552906951013422,0.00531470125974684,-0.00488774495896958,0.015945883979238,0.298207202790697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00663735522062645,0.00639117847471735,-0.0191640650310725,0.00588935458981955,0.299051718574653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42262,0.00701085146472322,0.00678235650552281,-0.0062825672861015,0.0203042702155479,0.301299588019716
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00991219173551717,0.00959029582588482,-0.0287091715542514,0.00888478808321707,0.301362328289245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00507671308951876,0.00494036267229746,-0.0147598239272218,0.00460639774818426,0.304160861458891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00305939527503537,0.00297846716821181,-0.00889719092473052,0.00277840037465978,0.304358044934548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSND,Barttin,39560,-0.00374462417019638,0.00364624894440863,-0.0108912721012373,0.00340202376084453,0.304452619871107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00541230492419758,0.0052901762057679,-0.00495644043910751,0.0157810502875027,0.306289610408742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00459714308918427,0.00449879417627692,-0.00422049349631849,0.013414779674687,0.306869112845031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00748064164035949,0.0073235150951374,-0.00687344794610981,0.0218347312268288,0.307061248561465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.00771266670139428,0.00755424726114429,-0.0225189913332371,0.00709365793044853,0.307286512306812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.00841234288505981,0.00837704353940938,-0.0248313482223022,0.00800666245218257,0.315296955750126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,39859,-0.00334094527718882,0.00332852914303508,-0.00986486239753757,0.00318297184315993,0.315530239260344
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00828135147110986,0.00830395210673028,-0.00799439465808147,0.0245570976003012,0.318651058452007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.0114663884697315,0.0115241097523334,-0.0111208666448421,0.034053643584305,0.319762451963304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.0058320472458029,0.00586450387277467,-0.00566238034483545,0.0173264748364412,0.320014429871584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTN,Titin,39575,-0.00740528598703844,0.00753233908359316,-0.022168670590881,0.00735809861680416,0.32556399200494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00301094900118465,0.00306757162460021,-0.00300149138303176,0.00902338938540106,0.326347247496521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.00378098576150161,0.00386602968671509,-0.00379643242445997,0.0113584039474632,0.328094037410326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42048,-0.00607071424741119,0.00630073703198246,-0.0184201588300968,0.00627873033527443,0.335317641346626
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00386145113731895,0.00401193213755114,-0.00400193585228129,0.0117248381269192,0.335823133946942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,39966,-0.00885660431815856,0.00923482720220136,-0.0269568656344732,0.00924365699815611,0.337557050440783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42016,0.0108253054819682,0.0113299959886684,-0.0113814866558217,0.0330320976197582,0.339364681288967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00623335964351507,0.00654857241440636,-0.00660184228872141,0.0190685615757515,0.341182615158004
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,41913,-0.0049672810977402,0.0052225506429732,-0.0152034803579677,0.00526891816248727,0.341559881146404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00266458415194093,0.00280575241635511,-0.00816385888799695,0.0028346905841151,0.342292516393868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00547952843277262,0.0057749345172991,-0.0167984000866789,0.00583934322113362,0.342719060850002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00459137794293215,0.00486643088431389,-0.0141295824761874,0.00494682659032307,0.345452895537565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00529858443099754,0.00562176093020754,-0.00572006699220923,0.0163172358542043,0.345950652383419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42246,-0.0044294899819416,0.00474201660207998,-0.0137238425220184,0.00486486255813516,0.350271855665776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0100084362249821,0.0107380096575453,-0.031054935153771,0.0110380627038068,0.35132410080691
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.0037145671344562,0.00398726202572252,-0.0115296007048723,0.00410046643595995,0.351555317718439
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00780662187741689,0.00838461730659444,-0.024240471798342,0.00862722804350822,0.351840562872265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00481491458713162,0.00517667543995203,-0.0149611984494376,0.00533136927517436,0.35232731536779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.00308510124116169,0.00331810088758337,-0.00958857898082511,0.00341837649850172,0.352501855448087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.0022909732817776,0.00247663670675958,-0.00714518122702637,0.00256323466347118,0.35496465887248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00422028007495795,0.00456908206341269,-0.00473512076933093,0.0131756809192468,0.355683336581951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.0052084183987291,0.00566372628264649,-0.0163093219127162,0.00589248511525802,0.357796923490443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.00611535470406265,0.00665992019746734,-0.0191687982910986,0.00693808888297333,0.358516745610539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42187,0.00271097148501118,0.00295480552178626,-0.00308044733768989,0.00850239030771226,0.358908071463894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,41913,-0.013682211237279,0.0149436061140721,-0.0429716792208604,0.0156072567463024,0.359898740392793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,39757,0.00559718469846927,0.00611442555009393,-0.00638708937971484,0.0175814587766534,0.359998067898521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00252687227525033,0.00276128743043628,-0.00288525108840478,0.00793899563890543,0.360155817547166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00268236374198694,0.00295250278457678,-0.00846926919975744,0.00310454171578355,0.363630754567593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.007599914595153,0.00839554722025877,-0.00885535795655419,0.0240551871468602,0.365362445447658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.004947491798012,0.00547456438857079,-0.00578265440358675,0.0156776379996107,0.366161964535852
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00342034653565913,0.0037864302873826,-0.00400105682761076,0.010841749898929,0.366377222704022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00550346457068481,0.00610230312060206,-0.0174639786870649,0.00645704954569522,0.367147449355917
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00490356786920114,0.00544680874319698,-0.0155793130058672,0.00577217726746495,0.367999308212974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00491977091446584,0.00552334464658834,-0.0059059845928473,0.015745526421779,0.37309390133656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00372259273248471,0.0041912412064138,-0.00449224003208634,0.0119374254970557,0.374460740070452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.00541915916376882,0.00613002895144632,-0.0174340159086036,0.00659569758106597,0.376696164182844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.00300920073334564,0.00340875504074558,-0.00969036061320698,0.00367195914651569,0.377367939594926
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.0106806744600747,0.0121111433248489,-0.0344185153767785,0.0130571664566291,0.377852842249229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0132568045623757,0.0150557154749446,-0.0427660068932671,0.0162523977685156,0.378598235985098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42070,-0.003325169480923,0.00378397633481593,-0.0107417630971622,0.00409142413531622,0.379552477030833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.0068124793718335,0.00776305653666081,-0.0220280701836887,0.00840311144002167,0.380206436181964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00439963612450255,0.00503122780636809,-0.0054615703759789,0.014260842624984,0.381880556653529
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00774539698985701,0.00886802960812252,-0.00963594104206313,0.0251267350217772,0.382460544355096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPGN,Epigen,39919,0.00437454528721806,0.0050370867695468,-0.00549814478109366,0.0142472353555298,0.385156963783904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00243507701604203,0.00281211817426606,-0.00307667460551944,0.0079468286376035,0.386547965776735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,39649,-0.00560947718034823,0.0064867106298479,-0.0183234300148501,0.00710447565415366,0.387186824511759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00259259135949445,0.00300516650835587,-0.00848271771587196,0.00329753499688306,0.388314895929147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.00249520858405431,0.00289637443353835,-0.00817210247378948,0.00318168530568087,0.388984822393073
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,39919,0.00362991241423982,0.00424343855245918,-0.00468722714858018,0.0119470519770598,0.392338058734462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00448628517583671,0.00526122141521857,-0.0058257087979917,0.0147982791496651,0.393839904978829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,39560,0.00613309865108507,0.00720997066335056,-0.00799844384908203,0.0202646411512522,0.394987235871837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00373242946324073,0.00439148086682064,-0.00487487303572772,0.0123397319622092,0.395385314380421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00539141852262563,0.00638420439522106,-0.0179044591372589,0.00712162209200765,0.39840873846791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00590735400523115,0.00700563478644697,-0.0196383981866672,0.00782369017620492,0.399118668967643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,39900,-0.00479883851740089,0.0057189596032273,-0.0160079993397264,0.00641032230492461,0.401425107577951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0036949555393014,0.00441288931062553,-0.00495430750952464,0.0123442185881274,0.402433037950916
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,39757,0.00484164274076371,0.00579388722584305,-0.00651437622188868,0.0161976617034161,0.403371583257228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.00401231797440576,0.00480347926550336,-0.0134271373347923,0.00540250138598082,0.403570207798834
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.0025810156386934,0.00309512417391757,-0.00348542774218504,0.00864745901957184,0.404353534845334
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00501425491182875,0.00602581026953533,-0.0067963332164605,0.016824843040118,0.405353917808561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.0020006073015811,0.0024233926879931,-0.00675045697004757,0.00274924236688537,0.409079601552086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.00286239787712029,0.00348296843364145,-0.00396422025281695,0.00968901600705752,0.411189658099292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.00663821835916055,0.00813278057604659,-0.00930203156989077,0.0225784682882119,0.414386378500049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00424316232120166,0.00522521030725395,-0.0144845745234194,0.00599824988101608,0.416776940583701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,39929,0.00788927332599316,0.00978400156055965,-0.0112873697327038,0.0270659163846901,0.42006131278646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00264072541316398,0.00331128741868257,-0.00913084875378181,0.00384939792745385,0.425179612892627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00271735213591048,0.00343371086794643,-0.00944742543708549,0.00401272116526453,0.428739187691982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00734732409568724,0.00934929747128255,-0.025671947139401,0.0109772989480266,0.431961012476628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.0037600366531404,0.00479720739146805,-0.0131625631404178,0.00564248983413699,0.433175648368961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,39638,0.00669186196641268,0.00854596259121765,-0.0100582247123739,0.0234419486451993,0.433618263874585
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,39919,-0.00225102519675088,0.00288811122138463,-0.00791172319066474,0.00340967279716299,0.435754034944105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00332158914467833,0.00426269616848093,-0.00503329534554429,0.011676473634901,0.435862295218012
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.00249960012853138,0.00321200116583206,-0.00879512241356222,0.00379592215649946,0.436460817261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.00755502434281849,0.00973286471234949,-0.0266314391790235,0.0115213904933865,0.43762170830581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00610306961200961,0.00787202784636351,-0.00932610496686287,0.0215322441908821,0.438187620163348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00288472161579403,0.00376100819787434,-0.00448685445203968,0.0102562976836277,0.443090244806739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00516137097330727,0.00673277705687986,-0.0183576140047918,0.00803487205817726,0.443330841332474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00259620499928913,0.00339038789308782,-0.00924136526974126,0.004048955271163,0.443838844799912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.00456236915284861,0.00598430301615126,-0.0162916030645051,0.00716686475880786,0.445841216551946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.00497879840176764,0.00659153197623495,-0.0178982010751881,0.00794060427165286,0.450062871782248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42144,0.00272153836773046,0.00360516149377903,-0.00434457816007643,0.00978765489553736,0.45032178628307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00297089478873047,0.00393569094362867,-0.0106848490382427,0.00474305946078172,0.450349227273437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,39925,-0.00392897226267188,0.00520894185234949,-0.0141384982932769,0.00628055376793312,0.450700064792285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.0062703685163672,0.00832585145050284,-0.0225890373593528,0.0100483003266184,0.451393633084586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00559869934401149,0.00745215359169277,-0.0202049203837293,0.00900752169570634,0.452496344008548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,41913,0.00763887678518005,0.0102101195308699,-0.012372957495325,0.0276507110656851,0.454372514213195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.00268035541021309,0.00358298686917587,-0.0097030096737978,0.00434229885337161,0.454426042136842
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00332438656819529,0.00446134588825115,-0.00541985137277696,0.0120686245091675,0.456194922139025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00404278327139474,0.00543067334971697,-0.00660133649405052,0.01468690303684,0.456629316799013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,41774,0.00512368588307751,0.00688669897386958,-0.00837424410570687,0.0186216158718619,0.45689133919336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00481024709446901,0.00647403056438934,-0.0174993470006721,0.0078788528117341,0.457493604215369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0102925159922648,0.0139179660288273,-0.0169866974242368,0.0375717294087664,0.459608302566406
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00495096680326592,0.00672869707790622,-0.0181392130759621,0.00823727946943027,0.461868899543717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.00707632210953216,0.00964467913335768,-0.0118272489918489,0.0259798932109132,0.463143257834113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00340041926949933,0.00464154959258405,-0.00569701793196541,0.0124978564709641,0.463815326569687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.00274267148062315,0.00374437590403637,-0.00459630529128813,0.0100816482525344,0.463890016888896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.0029095643137822,0.00397398951200409,-0.0106985837573102,0.00487945512974581,0.464088498557214
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00455183628771811,0.00622380199902922,-0.00764681563037917,0.0167504882058154,0.464574778260793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,41913,-0.00309589373762477,0.00426711684302649,-0.0114594427499567,0.00526765527470715,0.468143658913536
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00257480720051583,0.00354998599606517,-0.00953277975280356,0.0043831653517719,0.468283062536593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00277600595006636,0.00383078147385547,-0.0102843376388231,0.00473232573869035,0.468674752490886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0150442707847889,0.0207975424234266,-0.0558074539347051,0.0257189123651274,0.469466502576177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00366203475562681,0.00513656186373768,-0.0137296960085527,0.00640562649729905,0.475898542619656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42249,-0.00222778360640083,0.00314599246693968,-0.0083939288416026,0.00393836162880095,0.478874262719426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00292608419159966,0.00416669134580131,-0.00524063084617091,0.0110927992293702,0.482533971095616
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00469315201398766,0.00668952342521094,-0.0178046179274011,0.00841831389942578,0.482963806407178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00301805655403189,0.00430450823525827,-0.0114548926951381,0.00541877958707433,0.483231435484425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00230786999219253,0.00331315892880898,-0.00880166149265813,0.00418592150827308,0.486082125096345
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00277687447607047,0.0039989311402975,-0.00506103055891264,0.0106147795110536,0.487443262915108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00334057752752051,0.0048226653085079,-0.012793001532196,0.00611184647715497,0.488522798950149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.00305948230777349,0.00441981173986143,-0.0056033487023549,0.0117223133179019,0.488813695249708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,-0.00274553612268309,0.00398769022194951,-0.0105614089577041,0.00507033671233795,0.491148166969296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.00385960864994027,0.00561427087468277,-0.0148635795643185,0.00714436226443796,0.491804721198892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00363988572999679,0.00531235066391752,-0.00677232157128155,0.0140520930312751,0.493248479178078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.00412492792885216,0.0060299967904358,-0.0159437216381063,0.007693865780402,0.493946565125522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00323731773184156,0.00475397185600102,-0.0125551025696036,0.00608046710592044,0.495904091339024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00675358259045168,0.00994629180243986,-0.0262483145232338,0.0127411493423304,0.497148985540496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,39657,0.00540690288767997,0.00804537635576225,-0.010362034769614,0.021175840544974,0.501565297882457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.00247226707400827,0.00368136043415452,-0.00968773352495112,0.00474319937693458,0.501875690112675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.00225176709807646,0.00336635514939913,-0.00884982319089876,0.00434628899474584,0.50357093480286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00444402697310722,0.00666054054495356,-0.00861063249500177,0.0174986864412162,0.504647228007648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00219830022389086,0.00329870962965127,-0.00866377109800734,0.00426717065022563,0.505159071454089
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42310,0.00123485606305513,0.00187029536701008,-0.00243092285628463,0.00490063498239489,0.509106716572769
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00561305739193585,0.00850527479530002,-0.0222833959907239,0.0110572812068522,0.509299686799112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00302221576609354,0.00462471289692932,-0.00604222151188792,0.012086653044075,0.513452331948262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,39649,-0.00286084631420365,0.0044000392095844,-0.0114849231649891,0.00576323053658177,0.515585245974225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.0043847833460794,0.00674932426043852,-0.00884389220438009,0.0176134588965389,0.515923613609262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00241784814127504,0.00374098206526204,-0.00491447670663856,0.00975017298918865,0.518089700265997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00369939240306313,0.00573030014224072,-0.00753199587572869,0.0149307806818549,0.518559728693462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00374206022586221,0.00579890426733526,-0.0076237921381149,0.0151079125898393,0.518742821927412
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00272781678490691,0.00424755776102084,-0.00559739642669393,0.0110530299965078,0.520751295293143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00459284812158324,0.00715494567097625,-0.0186165416366967,0.00943084539353022,0.520943270963215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00438682479847618,0.00689551371023637,-0.0179020316705395,0.00912838207358711,0.524668671281729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0132426401364325,0.0208225247813806,-0.0540547887079384,0.0275695084350735,0.524802416265371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.00852566893155546,0.0134293714492035,-0.0348472369719944,0.0177958991088835,0.525535640353143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.00208180092637597,0.00329717214683379,-0.00438065648141825,0.0085442583341702,0.527798807320217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00292381315502232,0.00469243492165802,-0.0062733592914274,0.012120985601472,0.533237688759791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.0034318726700876,0.00551628417399897,-0.0142437896511256,0.00738004431095038,0.533866033387845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.00365964801378788,0.00588273800128825,-0.00787051846873709,0.0151898144963128,0.533889320102158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00208068478492933,0.00334767238326894,-0.00864212265613646,0.00448075308627779,0.534262602980317
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.00153677442360701,0.0024812325489877,-0.00639999021962289,0.00332644137240888,0.535692083406685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00325866030026491,0.00529526490883071,-0.0136373795215731,0.00712005892104327,0.538307011583003
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.00492757740254218,0.00802952837194198,-0.0206654530115484,0.0108102982064641,0.539438160538256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42262,0.00305745477624064,0.00499854667520704,-0.00673969670716516,0.0128546062596464,0.540767122257951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00291923275773417,0.00479646996192221,-0.0123203138831017,0.00648184836763338,0.542786008561092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00544706208608359,0.00896834193188579,-0.0230250122725797,0.0121308881004126,0.543620923731719
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.00290052607122843,0.00479115500846342,-0.0122911898878167,0.00649013774535986,0.544931265240372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,39649,0.00315746540888889,0.0052170736925841,-0.00706799902857595,0.0133829298463537,0.545046777845499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00389840391554686,0.00645027722227887,-0.00874413944011972,0.0165409472712134,0.545604651039989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.00311935194363728,0.00516331042209374,-0.00700073648366645,0.013239440370941,0.545761932778107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.00457531458177081,0.00759741395115662,-0.0194662459260378,0.0103156167624962,0.547037712434812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00662798480865776,0.0110076385243945,-0.0149469866991555,0.028202956316471,0.54710274074728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00547210742480946,0.00914073455826169,-0.0233879471590024,0.0124437323093835,0.549416057696364
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00381745214765911,0.00640539889761662,-0.00873712969166946,0.0163720339869877,0.551204705591181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00269192689338576,0.00453208819513317,-0.0115748197558468,0.00619096596907526,0.552543668520925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00211678080297332,0.00356775267014202,-0.00910957603645169,0.00487601443050505,0.552986409034767
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00452661284758321,0.00766380430855975,-0.0104944435971939,0.0195476692923603,0.554768468887164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.00412288478159735,0.00700646210398987,-0.00960978094222278,0.0178555505054175,0.556248908641136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00169198186925808,0.0028982131414207,-0.00737247962644265,0.0039885158879265,0.559365722857654
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00252872838007429,0.00435287632415202,-0.00600290921526367,0.0110603659754123,0.561297729179769
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00337858463716019,0.0058427528439188,-0.014830380211241,0.00807321093692065,0.563105370759294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00231019495243426,0.00399823492933986,-0.00552634550907187,0.0101467354139404,0.563408420164675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00339542772596864,0.00588655379306055,-0.0149330731603673,0.00814221770843005,0.564079024246336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00301509564945695,0.00523870019999738,-0.0132829480414518,0.00725275674253792,0.564936137919507
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00320979107558744,0.00562565917478853,-0.014236083058173,0.00781650090699807,0.568305814843224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00312690518168299,0.00549476936412545,-0.0076428427720029,0.0138966531353689,0.569320679405576
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.00213135405652003,0.00377331699938755,-0.00952705537531964,0.00526434726227957,0.572187704125646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.00180261891175057,0.00320032733837763,-0.00807526049497072,0.00447002267146959,0.573268733806245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,41913,0.00446303947120399,0.00793907765195572,-0.0110975527266292,0.0200236316690372,0.574015825968727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.00513540580419294,0.00922104132556647,-0.0129378351939174,0.0232086468023032,0.577589764521016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.00369161259440728,0.0066299935500522,-0.00930317476369504,0.0166863999525096,0.577670126382982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.00218298561411221,0.00393442129640419,-0.00989445135506442,0.00552848012684,0.579013102968588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00376783475983069,0.00683716964691699,-0.017168687267788,0.00963301774812661,0.581589319940801
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42123,0.00767106502398003,0.0139434809589694,-0.0196581576555999,0.03500028770356,0.582222680424067
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00505239677967052,0.00938326847805262,-0.0234436029966537,0.0133388094373126,0.590278932223832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00229670634098291,0.00429104045336617,-0.0107071456295806,0.00611373294761478,0.592499435600059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.0023855925126556,0.00446816159694329,-0.00637200421735324,0.0111431892426644,0.593413281973519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,0.00181599293875688,0.00341205246140471,-0.00487162988559636,0.00850361576311012,0.594578168775591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00274936891393336,0.00516627471315656,-0.0128752673517202,0.0073765295238535,0.594614602878604
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,41839,0.00261234007815439,0.00492606251011448,-0.00704274244166998,0.0122674225979788,0.595905927203444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00283694061067319,0.0054189662480398,-0.0134581144568312,0.00778423323548481,0.600621134769988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.0023399460943426,0.00448573745304955,-0.0111319915023197,0.00645209931363452,0.601930540779101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00271351798422997,0.00528113491918446,-0.0130645424258315,0.00763750645737156,0.607390806881603
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.00652505779346136,0.0127133530233188,-0.0183931141322436,0.0314432297191663,0.607790686168619
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.00202396590329889,0.0039762831271447,-0.00576954902590473,0.00981748083250251,0.610755726411569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,41913,0.00265351046412174,0.00521642920330352,-0.00757069077435317,0.0128777117025966,0.610982653676581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.00209908131180029,0.00413484597830923,-0.0102033794292864,0.0060052168056858,0.61170254881403
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,39929,0.00523364123039204,0.0103181219776169,-0.014989877845737,0.0254571603065211,0.61200466568875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00420160527174864,0.00839153974146115,-0.0122458126215152,0.0206490231650125,0.616595590079102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,39657,0.0025659830224612,0.00513018323931158,-0.00748917612658949,0.0126211421715119,0.616962689605219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00352463484735803,0.00705223902844009,-0.0102977536483845,0.0173470233431006,0.617233274322993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.0026316470804099,0.00531202421537342,-0.0130432145425418,0.007779920381722,0.620318375829262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,39560,0.00329205579559617,0.00665524211382806,-0.00975221874750682,0.0163363303386992,0.620852843017966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,41913,0.00324054421593854,0.00659029323298591,-0.00967643052071385,0.0161575189525909,0.622929135060545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42119,0.00418159481715476,0.00851831624311187,-0.0125143050193445,0.020877494653654,0.623509016778136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,41900,0.00206795259915016,0.0042193108184807,-0.00620189660507202,0.0103378018033723,0.624059757380124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00224461542261415,0.00458708405332876,-0.00674606932191022,0.0112353001671385,0.624614854010023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00133415212384722,0.00275416632324325,-0.00673231811740398,0.00406401386970954,0.628102634711518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.00183490494846521,0.00383074228665297,-0.00934315983030502,0.0056733499333746,0.6319501878967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,39575,0.00426972289589695,0.00897594225778269,-0.0133231239293571,0.021862569721151,0.634308133412067
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00267764759531262,0.00567452453941802,-0.0137997156925719,0.00844442050194669,0.637027756103974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00880592176494271,0.0187135462626207,-0.0454844724396793,0.0278726289097939,0.637961156975084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.00144507870089049,0.00308650159807093,-0.00749462183310952,0.00460446443132854,0.639655746413378
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,39560,0.00468672523332929,0.0100685693227296,-0.0150476706392207,0.0244211211058793,0.641596465623864
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00261374799044723,0.00563307035340123,-0.0136545658831136,0.00842706990221917,0.642656727655108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00154584235881422,0.00334342825490126,-0.00500727702079225,0.0080989617384207,0.643836123962968
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00184137799478529,0.00398980228162917,-0.00597863447720787,0.00966139046677846,0.644433862074777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00306988032459301,0.00670709823001342,-0.0162157928554193,0.0100760322062333,0.647172539522641
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,39736,-0.00171779944378849,0.00376488901958044,-0.00909698192216616,0.00566138303458917,0.648205967488496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00231094538036724,0.00507054919756505,-0.0122492218075947,0.00762733104686026,0.648572739886692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00223806549332634,0.00492916430029281,-0.0118992275219003,0.00742309653524758,0.649804899299436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.0034012612678787,0.00750968218977374,-0.0181202383598352,0.0113177158240778,0.650617456323476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00239406784750803,0.00538282387923244,-0.00815626695578756,0.0129444026508036,0.656501558490486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00162060349627771,0.00364610647354809,-0.00876697218443197,0.00552576519187655,0.656707912215277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,39757,-0.00170870205002759,0.00386368204937551,-0.00928151886680359,0.00586411476674841,0.658319003440132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.00364712569872987,0.00825837392912352,-0.019833538599812,0.0125392872023522,0.658767414360567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00176270832351072,0.00399192541648922,-0.00958688213982959,0.00606146549280816,0.65881015902698
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00355252166106771,0.00809355394413906,-0.0123108440694449,0.0194158873915803,0.660719011215479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.00180940907520288,0.00413506924746022,-0.00629532664981915,0.00991414480022492,0.661701656724122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00116388651506566,0.00266968267375282,-0.00639646455562118,0.00406869152548985,0.662871094561606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.00170239154027595,0.0039226857013763,-0.0059860724344216,0.00939085551497351,0.664307006501831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00274957864221295,0.00636813608017927,-0.0152311253593643,0.00973196807493841,0.665916085491562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.0015897475773302,0.00369613045972394,-0.00565466812372872,0.00883416327838911,0.667123049109272
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00180672490919585,0.00420976827062556,-0.00644442090123025,0.0100578707196219,0.667803271460834
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.00426702222277638,0.00995990566177831,-0.0237884373198619,0.0152543928743091,0.668353752362888
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00218297657604914,0.00510003687547418,-0.0121790488519785,0.00781309569988025,0.668636299521494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00169979938213486,0.00397242163335376,-0.00608614701923851,0.00948574578350822,0.668732304338723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00763886628857948,0.0180569202135645,-0.0277526973300069,0.0430304299071659,0.672271408866366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00165928908621203,0.00393844180958869,-0.0060600568605818,0.00937863503300586,0.673539859416533
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,41900,0.00121754563536319,0.00295483483870673,-0.00457393064850199,0.00700902191922838,0.680307942844563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0039940111011687,0.00970096722059178,-0.0230079068535286,0.0150198846511912,0.680557834085202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,39575,0.00142898219899465,0.00348017299045668,-0.00539215686230045,0.00825012126028974,0.681368997113293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.00236371323318989,0.00588690096096731,-0.0139020391166858,0.00917461265030603,0.688044549638486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00290443236172621,0.00725843559716463,-0.0171309661321689,0.0113221014087165,0.6890569283857
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,41913,0.00220209031223207,0.0055398214351552,-0.00865595970067212,0.0130601403251363,0.691003656698526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.00146184763691866,0.00367913040047807,-0.00574924794801836,0.00867294322185568,0.69112808807706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,39586,0.00225082034968218,0.00568833176913946,-0.00889830991783116,0.0133999506171955,0.692340852650254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00181764180346995,0.0046348200569543,-0.00726660550816047,0.0109018891151004,0.694939519127673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00201658124211574,0.00515339235373447,-0.0121172302554353,0.00808406777120381,0.695574660570546
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.0017235493337703,0.00443491341528037,-0.0104159796277198,0.00696888096017922,0.697555863738505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00126794443837946,0.00328646659229582,-0.00770941895927926,0.00517353008252034,0.699646240501963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.0010136340675105,0.00266291696437934,-0.00623295131769401,0.00420568318267301,0.703470417610093
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00232508901555978,0.00617092989726574,-0.00976993358308107,0.0144201116142006,0.706343619094412
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,39966,0.00194756399853058,0.00520232803086913,-0.00824899894197291,0.0121441269390341,0.708140554009491
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,39970,0.00143847596173843,0.00386040454429302,-0.00612791694507588,0.00900486886855274,0.709435912965275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.00167872050794635,0.0045512228828777,-0.00724167634249395,0.0105991173583866,0.712246339423023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00213379106627073,0.0058259316892972,-0.00928503504475178,0.0135526171772932,0.714178773659875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00231196118481086,0.00631398993215392,-0.0146873814518325,0.0100634590822108,0.714247892268291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,41913,0.00126015926953705,0.00345950402269836,-0.00552046861495173,0.00804078715402583,0.715669579319151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00269792349773015,0.0074319093381338,-0.0118686188050121,0.0172644658004724,0.716597648481216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,39657,0.00130962196827849,0.00360875636616838,-0.00576354050941153,0.0083827844459685,0.716685636923714
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.0046033064850719,0.0127840097906603,-0.0296599656747662,0.0204533527046224,0.718791876892644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00121990587182944,0.00341262557935259,-0.00546884026370164,0.00790865200736052,0.72074683067014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.00323383231225349,0.00914755326153224,-0.0146953720803497,0.0211630367048567,0.723705204184256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00211621148157894,0.00598772664901145,-0.00961973275048351,0.0138521557136414,0.723776729129745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00155103058029427,0.00440925464951558,-0.0101931696933448,0.00709110853275626,0.725019711283268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.00134335400627502,0.00382159622031587,-0.00883368259809412,0.00614697458554408,0.725206355989262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00161935476067501,0.00462678268235803,-0.0106878488180968,0.00744913929674672,0.726347345075684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.0015185942358438,0.00434311709538835,-0.00699391527111736,0.010031103742805,0.726604065933337
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,39560,0.00227854466917318,0.00652177551957344,-0.0105041353491908,0.0150612246875371,0.726814586752252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00203112520497308,0.00585581073313826,-0.0135085142419241,0.0094462638319779,0.728705773777663
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00151112215881811,0.00438492689519241,-0.007083334555759,0.0101055788733952,0.730388617086218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00207095192650073,0.00607777075432974,-0.00984147875198555,0.013983382604987,0.733304312571425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00169259077530256,0.00505649933679629,-0.0116033294754233,0.00821814792481817,0.737829622779034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00252676978239603,0.00760827277453509,-0.0123854448556928,0.0174389844204848,0.739812791399075
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.00244149827458181,0.00739255603393308,-0.012047911551927,0.0169309081010906,0.74120647413298
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00187151780454634,0.00568441773545739,-0.0130129765660428,0.00926994095695015,0.741983211992215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42145,-0.0013843976508922,0.00421989439425687,-0.00965539066363565,0.00688659536185126,0.742867946534868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.00282196688866193,0.00860807227506594,-0.0196937885477912,0.0140498547704673,0.743046788814396
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,41843,0.00576513101011367,0.0175879588167475,-0.0287072682707114,0.0402375302909387,0.743076748791006
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.000911658096752495,0.00278574147525736,-0.00637171138825692,0.00454839519475193,0.743478442637109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,39966,0.00152175433755025,0.00471451415676735,-0.00771869340971377,0.0107622020848143,0.746867242471504
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.00147446839233631,0.0045696978823173,-0.0104310762416782,0.0074821394570056,0.746957299960681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,39638,0.000638755780799521,0.00198406365711162,-0.00325000898713926,0.0045275205487383,0.747501830125125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,39806,0.00124773646742216,0.00387873202335608,-0.00635457829835575,0.00885005123320007,0.747696061888598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.00192697608897258,0.0061063095192103,-0.0138953427466248,0.0100413905686796,0.752332788806335
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.00173535206246137,0.00556620174115041,-0.0126451074751162,0.00917440335019343,0.755223326214422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.003629968974208,0.0116711532979058,-0.0265054294381034,0.0192454914896874,0.755790677162075
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00240163064546376,0.00772943497688109,-0.0127480619092232,0.0175513232001507,0.756025192742471
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,39586,0.00306457069268635,0.00992119396679916,-0.01638096948224,0.0225101108676127,0.757410057719628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00248311353703097,0.00822569853723083,-0.0136392555959415,0.0186054826700034,0.762753854499397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00131345436600702,0.0043511811865167,-0.00721486075956571,0.00984176949157976,0.762763136709669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,41843,-0.0025600599741614,0.00849680919632679,-0.0192138059989619,0.0140936860506391,0.763193041200578
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00285403459778864,0.00956918598383699,-0.0216096391261091,0.0159015699305319,0.765515992511009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00211054668812586,0.00711275736597483,-0.0160515511254365,0.0118304577491848,0.766680515481754
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000747422869330071,0.0025205032845001,-0.00419276356829012,0.00568760930695026,0.766825417440409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00216841023970115,0.00742182627218866,-0.0123783692537886,0.0167151897331909,0.770164719237296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00303520121851306,0.0104838238435124,-0.0175130935147711,0.0235834959517973,0.772194447790317
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.00130634196440563,0.00454504538119894,-0.00760194698274429,0.0102146309115556,0.773795293598436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,39736,-0.00162698704329371,0.00568017989181332,-0.0127601396312478,0.0095061655446604,0.774552360049575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,39929,0.000831358558255688,0.00290676283028369,-0.00486589658910034,0.00652861370561172,0.774876924628343
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00188345039596056,0.00659095980053929,-0.0110348308130965,0.0148017316050176,0.775065274435514
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTTG1,Securin,39757,-0.00129215100075724,0.00453181680490433,-0.0101745119383697,0.00759020993685525,0.775550840995136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00213175240146477,0.00754099363627813,-0.0126485951256404,0.0169120999285699,0.77742093567632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00129562122485306,0.0045932116394802,-0.0102983160382343,0.00770707358852814,0.777892727997217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00194631532995399,0.00690064520597831,-0.0154715799336715,0.0115789492737635,0.777911791492464
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00806471746494778,0.0289915499097517,-0.0487587203581655,0.064888155288061,0.780883418764564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00151241298737565,0.00543806345842443,-0.00914619139113623,0.0121710173658875,0.780928472815144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,39929,0.000657514603955165,0.00237453180937125,-0.00399656774241249,0.00531159695032282,0.781859762890995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42262,0.00131959292521188,0.0047690378630403,-0.0080277212863471,0.0106669071367709,0.782014633818518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.000856000173187524,0.00310219260747763,-0.00522429733746864,0.00693629768384368,0.782603824930397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00187668831996214,0.0068255434367638,-0.0152547534560192,0.0115013768160949,0.783359218590731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.00145351011694475,0.00532966581509412,-0.00899263488063973,0.0118996551145292,0.785073063090662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.0019054190765991,0.0070715709819965,-0.011954860048114,0.0157656982013122,0.787590185252125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00294389847981656,0.0109400245989439,-0.0243863466937466,0.0184985497341135,0.787862080294403
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00203759839214646,0.00759804721989775,-0.016929770943146,0.0128545741588531,0.788570426191314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.0014022535909877,0.00528638733844849,-0.0117635727743467,0.00895906559237133,0.790815959512299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00216214592883331,0.00816819342334851,-0.0138475131809298,0.0181718050385964,0.791243173102142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.000791633124150117,0.00303277302423315,-0.00515260200334686,0.0067358682516471,0.79407718793801
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.00150685032335803,0.00583678535480967,-0.00993324897206893,0.012946949618785,0.796284849696366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00164102206912414,0.00638811820397191,-0.0108796896106608,0.0141617337489091,0.797271124738594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000946064943793334,0.00369735110056288,-0.00630074321330991,0.00819287310089658,0.798050910302239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00231768747710312,0.00907542090422145,-0.0201055124493772,0.0154701374951709,0.79843296365721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.0016827705356928,0.00668539921990078,-0.0114206119353127,0.0147861530066983,0.801271169771468
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,41814,0.00164860661763375,0.00660179834277113,-0.0112909181341977,0.0145881313694652,0.802807123625981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.00135894953654413,0.0055233462984573,-0.0121847082815204,0.00946680920843217,0.805657127014934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,41843,-0.0035611268309617,0.0144748892976599,-0.0319319098543752,0.0248096561924518,0.805669784258701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00093437761213056,0.0038481849735492,-0.00660806493602587,0.00847682016028699,0.808157162443829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00113860204639164,0.00482943041972649,-0.0106042856690556,0.00832708157627229,0.813620812253367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,39586,-0.00188393039896038,0.00802765972165597,-0.0176181434534061,0.0138502826554853,0.814461561369729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00108761338733811,0.00463832496360773,-0.0101787303160093,0.00800350354133304,0.81461352844299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,39657,-0.000799594021531736,0.00362084817871284,-0.0078964564518089,0.00629726840874543,0.825228425452533
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.00132401006303299,0.00602550138695093,-0.0131339927814568,0.0104859726553908,0.826081382840287
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,39720,-0.000861458584406309,0.00395926182965483,-0.00862161177052978,0.00689869460171716,0.827759889471323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42119,0.0013761931229051,0.0064661419054576,-0.0112974450117918,0.014049831257602,0.831462272603079
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.000983792120713723,0.00465848488035328,-0.0101144224862062,0.00814683824477871,0.832748512493096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,39560,0.00147181232151113,0.0071023847813132,-0.0124488618498627,0.015392486492885,0.835835724837087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00132495104281695,0.00640040991611884,-0.011219852392776,0.0138697544784099,0.836005622476047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,41913,0.000680901042167811,0.00332365141787978,-0.00583345573687656,0.00719525782121218,0.837680452292702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42137,0.000749855966194763,0.00369500358345125,-0.00649235105736969,0.00799206298975921,0.839186684460637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.000963479536808841,0.00483554464394413,-0.00851418796532165,0.0104411470389393,0.842071262157132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.00133299686987079,0.00669944648910146,-0.0144639119885097,0.0117979182487681,0.842288265772467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00119739889654295,0.00610936523311983,-0.0131717547534578,0.0107769569603719,0.844618470775736
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.00159273580224523,0.00812990456818571,-0.0175273487558892,0.0143418771513988,0.844683636720627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,41976,-0.00137791037804585,0.00705062450894577,-0.0151971344155796,0.0124413136594878,0.845058542879745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00331997846163752,0.0169965238735799,-0.029993208330579,0.036633165253854,0.84513592863284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.000956189673629004,0.0049103673356804,-0.0105805096515626,0.00866813030430458,0.845608884273234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,39586,-0.000972712973484458,0.0050610850329567,-0.0108924396380796,0.00894701369111068,0.847593365062557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.000734421855456505,0.00383118665728608,-0.00824354770373721,0.0067747039928242,0.84798404416672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.00126695575830628,0.00672321371639302,-0.011910543125824,0.0144444546424366,0.85053068435784
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000527761900614383,0.00282839310750894,-0.00501588859010314,0.0060714123913319,0.851982102817373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,39560,-0.000861637152777532,0.00466089993914339,-0.00999700103349858,0.00827372672794351,0.853338363513809
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,39575,0.000950901871368148,0.00517584652829373,-0.00919375732408756,0.0110955610668239,0.854237217494123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,41900,0.000641589833625515,0.00351735535953846,-0.00625242667106986,0.00753560633832089,0.855266203278496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00106659592606875,0.00585611672777943,-0.0125445847125164,0.0104113928603789,0.855481200363239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,39979,-0.000649762214232477,0.00360157984839584,-0.00770885871708833,0.00640933428862337,0.856833656805234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00116491137849763,0.00677340728597313,-0.0121109669020097,0.014440789659005,0.863453503297855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.000970594692712693,0.00585994246769121,-0.0124560819293875,0.0105148925439621,0.868449523447495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.000478365779951067,0.00312278263253097,-0.00659901973971178,0.00564228817980964,0.878254103690277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.00056622419769314,0.00372586473106025,-0.00786891907057122,0.00673647067518494,0.87921233661635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.000881436901552194,0.00589047554153977,-0.0106638951598658,0.0124267689629701,0.881053233507813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.000855761605914226,0.00576741908289224,-0.0104483797965546,0.012159903008383,0.882046609447845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,39586,0.000706222383537915,0.00521647084189796,-0.00951806046658209,0.0109305052336579,0.89231140658619
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.000880670149244931,0.00682145493781243,-0.0142507218273573,0.0124893815288674,0.897278534314943
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000608712775853297,0.00478111363438378,-0.0099796954992455,0.00876226994753891,0.898692548040958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.000633934914402784,0.00504204042499708,-0.0092484643185915,0.0105163341473971,0.899948086735687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.0015573834757579,0.0124054556828792,-0.0227573096626854,0.0258720766142012,0.900098114129285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.000488959115222722,0.00424823171592803,-0.00881549327844165,0.00783757504799621,0.908370255074991
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,39657,0.000683695905722185,0.00621420031320267,-0.0114961367081551,0.0128635285195994,0.912394286644664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,39757,0.000603265725737419,0.00562384924159149,-0.0104194787877819,0.0116260102392567,0.914577358856661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00103637957341689,0.0100004466801351,-0.0185644959196479,0.0206372550664817,0.917462229596631
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.000669827574032557,0.00654620373361768,-0.0121607317438581,0.0135003868919232,0.91850211047295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.000346987304637638,0.00353531756392703,-0.00658223512065935,0.00727620972993462,0.921815594843032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,39657,-0.000278936467744773,0.0028487858442152,-0.00586255672240656,0.00530468378691702,0.922002232199369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.000441601046243874,0.00452065742981733,-0.00841888751619808,0.00930208960868583,0.922183795801638
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.000433997362596265,0.00461586494821263,-0.0086130979359005,0.00948109266109303,0.925092621153575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.0026249279253724,0.0282519443393436,-0.052748882979741,0.0579987388304858,0.925975585489532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.000795383386895027,0.00871864360927637,-0.0178839248610767,0.0162931580872867,0.927313158759171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.000371482989795954,0.00435171275385091,-0.00890083998734374,0.00815787400775183,0.931972953860056
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.000493598087818553,0.00598109621450569,-0.0112293504926126,0.0122165466682497,0.934229666158742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.000335718890556908,0.00425978034723772,-0.00801345059002903,0.00868488837114285,0.937184140827108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.000558283432121204,0.00755836164863243,-0.0142561053991984,0.0153726722634408,0.941120725772118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00048717731381488,0.00660089483344095,-0.0134249311873591,0.0124505765597294,0.941167092942823
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.000702101419785754,0.0096401702604795,-0.0181926322907541,0.0195968351303256,0.94194206963872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.000448298833983421,0.00620826590021529,-0.0126164999984054,0.0117199023304385,0.942436099139477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000312100061973278,0.00439946425493605,-0.00831084987770138,0.00893505000164794,0.943446418002713
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.000294577818283138,0.00452221235044369,-0.00915811402515277,0.0085689583885865,0.948063335055712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.000234104571740823,0.00366239868216587,-0.00741240598878592,0.00694419684530428,0.949033994712985
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.000208855811374646,0.00363231027105055,-0.00691047231988444,0.00732818394263373,0.954148399315703
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.00024685754890858,0.0043823106598308,-0.00883618644217695,0.00834247134435979,0.95507958297423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.000276599977919947,0.00519224247417914,-0.00990019527147117,0.0104533952273111,0.957516167068326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.000376211348282383,0.00823900371661051,-0.016524658632839,0.0157722359362742,0.963580292072973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.000117918429171454,0.00260789343942961,-0.00499355271211057,0.00522938957045348,0.963935832710417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCN,Decorin,41900,0.00011145910941107,0.00249016761693474,-0.00476926941978102,0.00499218763860316,0.96429953433013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42145,-0.000225503137313966,0.00513233018447277,-0.0102848702988806,0.00983386402425266,0.964954656837913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.000336008214128442,0.00797395456775165,-0.0159649591669217,0.0152929427386648,0.966389269862913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.000284409527363293,0.00713120499028794,-0.0142615713083277,0.0136927522536011,0.96818748883709
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,39934,-0.000148909483922641,0.00378448078027554,-0.0075664918132627,0.00726867284541742,0.968614108110733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.000138898975204677,0.00368805308008476,-0.00736748301217081,0.00708968506176145,0.969957842532426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,41820,0.000136518693387368,0.00385267951801141,-0.00741473316191499,0.00768777054868973,0.971733619326214
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.000392422897409872,0.011640836444394,-0.0232084623284221,0.0224236165336024,0.973108204891756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.000258908875323483,0.00777191835164466,-0.0149740510939,0.015491868844547,0.973425284683762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.000111786239496631,0.0034948871668858,-0.00696176508659279,0.00673819260759953,0.974483976298019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.000176773560817192,0.00617267304417924,-0.0122752127274085,0.0119216656057741,0.977153665329581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.000266553119276844,0.00931157879565908,-0.0185172475587686,0.017984141320215,0.977163408366423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEB,Nebulin,39575,-0.000122058699715451,0.00432944826875333,-0.00860777730647197,0.00836365990704107,0.977508997212742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.000174510758041764,0.00639661060371833,-0.0127118675413297,0.0123628460252462,0.978235501858991
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,39757,0.00015087585685105,0.00635315228871176,-0.012301302629024,0.0126030543427261,0.981053892823157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42115,0.000185322503419423,0.00798627179376228,-0.0154677702123547,0.0158384152191935,0.981486986321815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.000110695340367886,0.0054147731870768,-0.0105022601063027,0.0107236507870384,0.983690186813566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,9.94429811237617e-05,0.00540404773243428,-0.0104924905744474,0.0106913765366949,0.985318831749083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,41839,-9.15573509430611e-05,0.00549624899860889,-0.0108642053882165,0.0106810906863304,0.986709583454766
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,41913,-9.28491657143127e-05,0.00626010294454598,-0.0123626509370244,0.0121769526055958,0.988166519137425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.000149955802806827,0.0106136536242273,-0.0206528053006787,0.0209527169062924,0.988727659611923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,39657,-9.40228465644045e-05,0.0108962409733879,-0.0214506551544047,0.0212626094612759,0.993115355045851
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-6.24848286930492e-05,0.00771354532223472,-0.0151810336602731,0.015056064002887,0.993536824092121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-2.38688741930145e-05,0.00368911402589405,-0.00725453236494536,0.00720679461655933,0.994837753669328
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,39575,-2.94834438371872e-05,0.00547021355305047,-0.0107511020078161,0.0106921351201417,0.995699667911131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,3.50736154125726e-05,0.00718358294497107,-0.0140447489567307,0.0141148961875559,0.996104457549805
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,39757,-1.1742652741361e-05,0.00300178571567045,-0.00589524265545543,0.00587175734997271,0.996878842004223
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,1.18675296747554e-05,0.00441243538831602,-0.00863650583142464,0.00866024089077415,0.997854087935222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-1.30007704835607e-06,0.00307041226978957,-0.00601930812583592,0.00601670797173921,0.999662165163137
